BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy10841
(286 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 177 bits (450), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 141/241 (58%), Gaps = 12/241 (4%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFE-KHYFEVYAG 101
+VGG ++ G WPW ++L CGG ++ WV+TAAHC DG + + +Y+G
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + + I++H +K +E +D+AL++L APL Y + +PI LP +T
Sbjct: 61 ILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDT 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYED-RIAD-VICAGMPQGG 216
Y+ C GWG E G + +++V +P++ C K Y+D +I ++CAG +GG
Sbjct: 121 STIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
+D C+GDSGGPL+C G W + G+ S GEGCAR +PGVYT+V++++ W++ ++
Sbjct: 181 KDACKGDSGGPLVCK---HNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQS 237
Query: 277 A 277
+
Sbjct: 238 S 238
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 177 bits (450), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 140/241 (58%), Gaps = 12/241 (4%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFE-KHYFEVYAG 101
+VGG + G WPW ++L CGG ++ WV+TAAHC DG + + +Y+G
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + + I++H +K +E +D+AL++L APL Y + +PI LP +T
Sbjct: 61 ILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDT 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYED-RIAD-VICAGMPQGG 216
Y+ C GWG E G + +++V +P++ C K Y+D +I ++CAG +GG
Sbjct: 121 STIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
+D C+GDSGGPL+C G W + G+ S GEGCAR +PGVYT+V++++ W++ ++
Sbjct: 181 KDACKGDSGGPLVCK---HNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQS 237
Query: 277 A 277
+
Sbjct: 238 S 238
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 174 bits (440), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 89/235 (37%), Positives = 131/235 (55%), Gaps = 11/235 (4%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDG--FEKHYFEVYAGML 103
+VGG A+ GAWPW++ LY D CG ++ W+++AAHCV G E + G+
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLH 60
Query: 104 RRFSFSPTEQV-RPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
+ + + + V R + IV++ + R ND+A++ L + Y Y++PI LP+ +
Sbjct: 61 MKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQVF 120
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKHY---EDRIADVICAGMPQGGR 217
P C+ GWG V G D ++E VP+L C+ + ++ICAG +GG
Sbjct: 121 PPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEYNITENMICAGYEEGGI 180
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
D+CQGDSGGPL+C RW++AGV S G CA PN PGVY RVS+F W+ S
Sbjct: 181 DSCQGDSGGPLMCQ---ENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQS 232
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 172 bits (436), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 88/235 (37%), Positives = 131/235 (55%), Gaps = 11/235 (4%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDG--FEKHYFEVYAGML 103
+VGG + GAWPW++ALY D CG ++ W+++AAHCV G E ++ G+
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKWKAVLGLH 60
Query: 104 RRFSF-SPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
+ SP + R + +IV++ + + ND+A++ L + Y Y++PICLP+ +
Sbjct: 61 MASNLTSPQIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPEENQVF 120
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE-----DRIADVICAGMPQGGR 217
P C+ GWGA+ G D ++E VP+L K + + +++CAG GG
Sbjct: 121 PPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEYNITENMVCAGYEAGGV 180
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
D+CQGDSGGPL+C RW +AGV S G CA PN PGVY RV +F W+ S
Sbjct: 181 DSCQGDSGGPLMCQ---ENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQS 232
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 166 bits (419), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 97/241 (40%), Positives = 138/241 (57%), Gaps = 17/241 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRD--GF-FH-CGGVVLDESWVMTAAHCV--DGFEK-HYFEV 98
+VGG A LG +P+ ++ GF FH CG + +E++ +TA HCV D +E ++
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI 60
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV 158
AG L +EQ+ VS+I++H F + ND++LL+L+ L +N V PI LP+
Sbjct: 61 VAGELDMSVNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALPEQ 120
Query: 159 TETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPA----CKHYEDRIAD-VICAGMP 213
T GWG E G PD +++V VP++ + D I D +ICAG+P
Sbjct: 121 GHTAT--GDVIVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGADEILDSMICAGVP 178
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSN 273
+GG+D+CQGDSGGPL GS Y+AG+VS G GCARP PGVYT VS V W+ +N
Sbjct: 179 EGGKDSCQGDSGGPLAASDTGST---YLAGIVSWGYGCARPGYPGVYTEVSYHVDWIKAN 235
Query: 274 S 274
+
Sbjct: 236 A 236
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 164 bits (415), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 88/245 (35%), Positives = 130/245 (53%), Gaps = 22/245 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCV-DGFEKHYFEVYAGMLR 104
+ GG A G WPW +++ +G CGG ++ E WV++AAHC K +EV G +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
S+S +V + I+ H + + D+ALLQL+ P+ ++RY+RPI LP +
Sbjct: 61 LDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPN 120
Query: 165 YSTCTAVGWGAVFEHGP--DPDHMREVQVPIL--------------PACKHYEDRIADVI 208
CT GWG V P +++++VP++ P H+ D++
Sbjct: 121 GLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQE--DMV 178
Query: 209 CAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVP 268
CAG +GG+D CQGDSGGPL CPV +G WY+ G+VS G+ C N PGVYT S +
Sbjct: 179 CAGYVEGGKDACQGDSGGPLSCPV---EGLWYLTGIVSWGDACGARNRPGVYTLASSYAS 235
Query: 269 WLMSN 273
W+ S
Sbjct: 236 WIQSK 240
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 163 bits (412), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 88/245 (35%), Positives = 130/245 (53%), Gaps = 22/245 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCV-DGFEKHYFEVYAGMLR 104
+ GG A G WPW +++ +G CGG ++ E WV++AAHC K +EV G +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
S+S +V + I+ H + + D+ALLQL+ P+ ++RY+RPI LP +
Sbjct: 61 LDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPN 120
Query: 165 YSTCTAVGWGAVFEHGP--DPDHMREVQVPIL--------------PACKHYEDRIADVI 208
CT GWG V P +++++VP++ P H+ D++
Sbjct: 121 GLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQE--DMV 178
Query: 209 CAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVP 268
CAG +GG+D CQGDSGGPL CPV +G WY+ G+VS G+ C N PGVYT S +
Sbjct: 179 CAGYVEGGKDACQGDSGGPLSCPV---EGLWYLTGIVSWGDACGARNRPGVYTLASSYAS 235
Query: 269 WLMSN 273
W+ S
Sbjct: 236 WIQSK 240
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 163 bits (412), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 88/245 (35%), Positives = 130/245 (53%), Gaps = 22/245 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCV-DGFEKHYFEVYAGMLR 104
+ GG A G WPW +++ +G CGG ++ E WV++AAHC K +EV G +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
S+S +V + I+ H + + D+ALLQL+ P+ ++RY+RPI LP +
Sbjct: 61 LDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPN 120
Query: 165 YSTCTAVGWGAVFEHGP--DPDHMREVQVPIL--------------PACKHYEDRIADVI 208
CT GWG V P +++++VP++ P H+ D++
Sbjct: 121 GLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQE--DMV 178
Query: 209 CAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVP 268
CAG +GG+D CQGDSGGPL CPV +G WY+ G+VS G+ C N PGVYT S +
Sbjct: 179 CAGYVEGGKDACQGDSGGPLSCPV---EGLWYLTGIVSWGDACGARNRPGVYTLASSYAS 235
Query: 269 WLMSN 273
W+ S
Sbjct: 236 WIQSK 240
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 160 bits (404), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 84/240 (35%), Positives = 132/240 (55%), Gaps = 21/240 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + E G WPW +L DG CG +++ +W+++AAHC F Y R
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHC--------FTTYKNPARW 52
Query: 106 -----FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTE 160
+ P++ R + RI++H +K D++L +L++P+ Y V +CLPD +
Sbjct: 53 TASFGVTIKPSKMKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDASY 112
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPAC-----KHYEDRIA-DVICAGMPQ 214
+P G+GA+ G +H+R+ QV ++ A + Y D I ++CAG +
Sbjct: 113 EFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAGSLE 172
Query: 215 GGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNS 274
G D CQGDSGGPL+ ++ WY+AG+VS G+ CA+PN+PGVYTRV+ W+ S +
Sbjct: 173 GKTDACQGDSGGPLVS--SDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWITSKT 230
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 159 bits (402), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 129/242 (53%), Gaps = 17/242 (7%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEK--HYFEVYAGM 102
R+VGG+ LG WPW ++L DG CGG +L WV+TAAHC + + V+AG
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGA 176
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMF------KRAEMTNDLALLQLAAPLRYNRYVRPICLP 156
+ + SP V +V H + E +ND+AL+ L++PL Y++P+CLP
Sbjct: 177 VAQ--ASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLP 234
Query: 157 DVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP-----ACKHYEDRIA-DVICA 210
+ CT GWG +G ++E +VPI+ Y ++I + CA
Sbjct: 235 AAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCA 294
Query: 211 GMPQGGRDTCQGDSGGPLLCPVPGSQG-RWYVAGVVSHGEGCARPNEPGVYTRVSQFVPW 269
G P+GG D CQGDSGGP +C S+ RW + G+VS G GCA +PGVYT+VS F W
Sbjct: 295 GYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREW 354
Query: 270 LM 271
+
Sbjct: 355 IF 356
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 159 bits (402), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 91/242 (37%), Positives = 129/242 (53%), Gaps = 17/242 (7%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEK--HYFEVYAGM 102
R+VGG+ LG WPW ++L DG CGG +L WV+TAAHC + + V+AG
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGA 176
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMF------KRAEMTNDLALLQLAAPLRYNRYVRPICLP 156
+ + SP V +V H + E +ND+AL+ L++PL Y++P+CLP
Sbjct: 177 VAQ--ASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLP 234
Query: 157 DVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP-----ACKHYEDRIA-DVICA 210
+ CT GWG +G ++E +VPI+ Y ++I + CA
Sbjct: 235 AAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCA 294
Query: 211 GMPQGGRDTCQGDSGGPLLCPVPGSQG-RWYVAGVVSHGEGCARPNEPGVYTRVSQFVPW 269
G P+GG D CQGDSGGP +C S+ RW + G+VS G GCA +PGVYT+VS F W
Sbjct: 295 GYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREW 354
Query: 270 LM 271
+
Sbjct: 355 IF 356
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 159 bits (401), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 98/243 (40%), Positives = 138/243 (56%), Gaps = 24/243 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFF---HCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++A WPW ++L G + CGG ++ WV+TAAHCV G +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV-GPDVKDLAALRVQ 59
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
LR +Q+ PVSRI++H F A++ D+ALL+L P++ + +V + LP +ET
Sbjct: 60 LREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETF 119
Query: 163 EPYSTCTAVGWGAV--FEHGPDPDHMREVQVPI-----------LPACKHYEDRIA--DV 207
P C GWG V E P P +++V+VPI L A + RI D+
Sbjct: 120 PPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDM 179
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFV 267
+CAG + RD+CQGDSGGPL+C V G W AGVVS GEGCA+PN PG+YTRV+ ++
Sbjct: 180 LCAGNTR--RDSCQGDSGGPLVCKV---NGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 268 PWL 270
W+
Sbjct: 235 DWI 237
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 159 bits (401), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 98/243 (40%), Positives = 138/243 (56%), Gaps = 24/243 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFF---HCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++A WPW ++L G + CGG ++ WV+TAAHCV G +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV-GPDVKDLAALRVQ 59
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
LR +Q+ PVSRI++H F A++ D+ALL+L P++ + +V + LP +ET
Sbjct: 60 LREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETF 119
Query: 163 EPYSTCTAVGWGAV--FEHGPDPDHMREVQVPI-----------LPACKHYEDRIA--DV 207
P C GWG V E P P +++V+VPI L A + RI D+
Sbjct: 120 PPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDM 179
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFV 267
+CAG + RD+CQGDSGGPL+C V G W AGVVS GEGCA+PN PG+YTRV+ ++
Sbjct: 180 LCAGNTR--RDSCQGDSGGPLVCKV---NGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 268 PWL 270
W+
Sbjct: 235 DWI 237
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 159 bits (401), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 98/243 (40%), Positives = 138/243 (56%), Gaps = 24/243 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFF---HCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++A WPW ++L G + CGG ++ WV+TAAHCV G +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV-GPDVKDLAALRVQ 59
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
LR +Q+ PVSRI++H F A++ D+ALL+L P++ + +V + LP +ET
Sbjct: 60 LREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETF 119
Query: 163 EPYSTCTAVGWGAV--FEHGPDPDHMREVQVPI-----------LPACKHYEDRIA--DV 207
P C GWG V E P P +++V+VPI L A + RI D+
Sbjct: 120 PPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDM 179
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFV 267
+CAG + RD+CQGDSGGPL+C V G W AGVVS GEGCA+PN PG+YTRV+ ++
Sbjct: 180 LCAGNTR--RDSCQGDSGGPLVCKV---NGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 268 PWL 270
W+
Sbjct: 235 DWI 237
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 157 bits (396), Expect = 7e-39, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 128/241 (53%), Gaps = 17/241 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEK--HYFEVYAGML 103
+VGG+ LG WPW ++L DG CGG +L WV+TAAHC + + V+AG +
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAV 60
Query: 104 RRFSFSPTEQVRPVSRIVMHSMF------KRAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
+ SP V +V H + E +ND+AL+ L++PL Y++P+CLP
Sbjct: 61 AQ--ASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPA 118
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP-----ACKHYEDRIA-DVICAG 211
+ CT GWG +G ++E +VPI+ Y ++I + CAG
Sbjct: 119 AGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAG 178
Query: 212 MPQGGRDTCQGDSGGPLLCPVPGSQG-RWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
P+GG D CQGDSGGP +C S+ RW + G+VS G GCA +PGVYT+VS F W+
Sbjct: 179 YPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 238
Query: 271 M 271
Sbjct: 239 F 239
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 155 bits (391), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 99/243 (40%), Positives = 136/243 (55%), Gaps = 24/243 (9%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDGFF--HCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++A WPW ++L RD ++ CGG ++ WV+TAAHCV G +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCV-GPDVKDLATLRVQ 59
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
LR +Q+ PVSRI++H F + D+ALL+L P+ + V + LP +ET
Sbjct: 60 LREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETF 119
Query: 163 EPYSTCTAVGWGAVF--EHGPDPDHMREVQVPI-----------LPACKHYEDRIA--DV 207
P C GWG V E P P +++V+VPI L A + RI D+
Sbjct: 120 PPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDM 179
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFV 267
+CAG Q RD+CQGDSGGPL+C V G W AGVVS GEGCA+PN PG+YTRV+ ++
Sbjct: 180 LCAGNSQ--RDSCQGDSGGPLVCKV---NGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 268 PWL 270
W+
Sbjct: 235 DWI 237
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 154 bits (389), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 83/240 (34%), Positives = 124/240 (51%), Gaps = 12/240 (5%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYA 100
R+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+
Sbjct: 387 RIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 446
Query: 101 GMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTE 160
G+L + V I++H +K AE D+ALL+L + Y RPICLP +
Sbjct: 447 GILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGD 506
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQG 215
Y+ C GWG + +++ ++P++ C K Y +ICAG +G
Sbjct: 507 RNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREG 566
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
G+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 567 GKDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 623
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 154 bits (389), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 82/239 (34%), Positives = 123/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + V I++H +K AE D+ALL+L + Y RPICLP +
Sbjct: 61 ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 154 bits (388), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 82/239 (34%), Positives = 124/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + + V I++H +K AE D+ALL+L + Y RPICLP +
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 153 bits (387), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 98/243 (40%), Positives = 136/243 (55%), Gaps = 24/243 (9%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDGFF--HCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++A WPW ++L RD ++ CGG ++ WV+TAAHCV G +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCV-GPDVKDLATLRVQ 59
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
LR +Q+ PVSRI++H F + D+ALL+L P+ + V + LP +ET
Sbjct: 60 LREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETF 119
Query: 163 EPYSTCTAVGWGAVF--EHGPDPDHMREVQVPI-----------LPACKHYEDRIA--DV 207
P C GWG V E P P +++V+VPI L A + RI D+
Sbjct: 120 PPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDM 179
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFV 267
+CAG Q RD+C+GDSGGPL+C V G W AGVVS GEGCA+PN PG+YTRV+ ++
Sbjct: 180 LCAGNSQ--RDSCKGDSGGPLVCKV---NGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 268 PWL 270
W+
Sbjct: 235 DWI 237
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 153 bits (387), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 82/239 (34%), Positives = 123/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + V I++H +K AE D+ALL+L + Y RPICLP +
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 153 bits (386), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 82/239 (34%), Positives = 123/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + V I++H +K AE D+ALL+L + Y RPICLP +
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 152 bits (384), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 82/239 (34%), Positives = 122/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + V I++H +K AE D+ALL+L + Y RPI LP E
Sbjct: 61 ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGER 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 151 bits (381), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 81/239 (33%), Positives = 123/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + + V I++H +K AE D+ALL+L + Y RPI LP +
Sbjct: 61 ILNQSEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 150 bits (380), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 81/239 (33%), Positives = 122/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + V I++H +K AE D+ALL+L + Y RPI LP +
Sbjct: 61 ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 150 bits (379), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 81/239 (33%), Positives = 123/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + + V I++H +K AE D+ALL+L + Y RPI LP +
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 150 bits (379), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 81/239 (33%), Positives = 123/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + + V I++H +K AE D+ALL+L + Y RPI LP +
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 150 bits (379), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 84/239 (35%), Positives = 131/239 (54%), Gaps = 15/239 (6%)
Query: 39 PIL-GSGRVVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYF 96
P+L G R+V G++A G+WPW ++L + GF CGG +++E+WV+TAAHC G
Sbjct: 8 PVLSGLSRIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV 65
Query: 97 EVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP 156
V AG + S S Q ++++ +S + + ND+ LL+L+ +++ V +CLP
Sbjct: 66 -VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLP 124
Query: 157 DVTETPEPYSTCTAVGWGAV-FEHGPDPDHMREVQVPILP--ACKHY-EDRIAD-VICAG 211
++ +TC GWG + + PD +++ +P+L CK Y +I D +ICAG
Sbjct: 125 SASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAG 184
Query: 212 MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
G +C GDSGGPL+C G W + G+VS G + PGVY RV+ V W+
Sbjct: 185 AS--GVSSCMGDSGGPLVCK---KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV 238
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 150 bits (378), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 96/243 (39%), Positives = 135/243 (55%), Gaps = 24/243 (9%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDGFF--HCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++A WPW ++L RD ++ CGG ++ WV+TAAHC+ G +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCL-GPDVKDLATLRVQ 59
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
LR +Q+ PVSRI++H F + D+ALL+L P+ + V + LP +ET
Sbjct: 60 LREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETF 119
Query: 163 EPYSTCTAVGWGAV--FEHGPDPDHMREVQVPI-----------LPACKHYEDRIA--DV 207
P C GWG V E P P +++V+VPI L A + RI D+
Sbjct: 120 PPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDM 179
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFV 267
+CAG Q RD+C+GDSGGPL+C V G W AGVVS EGCA+PN PG+YTRV+ ++
Sbjct: 180 LCAGNSQ--RDSCKGDSGGPLVCKV---NGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYL 234
Query: 268 PWL 270
W+
Sbjct: 235 DWI 237
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 150 bits (378), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 81/239 (33%), Positives = 122/239 (51%), Gaps = 12/239 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
+VGG + G WPW + L+ CGG ++ W++TAAHC G E VY+G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+L + V I++H +K AE D+ALL+L + Y RPI LP +
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDR 120
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--AC-KHYEDR--IADVICAGMPQGG 216
Y+ C GWG + +++ ++P++ C K Y +ICAG +GG
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG 180
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+D C+GDSGGPL C W++ G+ S GEGCA+ PGVYT V ++V W++ ++
Sbjct: 181 KDACKGDSGGPLSCK---HNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 149 bits (375), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 129/238 (54%), Gaps = 13/238 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG+ A+ G +PW + L CGG +++E W++TAAHCV+ K V AG
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK--ITVVAGEHNI 58
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAPLRYNRYVRPICLPD--VTET 161
TEQ R V RI+ H F A T +D+ALL+L PL N YV PIC+ D T
Sbjct: 59 EETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDR----IADVICAGMPQGGR 217
+ + GWG VF G ++ ++VP++ ++ CAG +GGR
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGR 178
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
D+CQGDSGGP + V G+ ++ G++S GE CA + G+YT+VS++V W+ ++
Sbjct: 179 DSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 148 bits (374), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 93/245 (37%), Positives = 132/245 (53%), Gaps = 36/245 (14%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG K E + PW +A+YR + CGGV+LD +WV+TAAHC D ++V+ G
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCYDD----NYKVWLGKNNL 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEM-----------TNDLALLQLAAPLRYNRYVRPIC 154
F P+ Q R VS+ + H F + M +NDL LL+L+ P V+PI
Sbjct: 57 FKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKPIT 116
Query: 155 LPDVTETPEPYSTCTAVGWGAV----FEHGPDPDHMREVQVPILP----ACKHYEDRIAD 206
LP TE P+ STC A GWG++ F+ D + V + +LP A H E
Sbjct: 117 LP--TEEPKLGSTCLASGWGSITPTKFQF---TDDLYCVNLKLLPNEDCAKAHIEKVTDA 171
Query: 207 VICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQ 265
++CAG GG+DTC+GDSGGPL+C + G+ S G C P+ PGVYT++++
Sbjct: 172 MLCAGEMDGGKDTCKGDSGGPLIC-------DGVLQGITSWGHTPCGEPDMPGVYTKLNK 224
Query: 266 FVPWL 270
F W+
Sbjct: 225 FTSWI 229
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 148 bits (373), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 83/238 (34%), Positives = 130/238 (54%), Gaps = 13/238 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG+ A+ G +PW + L CGG +++E WV+TAAHC++ K V AG
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVK--ITVVAGEYNT 58
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRA--EMTNDLALLQLAAPLRYNRYVRPICLPD--VTET 161
PTEQ R V R + H + + ++D+ALL+L PL N YV PIC+ D T
Sbjct: 59 EETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADKEYTNI 118
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDR----IADVICAGMPQGGR 217
+ + GWG VF G ++ ++VP++ +++ CAG +GG+
Sbjct: 119 FLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKFTIYSNMFCAGFHEGGK 178
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
D+CQGDSGGP + V G+ ++ G++S GE CA + G+YT+VS++V W+ ++
Sbjct: 179 DSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAVKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 147 bits (372), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 129/238 (54%), Gaps = 13/238 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG+ A+ G +PW + L CGG +++E W++TAAHCV+ K V AG
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK--ITVVAGEHNI 58
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAPLRYNRYVRPICLPD--VTET 161
TEQ R V RI+ H F A T +D+ALL+L PL N YV PIC+ D T
Sbjct: 59 EETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDR----IADVICAGMPQGGR 217
+ + GWG VF G ++ ++VP++ ++ CAG +GGR
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGR 178
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
D+CQGDSGGP + V G+ ++ G++S GE CA + G+YT+VS++V W+ ++
Sbjct: 179 DSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 147 bits (371), Expect = 6e-36, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 129/238 (54%), Gaps = 13/238 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG+ A+ G +PW + L CGG +++E W++TAAHCV+ K V AG
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK--ITVVAGEHNI 58
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAPLRYNRYVRPICLPD--VTET 161
TEQ R V RI+ H + A T +D+ALL+L PL N YV PIC+ D T
Sbjct: 59 EETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDR----IADVICAGMPQGGR 217
+ + GWG VF G ++ ++VP++ ++ CAG +GGR
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTITNNMFCAGFHEGGR 178
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
D+CQGDSGGP + V G+ ++ G++S GE CA + G+YT+VS++V W+ ++
Sbjct: 179 DSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 147 bits (370), Expect = 9e-36, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 129/238 (54%), Gaps = 13/238 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG+ A+ G +PW + L CGG +++E W++TAAHCV+ K V AG
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK--ITVVAGEHNI 58
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRA--EMTNDLALLQLAAPLRYNRYVRPICLPD--VTET 161
TEQ R V RI+ H + A + +D+ALL+L PL N YV PIC+ D T
Sbjct: 59 EETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDR----IADVICAGMPQGGR 217
+ + GWG VF G ++ ++VP++ ++ CAG +GGR
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGR 178
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
D+CQGDSGGP + V G+ ++ G++S GE CA + G+YT+VS++V W+ ++
Sbjct: 179 DSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 146 bits (369), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 80/231 (34%), Positives = 126/231 (54%), Gaps = 14/231 (6%)
Query: 46 VVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
+V G++A G+WPW ++L + GF CGG +++E+WV+TAAHC G V AG
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFD 57
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ S S Q ++++ +S + + ND+ LL+L+ +++ V +CLP ++
Sbjct: 58 QGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAA 117
Query: 165 YSTCTAVGWGAV-FEHGPDPDHMREVQVPILP--ACKHY-EDRIAD-VICAGMPQGGRDT 219
+TC GWG + + PD +++ +P+L CK Y +I D +ICAG G +
Sbjct: 118 GTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSS 175
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
C GDSGGPL+C G W + G+VS G + PGVY RV+ V W+
Sbjct: 176 CMGDSGGPLVCK---KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV 223
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 145 bits (367), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 85/238 (35%), Positives = 129/238 (54%), Gaps = 13/238 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG+ A+ G +PW + L CGG +++E W++TAAHCV+ K V AG
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK--ITVVAGEHNI 58
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRA--EMTNDLALLQLAAPLRYNRYVRPICLPD--VTET 161
TEQ R V RI+ H + A + +D+ALL+L PL N YV PIC+ D T
Sbjct: 59 EETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDR----IADVICAGMPQGGR 217
+ + GWG VF G ++ ++VP++ ++ CAG +GGR
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGR 178
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
D+CQGD+GGP + V G+ ++ G++S GE CA + G+YT+VS++V W+ ++
Sbjct: 179 DSCQGDAGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 144 bits (363), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 91/238 (38%), Positives = 127/238 (53%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 78
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 79 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYV 132
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G ++E Q+P++ C YE R+ +CAG
Sbjct: 133 VADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 188
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGDSGGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 189 LAGGTDSCQGDSGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 243
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 144 bits (363), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 91/238 (38%), Positives = 127/238 (53%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 75
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 76 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYV 129
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G ++E Q+P++ C YE R+ +CAG
Sbjct: 130 VADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 185
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGDSGGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 186 LAGGTDSCQGDSGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 240
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 143 bits (361), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 92/243 (37%), Positives = 128/243 (52%), Gaps = 24/243 (9%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYF 96
P GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + +
Sbjct: 555 PKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSY 614
Query: 97 EVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP 156
+V G + + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 615 KVILGAHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLP 668
Query: 157 DVTETPEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV- 207
+ C GWG F G ++E Q+P++ C YE R+
Sbjct: 669 SPNYVVADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTE 724
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFV 267
+CAG GG D+CQGDSGGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV
Sbjct: 725 LCAGHLAGGTDSCQGDSGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFV 781
Query: 268 PWL 270
W+
Sbjct: 782 TWI 784
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 143 bits (360), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 127/238 (53%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 78
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 79 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYV 132
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G ++E Q+P++ C YE R+ +CAG
Sbjct: 133 VADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 188
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGD+GGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 189 LAGGTDSCQGDAGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 243
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 143 bits (360), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 77/237 (32%), Positives = 127/237 (53%), Gaps = 19/237 (8%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEV 98
P+ ++VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V
Sbjct: 16 PVDDDDKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQV 70
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV 158
G EQ ++I+ H F R + ND+ L++L++P++ N +V + LP
Sbjct: 71 RLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALP-- 128
Query: 159 TETPEPYSTCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMP 213
+ + C GWG G +PD ++ + P+LP Y +I D ++C G
Sbjct: 129 SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 188
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+GG+D+CQGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 189 EGGKDSCQGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 238
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 143 bits (360), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 127/238 (53%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 18 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 77
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 78 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYV 131
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G ++E Q+P++ C YE R+ +CAG
Sbjct: 132 VADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 187
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGD+GGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 188 LAGGTDSCQGDAGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 242
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 143 bits (360), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 127/238 (53%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 75
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 76 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYV 129
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G ++E Q+P++ C YE R+ +CAG
Sbjct: 130 VADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 185
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGD+GGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 186 LAGGTDSCQGDAGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 240
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 142 bits (359), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 127/238 (53%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 17 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 76
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 77 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYV 130
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G ++E Q+P++ C YE R+ +CAG
Sbjct: 131 VADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 186
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGD+GGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 187 LAGGTDSCQGDAGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 241
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 142 bits (358), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 91/238 (38%), Positives = 127/238 (53%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
GRVVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 15 GRVVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 74
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 75 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYM 128
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G ++E Q+P++ C YE R+ +CAG
Sbjct: 129 VADRTECFITGWGETQGTFGAG----LLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 184
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGDSGGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 185 LAGGTDSCQGDSGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 239
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 140 bits (354), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 76/239 (31%), Positives = 126/239 (52%), Gaps = 19/239 (7%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEV 98
P+ ++VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V
Sbjct: 4 PVDDDDKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQV 58
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV 158
G EQ ++I+ H F R + ND+ L++L++P++ N V + LP
Sbjct: 59 RLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP-- 116
Query: 159 TETPEPYSTCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMP 213
+ + C GWG G +PD ++ + P+LP Y +I D ++C G
Sbjct: 117 SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 176
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+GG+D+CQGD+GGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 177 EGGKDSCQGDAGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 228
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 140 bits (353), Expect = 8e-34, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 125/238 (52%), Gaps = 19/238 (7%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEV 98
P+ +VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V
Sbjct: 4 PVDDDDAIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQV 58
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV 158
G EQ ++I+ H F R + ND+ L++L++P++ N V + LP
Sbjct: 59 RLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP-- 116
Query: 159 TETPEPYSTCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMP 213
+ + C GWG G +PD ++ + P+LP Y +I D ++C G
Sbjct: 117 SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFL 176
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLM 271
+GG+D+CQGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 177 EGGKDSCQGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 227
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 140 bits (352), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 125/235 (53%), Gaps = 21/235 (8%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
E V V ++ H+ F + D+A+L+L P+ + V P LP T P
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLP--TAPP 114
Query: 163 EPYSTCTAVGWGAVFEHGPD-PDHMREVQVPILPACK---HYEDRI-ADVICAGMPQGGR 217
+ C GWG G D PD ++ + P+L K Y +I +++ C G +GG+
Sbjct: 115 ATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGK 174
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
D+CQGDSGGP++C + GVVS G+GCA+ N+PGVYT+V +V W+ +
Sbjct: 175 DSCQGDSGGPVVC-------NGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 222
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 139 bits (351), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 123/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG E + P+ ++L G+ CGG +++E WV++A HC K +V G
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H + R + ND+ L++L++ N +V I LP T P
Sbjct: 56 EVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLP--TAPPATG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACK---HYEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G D PD ++ + P+L K Y +I +++ C G +GG+D+C
Sbjct: 114 TKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD+GGP++C + GVVS G+GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDAGGPVVC-------NGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWI 216
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 139 bits (351), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 79/230 (34%), Positives = 122/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG E + P+ ++L G+ CGG +++E WV++A HC K +V G
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H + R + ND+ L++L++ N V I LP T P
Sbjct: 56 EVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLP--TAPPATG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACK---HYEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G D PD ++ + P+L K Y +I +++ C G +GG+D+C
Sbjct: 114 TKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + GVVS G+GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWI 216
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 139 bits (350), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 125/238 (52%), Gaps = 24/238 (10%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAG 101
G VVGG A +WPW ++L R G CGG ++ WV+TAAHC++ + ++V G
Sbjct: 16 GAVVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 75
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ + P Q VSR+ + K D+ALL+L++P V P CLP
Sbjct: 76 AHQEVNLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYV 129
Query: 162 PEPYSTCTAVGWG---AVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADV-ICAGM 212
+ C GWG F G + E Q+P++ C YE R+ +CAG
Sbjct: 130 VADRTECFITGWGETQGTFGAG----LLMEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 185
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GG D+CQGDSGGPL+C + ++ + GV S G GCARPN+PGVY RVS+FV W+
Sbjct: 186 LAGGTDSCQGDSGGPLVC---FEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 240
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 76/230 (33%), Positives = 123/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 123/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V I LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G + PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 139 bits (349), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 89/250 (35%), Positives = 129/250 (51%), Gaps = 25/250 (10%)
Query: 46 VVGGKKAELGAWPWLIAL-----YRDGFFH-CGGVVLDESWVMTAAHCVDGFEKHY---- 95
VVGG AE GAWPW+++L + + +H CGG++L+ WV+TAAHC +K
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 96 ----FEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVR 151
EV G + P Q R V I++H + ND+AL+++ P+ ++
Sbjct: 61 IFGANEVVWGSNK--PVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIG 118
Query: 152 PICLPDVTE-TPEPYSTCTAVGWGAVFEHGPDPD-HMREVQVPILP-----ACKHYEDRI 204
P CLP P TC GWG + E GP ++E +V ++ + + Y RI
Sbjct: 119 PGCLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNGRI 178
Query: 205 ADV-ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRV 263
+CAG P+G DTCQGDSGGPL+C ++ + V G+ S G GCAR PGVYT
Sbjct: 179 RSTNVCAGYPRGKIDTCQGDSGGPLMC-RDRAENTFVVVGITSWGVGCARAKRPGVYTST 237
Query: 264 SQFVPWLMSN 273
++ W+ S
Sbjct: 238 WPYLNWIASK 247
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 138 bits (348), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 82/231 (35%), Positives = 122/231 (52%), Gaps = 18/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + + P ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+EQ SR++ H + + ND+ L++L+ P N YV+P+ LP T
Sbjct: 56 KVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--TSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGGRDTCQ 221
+ CT GWG D + ++ + +PIL C + Y I + + CAG +GG+D+CQ
Sbjct: 114 TMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
GDSGGP++C + GVVS G GCA P PGVY +V F WL S
Sbjct: 174 GDSGGPVVC-------NGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 217
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 138 bits (347), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 83/232 (35%), Positives = 124/232 (53%), Gaps = 18/232 (7%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++VGG + + + P ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 20 KIVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHN 74
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+EQ SR++ H + + ND+ L++L+ P N YV+P+ LP T
Sbjct: 75 IKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--TSCAPA 132
Query: 165 YSTCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGGRDTC 220
+ CT GWG D + ++ + +PIL C + Y I + + CAG +GG+D+C
Sbjct: 133 GTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSC 192
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
QGDSGGP++C G + GVVS G GCA P PGVY +V F WL S
Sbjct: 193 QGDSGGPVVC-----NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 237
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 138 bits (347), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 76/230 (33%), Positives = 123/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G + PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 137 bits (346), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 90/243 (37%), Positives = 128/243 (52%), Gaps = 32/243 (13%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVYAGMLR 104
VVGG E + PW +A+Y CGGV+LD +WV+TAAHC VD +EV+ G +
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHCYVD-----QYEVWLGKNK 55
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKR-----------AEMTNDLALLQLAAPLRYNRYVRPI 153
F P+ Q R VS+ H F A+ ++DL LL+L+ P V+PI
Sbjct: 56 LFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKPI 115
Query: 154 CLPDVTETPEPYSTCTAVGWGAVF-EHGPDPDHMREVQVPILP---ACKHYEDRIADV-I 208
LP T+ P+P S C A GWG++ PD ++ V + +LP K Y ++ DV +
Sbjct: 116 ALP--TKEPKPGSKCLASGWGSITPTRWQKPDDLQCVFITLLPNENCAKVYLQKVTDVML 173
Query: 209 CAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFV 267
CAG GG+DTC+ DSGGPL+C + G S+G C +P P +YT + +F
Sbjct: 174 CAGEMGGGKDTCRDDSGGPLIC-------DGILQGTTSYGPVPCGKPGVPAIYTNLIKFN 226
Query: 268 PWL 270
W+
Sbjct: 227 SWI 229
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 137 bits (346), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 123/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD+GGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDAGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 137 bits (345), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+V G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVKWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 137 bits (345), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 128/241 (53%), Gaps = 14/241 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH-CGGVVLDESWVMTAAHC-VD--GF---EKHYFEV 98
VVGG A+ G WPW ++L+ G H CG ++ +W+++AAHC +D GF + +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 99 YAGMLRRFSFS-PTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
+ G+ + S P Q R + RI+ H F D+ALL+L P Y+ VRPICLPD
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMR--EVQVPILPACKHY--EDRIADVICAGMP 213
+ GWG G ++ E++V C++ + ++C G
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQQITPRMMCVGFL 180
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSN 273
GG D+CQGDSGGPL + GR + AGVVS G+GCA+ N+PGVYTR+ F W+ N
Sbjct: 181 SGGVDSCQGDSGGPL--SSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKEN 238
Query: 274 S 274
+
Sbjct: 239 T 239
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 137 bits (345), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 76/230 (33%), Positives = 122/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 137 bits (345), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 123/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + N++ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 137 bits (345), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+V G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVEWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 137 bits (345), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 128/241 (53%), Gaps = 14/241 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH-CGGVVLDESWVMTAAHC-VD--GF---EKHYFEV 98
VVGG A+ G WPW ++L+ G H CG ++ +W+++AAHC +D GF + +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 99 YAGMLRRFSFS-PTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
+ G+ + S P Q R + RI+ H F D+ALL+L P Y+ VRPICLPD
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMR--EVQVPILPACKHY--EDRIADVICAGMP 213
+ GWG G ++ E++V C++ + ++C G
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFL 180
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSN 273
GG D+CQGDSGGPL + GR + AGVVS G+GCA+ N+PGVYTR+ F W+ N
Sbjct: 181 SGGVDSCQGDSGGPL--SSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKEN 238
Query: 274 S 274
+
Sbjct: 239 T 239
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 137 bits (345), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 83/231 (35%), Positives = 123/231 (53%), Gaps = 18/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + + P ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 1 IVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+EQ SR++ H + + ND+ L++L+ P N YV+P+ LP T
Sbjct: 56 KVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--TSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGGRDTCQ 221
+ CT GWG D + ++ + +PIL C + Y I + + CAG +GG+D+CQ
Sbjct: 114 TMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
GDSGGP++C G + GVVS G GCA P PGVY +V F WL S
Sbjct: 174 GDSGGPVVC-----NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 217
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 137 bits (344), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD GGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDCGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 137 bits (344), Expect = 9e-33, Method: Compositional matrix adjust.
Identities = 82/231 (35%), Positives = 123/231 (53%), Gaps = 18/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + + P ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+EQ SR++ H + + ND+ L++L+ P N YV+P+ LP +
Sbjct: 56 KVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGGRDTCQ 221
+ CT GWG D + ++ + +PIL C + Y I + + CAG +GG+D+CQ
Sbjct: 114 TMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
GDSGGP++C G + GVVS G GCA P PGVY +V F WL S
Sbjct: 174 GDSGGPVVC-----NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 217
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 137 bits (344), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 82/231 (35%), Positives = 120/231 (51%), Gaps = 18/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + + ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 1 IVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+EQ SR++ H + + ND+ L++L+ P N YV+P+ LP T
Sbjct: 56 KVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--TSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTCQ 221
+ CT GWG D D ++ + +PIL Y I + + CAG +GG+D+CQ
Sbjct: 114 TMCTVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSYPGMITNAMFCAGYLEGGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
GDSGGP++C G + GVVS G GCA P PGVY +V F WL S
Sbjct: 174 GDSGGPVVC-----NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFSDWLTS 217
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 137 bits (344), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 123/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + N++ L++L++P++ N V + LP +
Sbjct: 56 NVLEGDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 137 bits (344), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 137 bits (344), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 75/229 (32%), Positives = 121/229 (52%), Gaps = 19/229 (8%)
Query: 48 GGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFS 107
GG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNINV 65
Query: 108 FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYST 167
EQ ++I+ H F R + ND+ L++L++P++ N V + LP + +
Sbjct: 66 LEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAGTQ 123
Query: 168 CTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTCQG 222
C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+CQG
Sbjct: 124 CLISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQG 183
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLM 271
DSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 184 DSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 225
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 137 bits (344), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 82/232 (35%), Positives = 123/232 (53%), Gaps = 18/232 (7%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++VGG + + + ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 15 KIVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHN 69
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+EQ SR++ H + + ND+ L++L+ P N YV+P+ LP T
Sbjct: 70 IKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--TSCAPA 127
Query: 165 YSTCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGGRDTC 220
+ CT GWG D + ++ + +PIL C + Y I + + CAG +GG+D+C
Sbjct: 128 GTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSC 187
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
QGDSGGP++C G + GVVS G GCA P PGVY +V F WL S
Sbjct: 188 QGDSGGPVVC-----NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 232
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 136 bits (343), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 136/252 (53%), Gaps = 26/252 (10%)
Query: 45 RVVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEV 98
+++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + V
Sbjct: 23 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIV 82
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRP 152
Y G R S + E V +++H + + ND+ALL++ + + +R ++
Sbjct: 83 YLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQT 142
Query: 153 ICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DR 203
ICLP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 143 ICLPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEV 200
Query: 204 IADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRV 263
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRV
Sbjct: 201 TTKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRV 257
Query: 264 SQFVPWLMSNSE 275
S F+PW+ S+++
Sbjct: 258 SHFLPWIRSHTK 269
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 136 bits (343), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 82/231 (35%), Positives = 123/231 (53%), Gaps = 18/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + + P ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KTRVEVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+EQ SR++ H + + ND+ L++L+ P N YV+P+ LP +
Sbjct: 56 KVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGGRDTCQ 221
+ CT GWG D + ++ + +PIL C + Y I + + CAG +GG+D+CQ
Sbjct: 114 TMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
GDSGGP++C G + GVVS G GCA P PGVY +V F WL S
Sbjct: 174 GDSGGPVVC-----NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNNWLTS 217
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 136 bits (343), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+ +C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKSSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 136 bits (342), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 75/229 (32%), Positives = 121/229 (52%), Gaps = 19/229 (8%)
Query: 48 GGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFS 107
GG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNINV 65
Query: 108 FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYST 167
EQ ++I+ H F R + ND+ L++L++P++ N V + LP + +
Sbjct: 66 LEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAGTQ 123
Query: 168 CTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTCQG 222
C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+CQG
Sbjct: 124 CLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQG 183
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLM 271
DSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 184 DSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 225
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 81/248 (32%), Positives = 129/248 (52%), Gaps = 21/248 (8%)
Query: 46 VVGGKKAELGAWPWLIAL-----YRDGFFH-CGGVVLDESWVMTAAHCVDGFEK--HYFE 97
++GG+ A GAWPW+++L + + +H CGG +L+ W++TAAHC +K +
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 98 VYAGMLRRFS----FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPI 153
++ + P Q R V +I++H + + ND+AL+++ P+ ++ P
Sbjct: 61 IFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPG 120
Query: 154 CLPDVTETPEPY-STCTAVGWGAVFEHGPDPDHM-REVQVPILP-----ACKHYEDRIAD 206
CLP P TC GWG + E+ M +E +V ++ + + Y RI
Sbjct: 121 CLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYNGRIRS 180
Query: 207 V-ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQ 265
+CAG P+G DTCQGDSGGPL+C ++ + V G+ S G GCAR PGVYT
Sbjct: 181 TNVCAGYPEGKIDTCQGDSGGPLMCK-DSAENSYVVVGITSWGVGCARAKRPGVYTSTWS 239
Query: 266 FVPWLMSN 273
++ W+ S
Sbjct: 240 YLNWIASK 247
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 80/251 (31%), Positives = 135/251 (53%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
CLP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 121 CLPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 82/236 (34%), Positives = 124/236 (52%), Gaps = 28/236 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDG-----FEKHYFEVYA 100
+VGG + + + P ++L G+ CGG +++E+WV++AAHC +H +V
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVAVRLGEHNIKVTE 59
Query: 101 GMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTE 160
G +EQ SR++ H + + ND+ L++L+ P N YV+P+ LP +
Sbjct: 60 G---------SEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP--SS 108
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGG 216
+ CT GWG D D ++ + +PIL C + Y I + + CAG +GG
Sbjct: 109 CAPAGTMCTVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGG 168
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+D+CQGDSGGP++C G + GVVS G GCA P PGVY +V F WL S
Sbjct: 169 KDSCQGDSGGPVVC-----NGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 217
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 135 bits (341), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 80/251 (31%), Positives = 135/251 (53%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
CLP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 121 CLPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 135 bits (340), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 134/250 (53%), Gaps = 26/250 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
CLP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 121 CLPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNS 274
F+PW+ S++
Sbjct: 236 HFLPWIRSHT 245
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 135 bits (340), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 85/233 (36%), Positives = 126/233 (54%), Gaps = 36/233 (15%)
Query: 58 PWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPV 117
PW +A+YR + CGGV+LD +WV+TAAHC + ++V+ G P++Q R V
Sbjct: 16 PWHVAVYRFNKYQCGGVLLDRNWVLTAAHCYND----KYQVWLGKNNFLEDEPSDQHRLV 71
Query: 118 SRIVMHSMFKRA-----------EMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYS 166
S+ + H F + + +NDL LL+L+ P V+PI LP TE P+ S
Sbjct: 72 SKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLP--TEEPKLGS 129
Query: 167 TCTAVGWGAV----FEHGPDPDHMREVQVPILP---ACKHYEDRIAD-VICAGMPQGGRD 218
TC A GWG+ F++ PD ++ V + +LP K +E ++ D ++CAG GG
Sbjct: 130 TCLASGWGSTTPIKFKY---PDDLQCVNLKLLPNEDCDKAHEMKVTDAMLCAGEMDGGSY 186
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHG-EGCARPNEPGVYTRVSQFVPWL 270
TC+ DSGGPL+C + G+ S G E C P EP VYT++ +F W+
Sbjct: 187 TCEHDSGGPLIC-------DGILQGITSWGPEPCGEPTEPSVYTKLIKFSSWI 232
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 135 bits (340), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 133/250 (53%), Gaps = 26/250 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
CLP + P+ ++C G+G E D + ++++ ++ H E +
Sbjct: 121 CLPSMYNDPQFGTSCEITGFGK--EQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNS 274
F+PW+ S++
Sbjct: 236 HFLPWIRSHT 245
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 135 bits (339), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 80/251 (31%), Positives = 134/251 (53%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
CLP + P+ ++C G+G E D + ++++ ++ H E +
Sbjct: 121 CLPSMYNDPQFGTSCEITGFGK--EASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 134 bits (338), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPA--CKHYEDRIA--DVICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP C+ I +++C G +GG+D C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASSSFIITDNMVCVGFLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 134 bits (338), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 74/229 (32%), Positives = 121/229 (52%), Gaps = 19/229 (8%)
Query: 48 GGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFS 107
GG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNINV 65
Query: 108 FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYST 167
EQ ++I+ H F R + ND+ L++L++P++ N V + LP + +
Sbjct: 66 LEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAGTQ 123
Query: 168 CTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTCQG 222
C GWG G +PD ++ + P+LP Y +I D ++C G +GG+D+CQG
Sbjct: 124 CLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQG 183
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLM 271
+SGGP++C + G+VS G GCA P+ PGVYT+V +V W+
Sbjct: 184 NSGGPVVC-------NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 225
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 134 bits (337), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 80/231 (34%), Positives = 121/231 (52%), Gaps = 18/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + + P ++L G+ CGG +++E+WV++AAHC K EV G
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+EQ SR++ H + + ND+ L++L+ N YV+P+ LP +
Sbjct: 56 KVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKH-YEDRIAD-VICAGMPQGGRDTCQ 221
+ CT GWG D + ++ + +PIL C + Y I + + CAG +GG+D+CQ
Sbjct: 114 TMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
GDSGGP++C + GVVS G GCA P PGVY +V F WL S
Sbjct: 174 GDSGGPVVC-------NGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTS 217
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 134 bits (337), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 81/230 (35%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG E + P+ ++L G+ CGG ++ E WV++AAHC K +V G
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGYHFCGGSLISEQWVVSAAHCY----KTRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H + R + ND+ L++L++P N V I LP T P
Sbjct: 56 KVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLP--TAPPAAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPA--CK-HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G D PD ++ + P+L CK Y +I + + C G +GG+D+C
Sbjct: 114 TECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
Q D+GGP++C G+ + GVVS G GCA N PGVYT+V +V W+
Sbjct: 174 QRDAGGPVVC-----NGQ--LQGVVSWGHGCAWKNRPGVYTKVYNYVDWI 216
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 134 bits (337), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 133/250 (53%), Gaps = 26/250 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
CLP + P+ ++C G+G E D + ++++ ++ H E +
Sbjct: 121 CLPSMYNDPQFGTSCEITGFGK--EASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNS 274
F+PW+ S++
Sbjct: 236 HFLPWIRSHT 245
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 134 bits (337), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 79/237 (33%), Positives = 124/237 (52%), Gaps = 19/237 (8%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEV 98
P+ ++VGG P+ ++L G+ CGG +++ WV++AAHC K +V
Sbjct: 8 PVDDDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQV 62
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV 158
G EQ S+ ++H + + ND+ L++L + N V I LP
Sbjct: 63 RLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP-- 120
Query: 159 TETPEPYSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMP 213
T + C GWG G PD ++ ++ PIL +CK Y +I +++ CAG
Sbjct: 121 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYL 180
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+GG+D+CQGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 181 EGGKDSCQGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 230
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 134 bits (337), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 133/252 (52%), Gaps = 26/252 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
CLP + P+ ++C G+G E D + ++++ ++ H E +
Sbjct: 121 CLPSMYNDPQFGTSCEITGFGK--EASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDACQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSER 276
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTKE 247
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 134 bits (336), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 79/237 (33%), Positives = 124/237 (52%), Gaps = 19/237 (8%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEV 98
P+ ++VGG P+ ++L G+ CGG +++ WV++AAHC K +V
Sbjct: 14 PVDDDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQV 68
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV 158
G EQ S+ ++H + + ND+ L++L + N V I LP
Sbjct: 69 RLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP-- 126
Query: 159 TETPEPYSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMP 213
T + C GWG G PD ++ ++ PIL +CK Y +I +++ CAG
Sbjct: 127 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYL 186
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+GG+D+CQGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 187 EGGKDSCQGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 236
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 134 bits (336), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 82/234 (35%), Positives = 126/234 (53%), Gaps = 15/234 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAGMLR 104
+VGGK A +G +P+ ++L G CG +LD + V+TAAHCVDG + +V+ G
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHRCGASILDNNNVLTAAHCVDGLSNLNRLKVHVGT-- 58
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
S + V V V++ + + ND+AL+ L P+++N V+PI L E E
Sbjct: 59 -NYLSESGDVYDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTNDEDLES 117
Query: 165 YSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRIADVICAGMPQGGRDTCQG 222
+ CT GWG+ G P+ ++E+++ + P C+ + R+ D + + G C G
Sbjct: 118 -NPCTLTGWGSTRLGGNTPNALQEIELIVHPQKQCERDQWRVIDSHICTLTKRGEGACHG 176
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
DSGGPL+ G+Q G+VS G CA EP VYTRVS FV W+ +N ++
Sbjct: 177 DSGGPLV--ANGAQ-----IGIVSFGSPCAL-GEPDVYTRVSSFVSWINANLKK 222
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 134 bits (336), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 127/241 (52%), Gaps = 14/241 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFH-CGGVVLDESWVMTAAHC-VD--GF---EKHYFEV 98
VVGG A+ G WPW ++L+ G H CG ++ +W+++AAHC +D GF + +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 99 YAGMLRRFSFS-PTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
+ G+ + S P Q R + RI+ H F D+ALL+L P Y+ VRPI LPD
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLPD 120
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMR--EVQVPILPACKHY--EDRIADVICAGMP 213
+ GWG G ++ E++V C++ + ++C G
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFL 180
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSN 273
GG D+CQGDSGGPL + GR + AGVVS G+GCA+ N+PGVYTR+ F W+ N
Sbjct: 181 SGGVDSCQGDSGGPL--SSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKEN 238
Query: 274 S 274
+
Sbjct: 239 T 239
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 133 bits (335), Expect = 9e-32, Method: Compositional matrix adjust.
Identities = 78/231 (33%), Positives = 122/231 (52%), Gaps = 19/231 (8%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 6 KIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDN 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 61 INVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASA 118
Query: 165 YSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDT 219
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+
Sbjct: 119 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDS 178
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
CQGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 179 CQGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 222
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 133 bits (335), Expect = 9e-32, Method: Compositional matrix adjust.
Identities = 85/242 (35%), Positives = 132/242 (54%), Gaps = 21/242 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDG---FFH-CGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
VVGG+ A +WPW ++L D + H CGG ++D+SWV+TAAHC+ + V G
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCIS--SSRTYRVVLG 58
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAPLRYNRYVRPICLPDV- 158
+ P VS++V+H + +++ ND+ALL+LA+P+ ++ CLP
Sbjct: 59 RHSLSTNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCLPAAG 118
Query: 159 TETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKH---YEDRI-ADVICAGM 212
T P Y C GWG + +G PD +++ Q+ ++ C + + ++ICAG
Sbjct: 119 TILPNNY-VCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGSTVKTNMICAG- 176
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE--GCARPNEPGVYTRVSQFVPWL 270
G +C GDSGGPL C G+ G+W V G+VS G GC ++P V+TRVS ++ W+
Sbjct: 177 GDGIISSCNGDSGGPLNC--QGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNYIDWI 234
Query: 271 MS 272
S
Sbjct: 235 NS 236
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 133 bits (335), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + P+ ++L G+ CGG ++++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F R + ND+ L++L++P++ N V + LP +
Sbjct: 56 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALP--SSCAPAG 113
Query: 166 STCTAVGWGAVFEHG-PDPDHMREVQVPILPACK---HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G +PD ++ + P+LP Y +I D ++C G +GG+ +C
Sbjct: 114 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKGSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA P+ P VYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGELQGIVSWGYGCALPDNPDVYTKVCNYVDWI 216
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 133 bits (335), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 78/231 (33%), Positives = 122/231 (52%), Gaps = 19/231 (8%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 5 KIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDN 59
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 60 INVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASA 117
Query: 165 YSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDT 219
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+
Sbjct: 118 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDS 177
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
CQGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 178 CQGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 221
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 133 bits (334), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 79/252 (31%), Positives = 135/252 (53%), Gaps = 26/252 (10%)
Query: 45 RVVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEV 98
+++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + V
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIV 74
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRP 152
Y G R S + E V +++H + + ND+ALL++ + + +R ++
Sbjct: 75 YLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQT 134
Query: 153 ICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DR 203
I LP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 135 ISLPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEV 192
Query: 204 IADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRV 263
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRV
Sbjct: 193 TTKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRV 249
Query: 264 SQFVPWLMSNSE 275
S F+PW+ S+++
Sbjct: 250 SHFLPWIRSHTK 261
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 133 bits (334), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHC----XKSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGXLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 132 bits (333), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 78/237 (32%), Positives = 124/237 (52%), Gaps = 19/237 (8%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEV 98
P+ ++VGG P+ ++L G+ CGG +++ WV++AAHC K +V
Sbjct: 14 PVDDDDKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQV 68
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV 158
G EQ S+ ++H + + ND+ L++L + N V I LP
Sbjct: 69 RLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP-- 126
Query: 159 TETPEPYSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMP 213
T + C GWG G PD ++ ++ PIL +CK Y +I +++ CAG
Sbjct: 127 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYL 186
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+GG+D+CQGD+GGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 187 EGGKDSCQGDAGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 236
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 132 bits (333), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 79/251 (31%), Positives = 133/251 (52%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
LP + P+ ++C G+G E D + ++++ ++ H E +
Sbjct: 121 ALPSMYNDPQFGTSCEITGFGK--EQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 132 bits (333), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPGQITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 132 bits (333), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
LP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 121 SLPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 132 bits (333), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 132 bits (333), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 82/230 (35%), Positives = 119/230 (51%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG E + P+ ++L F CGG ++ E WV++AAHC K +V G
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF-CGGSLISEQWVVSAAHCY----KTRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ +I+ H + R + ND+ L++L++P N V I LP T P
Sbjct: 56 KVLEGNEQFINAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLP--TAPPAAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPA--CK-HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G D PD ++ + P+L CK Y +I + + C G +GG+D+C
Sbjct: 114 TECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
Q DSGGP++C G+ + GVVS G GCA N PGVYT+V +V W+
Sbjct: 174 QRDSGGPVVC-----NGQ--LQGVVSWGHGCAWKNRPGVYTKVYNYVDWI 216
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 132 bits (332), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
LP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 121 ALPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 132 bits (332), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 81/230 (35%), Positives = 120/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG E + P+ ++L F CGG ++ E WV++AAHC K +V G
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF-CGGSLISEQWVVSAAHCY----KTRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H + R + ND+ L++L++P N V I LP T P
Sbjct: 56 KVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLP--TAPPAAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPA--CK-HYEDRIAD-VICAGMPQGGRDTC 220
+ C GWG G D PD ++ + P+L CK Y +I + + C G +GG+D+C
Sbjct: 114 TECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
Q D+GGP++C G+ + GVVS G GCA N PGVYT+V +V W+
Sbjct: 174 QRDAGGPVVC-----NGQ--LQGVVSWGHGCAWKNRPGVYTKVYNYVDWI 216
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 132 bits (332), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 79/251 (31%), Positives = 133/251 (52%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
LP + P+ ++C G+G E D + ++++ ++ H E +
Sbjct: 121 ALPSMYNDPQFGTSCEITGFGK--EQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 132 bits (332), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
LP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 121 SLPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 132 bits (331), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 79/250 (31%), Positives = 133/250 (53%), Gaps = 26/250 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
LP + P+ ++C G+G E+ D + ++++ ++ H E +
Sbjct: 121 ALPSMYNDPQFGTSCEITGFGK--ENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGDSGGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDSGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNS 274
F+PW+ S++
Sbjct: 236 HFLPWIRSHT 245
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 131 bits (330), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 131 bits (330), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/240 (33%), Positives = 125/240 (52%), Gaps = 20/240 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGGK G PW + L +G CGG +++ WV++AAHC D K++ + A +L
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKI-KNWRNLIA-VLGE 58
Query: 106 FSFSP---TEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
S EQ R V+++++ S + +D+ALL+L P+ +V P+CLP+ T +
Sbjct: 59 HDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSE 118
Query: 163 EPYSTC---TAVGWGAVFEHGPDPDHMREVQVPILPA--CKHYEDRIAD-------VICA 210
+ GWG + + G ++ + VP L C ++ D + CA
Sbjct: 119 RTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCA 178
Query: 211 GMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
G G +D+C+GDSGGP +G WY+ G+VS G+GCA GVYTRVSQ++ WL
Sbjct: 179 GYSDGSKDSCKGDSGGP---HATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWL 235
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 131 bits (330), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 78/251 (31%), Positives = 133/251 (52%), Gaps = 26/251 (10%)
Query: 46 VVGGKKAELGAWPWLIALYR-----DGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVY 99
++GG+ + PW A+YR + CGG ++ WV++A HC +D +K + VY
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAP----LRYNRYVRPI 153
G R S + E V +++H + + ND+ALL++ + + +R ++ I
Sbjct: 61 LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI 120
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYE---------DRI 204
LP + P+ ++C G+G E D + ++++ ++ H E +
Sbjct: 121 ALPSMYNDPQFGTSCEITGFGK--EQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVT 178
Query: 205 ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
++CA PQ D+CQGD+GGPL+C + QGR + G+VS G GCA ++PGVYTRVS
Sbjct: 179 TKMLCAADPQWKTDSCQGDAGGPLVCSL---QGRMTLTGIVSWGRGCALKDKPGVYTRVS 235
Query: 265 QFVPWLMSNSE 275
F+PW+ S+++
Sbjct: 236 HFLPWIRSHTK 246
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 131 bits (329), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 121/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V + LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVCA-----GK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 131 bits (329), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 78/229 (34%), Positives = 120/229 (52%), Gaps = 19/229 (8%)
Query: 47 VGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRF 106
VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNIN 56
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYS 166
EQ S+ ++H + + ND+ L++L + N V I LP T +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAGT 114
Query: 167 TCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTCQ 221
C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+CQ
Sbjct: 115 QCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQ 174
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 175 GDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 131 bits (329), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 81/240 (33%), Positives = 124/240 (51%), Gaps = 20/240 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGGK G PW + L +G CGG +++ WV++AAHC D K++ + A +L
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKI-KNWRNLIA-VLGE 58
Query: 106 FSFSP---TEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
S EQ R V+++++ S + +D+ALL+L P+ +V P+CLP+ T +
Sbjct: 59 HDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSE 118
Query: 163 EPYSTC---TAVGWGAVFEHGPDPDHMREVQVPILPA--CKHYEDRIAD-------VICA 210
+ GWG + + G + + VP L C ++ D + CA
Sbjct: 119 RTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCA 178
Query: 211 GMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
G G +D+C+GDSGGP +G WY+ G+VS G+GCA GVYTRVSQ++ WL
Sbjct: 179 GYSDGSKDSCKGDSGGP---HATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWL 235
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 131 bits (329), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 120/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 130 bits (328), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 78/232 (33%), Positives = 125/232 (53%), Gaps = 19/232 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + + +L + G+ CGG ++ +WV++AAHC K +V G
Sbjct: 1 IVGGYECRKNSASYQASL-QSGYHFCGGSLISSTWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
TEQ +++MH + + ND+ L++L+ P N YV + LP +
Sbjct: 56 AVNEGTEQFIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALP--SSCASSG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPA--CKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG + + PD +R + +PIL + C Y +I +++ CAG +GG+D+C
Sbjct: 114 TRCLVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSAYPGQITSNMFCAGFMEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
QGDSGGP++C G+ + GVVS G GCA+ N+PGVYT+V + W+ S
Sbjct: 174 QGDSGGPVVC-----NGQ--LQGVVSWGYGCAQRNKPGVYTKVCNYRSWISS 218
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 130 bits (328), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 80/231 (34%), Positives = 121/231 (52%), Gaps = 17/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG A G +P+++++ R+G CGG +L+ + V+TAAHCV G+ + F++ AG L R
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
S T +S + +H + + NDLA+L+L+ + + L P
Sbjct: 61 TSGGITSS---LSSVRVHPSY--SGNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAG 115
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKHYEDRIA---DVICAGMPQGGRDT 219
S+ T GWGA E G P ++ +V VPI+ C+ A + CAG+ GG+D+
Sbjct: 116 SSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSAITNQMFCAGVSSGGKDS 175
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
CQGDSGGP++ + G VS G GCARPN GVY V ++
Sbjct: 176 CQGDSGGPIV------DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 130 bits (328), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 79/236 (33%), Positives = 121/236 (51%), Gaps = 17/236 (7%)
Query: 45 RVVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
R+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 15 RIVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVG 70
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---V 158
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 71 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 130
Query: 159 TETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQ 214
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 131 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDT 190
Query: 215 GGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 191 KQEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 243
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 130 bits (327), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 120/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD GGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDXGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 130 bits (327), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 78/229 (34%), Positives = 120/229 (52%), Gaps = 19/229 (8%)
Query: 47 VGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRF 106
VGG P+ ++L G+ CGG ++D WV++AAHC K +V G
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLIDSQWVVSAAHCY----KSGIQVRLGEDNIN 56
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYS 166
EQ S+ ++H + + ND+ L++L + + V I LP T +
Sbjct: 57 VVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLP--TSCASAGT 114
Query: 167 TCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTCQ 221
C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+CQ
Sbjct: 115 QCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQ 174
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 175 GDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 129 bits (325), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 80/230 (34%), Positives = 120/230 (52%), Gaps = 17/230 (7%)
Query: 47 VGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRF 106
VGG A G +P+++++ R+G CGG +L+ + V+TAAHCV G+ + F++ AG L R
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSRT 61
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYS 166
S T +S + +H + + NDLA+L+L+ + + L P S
Sbjct: 62 SGGITSS---LSSVRVHPSY--SGNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGS 116
Query: 167 TCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKHYEDRIA---DVICAGMPQGGRDTC 220
+ T GWGA E G P ++ +V VPI+ C+ A + CAG+ GG+D+C
Sbjct: 117 SATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSAITNQMFCAGVSSGGKDSC 176
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++ + G VS G GCARPN GVY V ++
Sbjct: 177 QGDSGGPIV------DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 129 bits (324), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 116/230 (50%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS GEGCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVCS-----GK--LQGIVSWGEGCAQKNKPGVYTKVCNYVSWI 216
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 129 bits (324), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 120/230 (52%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 129 bits (323), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 79/231 (34%), Positives = 120/231 (51%), Gaps = 17/231 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG A G +P+++++ R+G CGG +L+ + V+TAAHCV G+ + F++ AG L R
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
S T +S + +H + + NDLA+L+L+ + + L P
Sbjct: 61 TSGGITSS---LSSVRVHPSY--SGNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAG 115
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKHYEDRIA---DVICAGMPQGGRDT 219
S+ T GWGA E G P ++ +V VPI+ C+ A + CAG+ GG+D+
Sbjct: 116 SSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSAITNQMFCAGVSSGGKDS 175
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
CQGD GGP++ + G VS G GCARPN GVY V ++
Sbjct: 176 CQGDXGGPIV------DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 76/230 (33%), Positives = 118/230 (51%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + P+ ++L F CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F + ND+ L++L++P N V + LP
Sbjct: 56 DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR--SCAAAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTC 220
+ C GWG G P ++ ++ P+L +CK Y +I ++IC G QGG+D+C
Sbjct: 114 TECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 121/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
+ E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTAAEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 128 bits (322), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 115/230 (50%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDRIA----DVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL A ++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSAIITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 76/230 (33%), Positives = 117/230 (50%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYED--RI--ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL RI +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSRIITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 128 bits (321), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 128 bits (321), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 127 bits (320), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 127 bits (320), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 127 bits (320), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 115/230 (50%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSYIITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 127 bits (320), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 78/235 (33%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 127 bits (320), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 75/232 (32%), Positives = 119/232 (51%), Gaps = 19/232 (8%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++VGG + P+ ++L F CGG +++ WV++AAHC K +V G
Sbjct: 8 KIVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY----KSRIQVRLGEHN 62
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
EQ ++I+ H F + ND+ L++L++P N V + LP
Sbjct: 63 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLP--RSCAAA 120
Query: 165 YSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDT 219
+ C GWG G P ++ ++ P+L +CK Y +I ++IC G +GG+D+
Sbjct: 121 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDS 180
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLM 271
CQGDSGGP++C + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 181 CQGDSGGPVVC-------NGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 225
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 127 bits (320), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 81/232 (34%), Positives = 124/232 (53%), Gaps = 22/232 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQL--AAPLRYNRYVRPICLPDVTETPE 163
EQ S+ ++H + + ND+ L++L AA L +R V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSR-VASISLP--TSCAS 112
Query: 164 PYSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRD 218
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG +GG+D
Sbjct: 113 AGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKD 172
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+CQGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 173 SCQGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 217
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 127 bits (319), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 122/244 (50%), Gaps = 31/244 (12%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM-- 102
R+VGGK+A+LG PW +A+ CGG+ + W++TAAHC+ + H ++++ +
Sbjct: 321 RIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCLRASKTHRYQIWTTVVD 380
Query: 103 -----LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQL-----AAPLRYNRYVRP 152
L+R + V RI+ H + ND+AL+++ R + P
Sbjct: 381 WIHPDLKRIV------IEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELPRSI-P 433
Query: 153 ICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQ---VPILPAC-KHYEDRI--AD 206
C+P +P TC GWG D + + +Q V ++ C K Y +R +
Sbjct: 434 ACVPWSPYLFQPNDTCIVSGWG----REKDNERVFSLQWGEVKLISNCSKFYGNRFYEKE 489
Query: 207 VICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQF 266
+ CAG G D C+GDSGGPL+C + YV GVVS GE C +P PGVYT+V+ +
Sbjct: 490 MECAGTYDGSIDACKGDSGGPLVC--MDANNVTYVWGVVSWGENCGKPEFPGVYTKVANY 547
Query: 267 VPWL 270
W+
Sbjct: 548 FDWI 551
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 127 bits (318), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS GEGCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVCS-----GK--LQGIVSWGEGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 127 bits (318), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 115/230 (50%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSWIITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 127 bits (318), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 77/235 (32%), Positives = 120/235 (51%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG++ + G PW LI +GF CGG +L E +++TAAHC+ ++ F+V G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGF--CGGTILSEFYILTAAHCL--YQAKRFKVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V ++ H+ F + D+A+L+L P+ + V P CLP+
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRI--ADVICAGMPQG 215
T T G+G E G ++ ++VP + +CK I ++ CAG
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTK 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGD+GGP V + ++V G+VS GEGCAR + G+YT+V+ F+ W+
Sbjct: 177 QEDACQGDAGGP---HVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 127 bits (318), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 118/230 (51%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + P+ ++L F CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F + ND+ L++L++P N V + LP
Sbjct: 56 DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR--SCAAAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTC 220
+ C GWG G P ++ ++ P+L +CK Y +I ++IC G +GG+D+C
Sbjct: 114 TECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 127 bits (318), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 7 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 66
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 67 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENL 126
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 127 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 185
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 186 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 245
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 246 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 127 bits (318), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS GEGCA+ N+PG+YT+V +V W+
Sbjct: 174 QGDSGGPVVCS-----GK--LQGIVSWGEGCAQKNKPGIYTKVCNYVSWI 216
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 118/230 (51%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + P+ ++L F CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCAANSVPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F + ND+ L++L++P N V + LP
Sbjct: 56 DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR--SCAAAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTC 220
+ C GWG G P ++ ++ P+L +CK Y +I ++IC G +GG+D+C
Sbjct: 114 TECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAYPGQITGNMICVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 13 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 72
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 73 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 132
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 133 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 191
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 192 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 251
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 252 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 288
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 82/235 (34%), Positives = 115/235 (48%), Gaps = 17/235 (7%)
Query: 46 VVGGKKAELGAWPW---LIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG+ G PW L+ +GF CGG +L+E +V+TAAHC+ + F V G
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGF--CGGTILNEFYVLTAAHCLH--QAKRFTVRVGD 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD---VT 159
E V V HS F + D+A+L+L P+R+ R V P CLP+
Sbjct: 57 RNTEQEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWAE 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYEDRIA--DVICAGMPQG 215
T T G+G E G ++ ++VP + CK ++ CAG
Sbjct: 117 ATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSFTITPNMFCAGYDTQ 176
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
D CQGDSGGP V + ++V G+VS GEGCAR + GVYT+VS F+ W+
Sbjct: 177 PEDACQGDSGGP---HVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWI 228
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 9 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 68
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 69 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 128
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 129 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 187
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 188 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 247
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 248 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 284
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 126 bits (316), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 7 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 66
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 67 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 126
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 127 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 185
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 186 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 245
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 246 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 126 bits (316), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 7 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 66
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 67 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 126
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 127 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 185
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 186 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 245
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 246 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 126 bits (316), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 7 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 66
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 67 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 126
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 127 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 185
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 186 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 245
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 246 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 126 bits (316), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 6 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 65
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 66 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 125
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 126 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 184
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 185 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 244
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 245 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 281
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 126 bits (316), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 9 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 68
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 69 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 128
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 129 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 187
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 188 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 247
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 248 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 284
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 126 bits (316), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 13 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 72
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 73 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 132
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 133 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 191
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 192 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 251
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 252 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 288
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 126 bits (316), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 90/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 142 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 201
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 202 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 261
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 262 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 320
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P
Sbjct: 321 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 380
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 381 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 417
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 113/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +L+ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLLNSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PG+YT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGIYTKVCNYVSWI 216
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 75/229 (32%), Positives = 117/229 (51%), Gaps = 19/229 (8%)
Query: 47 VGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRF 106
VGG + P+ ++L F CGG +++ WV++AAHC K +V G
Sbjct: 2 VGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY----KSRIQVRLGEHNID 56
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYS 166
EQ ++I+ H F + ND+ L++L++P N V + LP +
Sbjct: 57 VLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR--SCAAAGT 114
Query: 167 TCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTCQ 221
C GWG G P ++ ++ P+L +CK Y +I ++IC G +GG+D+CQ
Sbjct: 115 ECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQ 174
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GDSGGP++C + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 175 GDSGGPVVC-------NGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD+GGP++C G+ + G+VS GEGCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDAGGPVVCS-----GK--LQGIVSWGEGCAQKNKPGVYTKVCNYVSWI 216
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 125 bits (314), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 89/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 8 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 67
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 68 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 127
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 128 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 186
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GD+GGP + P
Sbjct: 187 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPF 246
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 247 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 283
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 125 bits (314), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 89/278 (32%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D +L S GR+V G AE+G PW + L+R CG ++ +
Sbjct: 26 PLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDR 85
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEM 131
WV+TAAHC+ F ++ V G R + E++ + +I +H + R +
Sbjct: 86 WVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENL 145
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTC----TAVGWGAVFEHGP------ 181
D+AL++L P+ ++ Y+ P+CLPD ET GWG + E
Sbjct: 146 DRDIALMKLKKPVAFSDYIHPVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKG 204
Query: 182 DPDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPG 234
P ++ V +PI+ P CK RI D + CAG P G+ D C+GD+GGP + P
Sbjct: 205 QPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPF 264
Query: 235 SQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
+ RWY G+VS GEGC R + G YT V + W+
Sbjct: 265 NN-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 301
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 125 bits (313), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 83/248 (33%), Positives = 124/248 (50%), Gaps = 23/248 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYED-RIAD-V 207
PD ET GWG + E P ++ V +PI+ P CK RI D +
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKDSTRIRITDNM 179
Query: 208 ICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G YT V
Sbjct: 180 FCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYGFYTHVF 238
Query: 265 QFVPWLMS 272
+ W+
Sbjct: 239 RLKKWIQK 246
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 125 bits (313), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 113/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 125 bits (313), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 84/248 (33%), Positives = 125/248 (50%), Gaps = 24/248 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYED-RIAD-V 207
PD ET GWG + E G P ++ V +PI+ P CK RI D +
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKEKG-QPSVLQVVNLPIVERPVCKDSTRIRITDNM 178
Query: 208 ICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G YT V
Sbjct: 179 FCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYGFYTHVF 237
Query: 265 QFVPWLMS 272
+ W+
Sbjct: 238 RLKKWIQK 245
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 125 bits (313), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 84/248 (33%), Positives = 126/248 (50%), Gaps = 24/248 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R ++ E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYED-RIAD-V 207
PD ET GWG + E G P ++ V +PI+ P CK RI D +
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETG-QPSVLQVVNLPIVERPVCKDSTRIRITDNM 178
Query: 208 ICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G YT V
Sbjct: 179 FCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRDGKYGFYTHVF 237
Query: 265 QFVPWLMS 272
+ W+
Sbjct: 238 RLKKWIQK 245
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (313), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PG+YT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGIYTKVCNYVSWI 216
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 124 bits (311), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 84/248 (33%), Positives = 125/248 (50%), Gaps = 24/248 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYED-RIAD-V 207
PD ET GWG + E G P ++ V +PI+ P CK RI D +
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETG-QPSVLQVVNLPIVERPVCKDSTRIRITDNM 178
Query: 208 ICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G YT V
Sbjct: 179 FCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYGFYTHVF 237
Query: 265 QFVPWLMS 272
+ W+
Sbjct: 238 RLKKWIQK 245
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 124 bits (310), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD+GGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDAGGPVVCS-----GK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 124 bits (310), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 74/230 (32%), Positives = 117/230 (50%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + P+ ++L F CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F + ND+ L++L++P V + LP
Sbjct: 56 DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPR--SCAAAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTC 220
+ C GWG G P ++ ++ P+L +CK Y +I ++IC G +GG+D+C
Sbjct: 114 TECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-------NGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 124 bits (310), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PG YT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGFYTKVCNYVSWI 216
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 124 bits (310), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 78/236 (33%), Positives = 123/236 (52%), Gaps = 16/236 (6%)
Query: 44 GRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGML 103
GR++GG++AE A P++ ++ +G CGGV++ E WV++AAHC++ +V G
Sbjct: 6 GRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAH 65
Query: 104 RRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE 163
P++++ V R V H + + +DL LLQL+ VRP+ V
Sbjct: 66 SLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 125
Query: 164 PYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACK---HYEDRIAD-VICAGMPQGGR 217
P + C GWG V G PD ++ V +P+L C H++ I + ++CA R
Sbjct: 126 PGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRR 183
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMS 272
D+C+GDSGGPL+C + GVV+ G C +PG+YTRV+ + W+ S
Sbjct: 184 DSCKGDSGGPLVCG-------GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 232
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 124 bits (310), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD+GGP++C G+ + G+VS GEGCA+ N+PG YT+V +V W+
Sbjct: 174 QGDAGGPVVCS-----GK--LQGIVSWGEGCAQKNKPGFYTKVCNYVSWI 216
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 123 bits (309), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ C G +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCVGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS GEGCA+ N+PG YT+V +V W+
Sbjct: 174 QGDSGGPVVCS-----GK--LQGIVSWGEGCAQKNKPGFYTKVCNYVSWI 216
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 123 bits (308), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 84/254 (33%), Positives = 125/254 (49%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R +PG
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKPG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 123 bits (308), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PG YT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGFYTKVCNYVSWI 216
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 122 bits (307), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 87/243 (35%), Positives = 120/243 (49%), Gaps = 31/243 (12%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + E + PW ALY F CGG+++ WV+TAAHC+ ++++ G
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCI----SDNYQLWLGRHNL 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTN-----------DLALLQLAAPL-RYNRYVRPI 153
F T Q VS H F + + N DL LL+L P V+ +
Sbjct: 57 FDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVV 116
Query: 154 CLPDVTETPEPYSTCTAVGWGAVF-EHGPDPDHMREVQVPILP--ACK--HYEDRIADVI 208
LP TE PE STC A GWG++ E+ PD ++ V + ILP CK H + ++
Sbjct: 117 ELP--TEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFML 174
Query: 209 CAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFV 267
C G +GG+DTC GDSGGPL+C + GV S G C PN+P V RV +V
Sbjct: 175 CVGHLEGGKDTCVGDSGGPLMCDG-------VLQGVTSWGYVPCGTPNKPSVAVRVLSYV 227
Query: 268 PWL 270
W+
Sbjct: 228 KWI 230
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 122 bits (306), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 88/281 (31%), Positives = 129/281 (45%), Gaps = 30/281 (10%)
Query: 25 PLGARNMATDMAGNPILGS---GRVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDES 79
PL + D + S GR+V G+ AE+G PW + L+R CG ++ +
Sbjct: 26 PLFEKKQVQDQTEKELFESYIEGRIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDR 85
Query: 80 WVMTAAHCV------DGFEKHYFEVYAGMLRRFSFS-PTEQVRPVSRIVMHSMFKRAE-M 131
WV+TAAHC+ F V G R + E++ + +I +H + E +
Sbjct: 86 WVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENL 145
Query: 132 TNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYS---TCTAVGWGAVFEHGP------D 182
D+ALL+L P+ + Y+ P+CLPD + GWG E
Sbjct: 146 DRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQ 205
Query: 183 PDHMREVQVPIL--PACK-HYEDRIAD-VICAGMP--QGGR-DTCQGDSGGPLLCPVPGS 235
P ++ V +P++ P CK RI D + CAG +G R D C+GDSGGP + P
Sbjct: 206 PSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSP-Y 264
Query: 236 QGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
RWY G+VS GEGC R + G YT V + W+ +R
Sbjct: 265 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDR 305
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 122 bits (306), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 78/242 (32%), Positives = 121/242 (50%), Gaps = 27/242 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVYAGMLR 104
++ G G+ PW +AL HCGGV+++E WV+TAAHC ++ + H G R
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRR 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
++ R H + NDL L++L + R + V+ + LP E P
Sbjct: 61 AQRIKASKSFR-------HPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE--PP 111
Query: 165 YSTCTAVGWGAVFEHGPD---PDHMREVQVPILP---ACKHYEDRIAD-VICAGMPQGGR 217
+TCT GWG PD P + V V ++ K Y+D + + ++CAG+P +
Sbjct: 112 GTTCTVSGWGTTTS--PDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKK 169
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMSNSER 276
+ C GDSGGPL+C R + G+VS G C +PN+PGVYT+V +F W+ ++
Sbjct: 170 NACNGDSGGPLVC-------RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKK 222
Query: 277 AK 278
+
Sbjct: 223 HR 224
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 122 bits (306), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 78/234 (33%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHC-VDGFEKHYFEVYAGMLR 104
++ G G+ PW +AL HCGGV+++E WV+TAAHC ++ + H G R
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRR 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
++ R H + NDL L++L + R + V+ + LP E P
Sbjct: 61 AQRIKASKSFR-------HPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE--PP 111
Query: 165 YSTCTAVGWGAVFEHGPD---PDHMREVQVPILP---ACKHYEDRIAD-VICAGMPQGGR 217
+TCT GWG PD P + V V ++ K Y+D + + ++CAG+P +
Sbjct: 112 GTTCTVSGWGTTTS--PDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKK 169
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
+ C GDSGGPL+C R + G+VS G C +PN+PGVYT+V +F W+
Sbjct: 170 NACNGDSGGPLVC-------RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWI 216
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PG YT++ +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGFYTKLCNYVSWI 216
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 81/239 (33%), Positives = 118/239 (49%), Gaps = 21/239 (8%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDG--FFH-CGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
VVGG+ A+ +WPW I+L Y+ G ++H CGG ++ + WVMTAAHCVD + V G
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVD--SARTWRVVLG 58
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTN--DLALLQLAAPLRYNRYVRPICLPDVT 159
+ EQ+ V+ + +HS + ++ D+ALL+L N V+ LP
Sbjct: 59 EHNLNTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAALPPSN 118
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHY----EDRIADVICAGMP 213
+ + C GWG GP D +++ +P + C ++CAG
Sbjct: 119 QILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGSTVKTTMVCAG-- 176
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVS--HGEGCARPNEPGVYTRVSQFVPWL 270
G C GDSGGPL C V GS +YV GV S GC +P V+TRVS ++ W+
Sbjct: 177 GGANSGCNGDSGGPLNCQVNGS---YYVHGVTSFVSSSGCNASKKPTVFTRVSAYISWM 232
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ CAG +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGD+GGP++C G+ + G+VS G GCA+ N+PG YT+V +V W+
Sbjct: 174 QGDAGGPVVC-----SGK--LQGIVSWGSGCAQKNKPGFYTKVCNYVSWI 216
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 84/254 (33%), Positives = 125/254 (49%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGCAR + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCARKGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 74/239 (30%), Positives = 118/239 (49%), Gaps = 19/239 (7%)
Query: 46 VVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++ GK G PW + L CG V++ SWV+TAAHC+D +K + LR
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLR 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV----TE 160
R+ E + + +H + ++ ND+ALL LA P ++ + PICLPD E
Sbjct: 61 RWE--KWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERE 118
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMRE-----VQVPILP--ACKHYEDRIA--DVICAG 211
+ GWG + R +++P++P C + +++CAG
Sbjct: 119 LNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAG 178
Query: 212 MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+ +D C+GDSGGP+ V G W++ G+VS GEGC + GVYT+VS+++ W+
Sbjct: 179 ILGDRQDACEGDSGGPM---VASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWI 234
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 121 bits (304), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 74/239 (30%), Positives = 118/239 (49%), Gaps = 19/239 (7%)
Query: 46 VVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++ GK G PW + L CG V++ SWV+TAAHC+D +K + LR
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLR 60
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDV----TE 160
R+ E + + +H + ++ ND+ALL LA P ++ + PICLPD E
Sbjct: 61 RWE--KWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERE 118
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMRE-----VQVPILP--ACKHYEDRIA--DVICAG 211
+ GWG + R +++P++P C + +++CAG
Sbjct: 119 LNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAG 178
Query: 212 MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+ +D C+GDSGGP+ V G W++ G+VS GEGC + GVYT+VS+++ W+
Sbjct: 179 ILGDRQDACEGDSGGPM---VASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWI 234
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 121 bits (304), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 75/229 (32%), Positives = 110/229 (48%), Gaps = 18/229 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + + ++L G+ CGG ++ + WV++AAHC K V G
Sbjct: 1 IVGGYECTKHSQAHQVSL-NSGYHFCGGSLVSKDWVVSAAHCY----KSVLRVRLGEHHI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
TEQ S ++ H + + ND+ L++L P N+YV + LP TE
Sbjct: 56 RVNEGTEQYISSSSVIRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALP--TECAADA 113
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP---ACKHYEDRIA-DVICAGMPQGGRDTCQ 221
+ CT GWG D D ++ + +PIL Y I + CAG +GG+D+CQ
Sbjct: 114 TMCTVSGWGNTMSSVADGDKLQCLSLPILSHADCANSYPGMITQSMFCAGYLEGGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
GDSGGP++C + GVVS G GCA + PGVY +V W+
Sbjct: 174 GDSGGPVVC-------NGVLQGVVSWGYGCAERDHPGVYAKVCVLSGWV 215
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 121 bits (304), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 77/253 (30%), Positives = 125/253 (49%), Gaps = 27/253 (10%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGF------FHCGGVVLDESWVMTAAHCV-DGFEKHYFE 97
R+ GG A++ + PW A++ F CGG+++ W+++AAHC + F H+
Sbjct: 13 RIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLT 72
Query: 98 VYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAP----LRYNRYVRPI 153
V G R EQ V + ++H F ND+ALLQL + + + VR +
Sbjct: 73 VILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTV 132
Query: 154 CLPDVTETPEPYSTCTAVGWGAVFEHGP-DPDHMREVQVPILPACK----HYEDRIA--D 206
CLP ++ C G+G P + ++E V + P+ + H +R +
Sbjct: 133 CLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDN 192
Query: 207 VICAGMPQGG------RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVY 260
++CAG + G D CQGDSGGPL+C + GR + G++S G GC + + PGVY
Sbjct: 193 MLCAGDTRSGGPQANLHDACQGDSGGPLVCL---NDGRMTLVGIISWGLGCGQKDVPGVY 249
Query: 261 TRVSQFVPWLMSN 273
T+V+ ++ W+ N
Sbjct: 250 TKVTNYLDWIRDN 262
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 121 bits (303), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 77/234 (32%), Positives = 121/234 (51%), Gaps = 16/234 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++AE A P++ ++ +G CGGV++ E WV++AAHC++ +V G
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
P++++ V R V H + + +DL LLQL+ VRP+ V EP
Sbjct: 61 SQPEPSKRLYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVEPG 120
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPIL--PACK---HYEDRIAD-VICAGMPQGGRDT 219
+ C GWG V G PD ++ V +P+L C H++ I ++CA RD+
Sbjct: 121 TLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCA--ESNRRDS 178
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMS 272
C+GDSGGPL+C + GVV+ G C +PG+YTRV+ + W+ S
Sbjct: 179 CKGDSGGPLVCG-------GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 121 bits (303), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 85/236 (36%), Positives = 117/236 (49%), Gaps = 20/236 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRD---GFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
VVGG +A G +P+++ L + GF CGG + + V+TAAHCV G + G
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGF--CGGALYAQDIVLTAAHCVSGSGNNTSITATGG 58
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
+ S +VR ++++ F + D AL++LA P+ +P L T T
Sbjct: 59 VVDLQSSSAVKVRS-TKVLQAPGFTKETYGKDWALIKLAQPIN-----QPT-LKIATTTA 111
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRIA---DVICAGMPQ-GG 216
T T GWGA E G ++ + VP + AC+ I ++ICAG P GG
Sbjct: 112 YNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMICAGYPDTGG 171
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
DTCQGDSGGP+ + W G+VS G GCARP PGVYT VS F + S
Sbjct: 172 VDTCQGDSGGPMF--RKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 225
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 121 bits (303), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 77/234 (32%), Positives = 122/234 (52%), Gaps = 16/234 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++AE A P++ ++ +G CGGV++ E WV++AAHC++ +V G
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
P++++ V R V H ++ + +DL LLQL+ VRP+ V P
Sbjct: 61 SQPEPSKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPG 120
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPIL--PACK---HYEDRIAD-VICAGMPQGGRDT 219
+ C GWG V G PD ++ V +P+L C H++ I + ++CA RD+
Sbjct: 121 TLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDS 178
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMS 272
C+GDSGGPL+C + GVVS G C +PG+YTRV+ + W+ S
Sbjct: 179 CKGDSGGPLVCG-------GVLEGVVSWGSRVCGNRKKPGIYTRVASYAAWIDS 225
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 121 bits (303), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 84/254 (33%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D CQGDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 121 bits (303), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 122/242 (50%), Gaps = 32/242 (13%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG K E + PW +A+ + + CGGV++D SWV+TAAHC + ++V G
Sbjct: 1 IVGGYKCEKNSQPWQVAVINE--YLCGGVLIDPSWVITAAHCY----SNNYQVLLGRNNL 54
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTND-----------LALLQLAAPLRYNRYVRPIC 154
F P Q R V + H + +TND L LL L+ P V+ I
Sbjct: 55 FKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGGVKVID 114
Query: 155 LPDVTETPEPYSTCTAVGWGAVFEHGPDPDH-MREVQVPILPACK---HYEDRIADV-IC 209
LP T+ P+ STC A GWG+ H ++ V + +L K Y+D + DV +C
Sbjct: 115 LP--TKEPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKCIETYKDNVTDVMLC 172
Query: 210 AGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVP 268
AG +GG+DTC GDSGGPL+C + G+ S G CA+P P +Y ++ +F
Sbjct: 173 AGEMEGGKDTCAGDSGGPLIC-------DGVLQGITSGGATPCAKPKTPAIYAKLIKFTS 225
Query: 269 WL 270
W+
Sbjct: 226 WI 227
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 120 bits (302), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 76/234 (32%), Positives = 121/234 (51%), Gaps = 16/234 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++AE A P++ ++ +G CGGV++ E WV++AAHC++ +V G
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
P++++ V R V H + + +DL LLQL+ VRP+ V P
Sbjct: 61 SQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPG 120
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPIL--PACK---HYEDRIAD-VICAGMPQGGRDT 219
+ C GWG V G PD ++ V +P+L C H++ I + ++CA RD+
Sbjct: 121 TLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDS 178
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMS 272
C+GDSGGPL+C + GVV+ G C +PG+YTRV+ + W+ S
Sbjct: 179 CKGDSGGPLVCG-------GVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDS 225
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 120 bits (302), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 75/230 (32%), Positives = 116/230 (50%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CA +G D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAYGLEGKGDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GC N+PGVYT+V +V W+
Sbjct: 174 QGDSGGPVVC-----SGK--LQGIVSWGSGCQAKNKPGVYTKVCNYVSWI 216
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 120 bits (302), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 119/230 (51%), Gaps = 22/230 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + + ND+ L++L + N V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPIL--PACKH-YEDRI-ADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +CK Y +I +++ CAG+ G D+C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGLE--GGDSC 171
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 172 QGDSGGPVVC-----SGK--LQGIVSWGSGCAK-NKPGVYTKVCNYVSWI 213
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 120 bits (301), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 125/255 (49%), Gaps = 29/255 (11%)
Query: 45 RVVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYF 96
R+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 60
Query: 97 EVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPIC 154
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+C
Sbjct: 61 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 120
Query: 155 LPDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED 202
LPD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 LPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 179
Query: 203 -RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEP 257
RI D + CAG P G+ D C+GD+GGP + P + RWY G+VS GEGC R +
Sbjct: 180 IRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKY 238
Query: 258 GVYTRVSQFVPWLMS 272
G YT V + W+
Sbjct: 239 GFYTHVFRLKKWIQK 253
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 120 bits (301), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 85/239 (35%), Positives = 124/239 (51%), Gaps = 20/239 (8%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDG--FFH-CGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
VVGG +A+ +WP I+L YR G + H CGG ++ ++WVMTAAHCVD + F V G
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVD--RELTFRVVVG 58
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTN--DLALLQLAAPLRYNRYVRPICLPDVT 159
+ TEQ V +IV+H + ++ D+ALL+LA + N YV+ LP
Sbjct: 59 EHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAG 118
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVP-----ILPACKHYEDRIAD-VICAGMP 213
S C GWG +G +++ +P I + ++ + + ++CAG
Sbjct: 119 TILRNNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAG-G 177
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE--GCARPNEPGVYTRVSQFVPWL 270
G R CQGDSGGPL C V G++ V GV S GC +P V+TRVS ++ W+
Sbjct: 178 DGVRSGCQGDSGGPLHCLV---NGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWI 233
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 120 bits (301), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 72/230 (31%), Positives = 111/230 (48%), Gaps = 19/230 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG P+ ++L G+ CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCY----KSGIQVRLGEDNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ S+ ++H + ND+ L++L + V I LP T
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLXSRVASISLP--TSCASAG 113
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPACKHYEDR----IADVICAGMPQGGRDTC 220
+ C GWG G PD ++ ++ PIL +++ C G +GG+D C
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCVGYLEGGKDAC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
QGDSGGP++C G+ + G+VS GEGCA+ N+PG YT+V +V W+
Sbjct: 174 QGDSGGPVVCS-----GK--LQGIVSWGEGCAQKNKPGFYTKVCNYVSWI 216
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 120 bits (301), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 85/239 (35%), Positives = 124/239 (51%), Gaps = 20/239 (8%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDG--FFH-CGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
VVGG +A+ +WP I+L YR G + H CGG ++ ++WVMTAAHCVD + F V G
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVD--RELTFRVVVG 58
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTN--DLALLQLAAPLRYNRYVRPICLPDVT 159
+ TEQ V +IV+H + ++ D+ALL+LA + N YV+ LP
Sbjct: 59 EHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAG 118
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVP-----ILPACKHYEDRIAD-VICAGMP 213
S C GWG +G +++ +P I + ++ + + ++CAG
Sbjct: 119 TILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAG-G 177
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE--GCARPNEPGVYTRVSQFVPWL 270
G R CQGDSGGPL C V G++ V GV S GC +P V+TRVS ++ W+
Sbjct: 178 DGVRSGCQGDSGGPLHCLV---NGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWI 233
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 125/254 (49%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFE------HGPDPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E + P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKIG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 77/250 (30%), Positives = 120/250 (48%), Gaps = 28/250 (11%)
Query: 44 GRVVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCV-------------- 88
++ G+ A+ G PW+ L + +G CGG +L SW++TAAHC+
Sbjct: 154 AQIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPEDPTLRDS 213
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNR 148
D F++ G R EQ V +H + ND+AL++L N
Sbjct: 214 DLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNA 273
Query: 149 YVRPICLPDVTETPEPYSTCTAV-GWGAVFEHGPDPDHMREVQVPIL--PACKH-----Y 200
+V PICLP E P+ V GWG F P+ + E+++PI+ C+
Sbjct: 274 FVMPICLP---EGPQQEGAMVIVSGWGKQFLQR-FPETLMEIEIPIVDHSTCQKAYAPLK 329
Query: 201 EDRIADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVY 260
+ D+ICAG +GG+D C GDSGGP++ + +G+WY+ G VS G+ C + + GVY
Sbjct: 330 KKVTRDMICAGEKEGGKDACAGDSGGPMVT-LNRERGQWYLVGTVSWGDDCGKKDRYGVY 388
Query: 261 TRVSQFVPWL 270
+ + W+
Sbjct: 389 SYIHHNKDWI 398
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 120 bits (300), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 76/234 (32%), Positives = 121/234 (51%), Gaps = 16/234 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++AE A P++ ++ +G CGGV++ E WV++AAHC++ +V G
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
P++++ V R V H + + +DL LLQL+ VRP+ V P
Sbjct: 61 SQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPG 120
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPIL--PACK---HYEDRIAD-VICAGMPQGGRDT 219
+ C GWG V G PD ++ V +P+L C H++ I + ++CA RD+
Sbjct: 121 TLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDS 178
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMS 272
C+GDSGGPL+C + GVV+ G C +PG+YTRV+ + W+ S
Sbjct: 179 CKGDSGGPLVCG-------GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 82/248 (33%), Positives = 123/248 (49%), Gaps = 26/248 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYED-RIAD-V 207
PD ET GWG + P ++ V +PI+ P CK RI D +
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNL---KGQPSVLQVVNLPIVERPVCKDSTRIRITDNM 176
Query: 208 ICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G YT V
Sbjct: 177 FCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYGFYTHVF 235
Query: 265 QFVPWLMS 272
+ W+
Sbjct: 236 RLKKWIQK 243
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 27/252 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRD------GFFHCGGVVLDESWVMTAAHCV-DGFEKHYFEV 98
+ GG A++ + PW A++ F CGG+++ W+++AAHC + F H+ V
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAP----LRYNRYVRPIC 154
G R EQ V + ++H F ND+ALLQL + + + VR +C
Sbjct: 61 ILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVC 120
Query: 155 LPDVTETPEPYSTCTAVGWGAVFEHGP-DPDHMREVQVPILPACK----HYEDRIA--DV 207
LP ++ C G+G P + ++E V + P+ + H +R ++
Sbjct: 121 LPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNM 180
Query: 208 ICAGMPQGG------RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYT 261
+CAG + G D CQGDSGGPL+C + GR + G++S G GC + + PGVYT
Sbjct: 181 LCAGDTRSGGPQANLHDACQGDSGGPLVCL---NDGRMTLVGIISWGLGCGQKDVPGVYT 237
Query: 262 RVSQFVPWLMSN 273
+V+ ++ W+ N
Sbjct: 238 KVTNYLDWIRDN 249
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 85/239 (35%), Positives = 123/239 (51%), Gaps = 20/239 (8%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDG--FFH-CGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
VVGG +A+ +WP I+L YR G + H CGG ++ ++WVMTAAHCVD + F V G
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVD--RELTFRVVVG 58
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTN--DLALLQLAAPLRYNRYVRPICLPDVT 159
TEQ V +IV+H + ++ D+ALL+LA + N YV+ LP
Sbjct: 59 EHNLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAG 118
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVP-----ILPACKHYEDRIAD-VICAGMP 213
S C GWG +G +++ +P I + ++ + + ++CAG
Sbjct: 119 TILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAG-G 177
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE--GCARPNEPGVYTRVSQFVPWL 270
G R CQGDSGGPL C V G++ V GV S GC +P V+TRVS ++ W+
Sbjct: 178 DGVRSGCQGDSGGPLHCLV---NGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWI 233
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 119 bits (299), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 119 bits (299), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKFG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 119 bits (298), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 77/248 (31%), Positives = 119/248 (47%), Gaps = 28/248 (11%)
Query: 46 VVGGKKAELGAWPWLIAL-YRDGFFHCGGVVLDESWVMTAAHCV--------------DG 90
+ G+ A+ G PW+ L + +G CGG +L SW++TAAHC+ D
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDL 60
Query: 91 FEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYV 150
F++ G R EQ V +H + ND+AL++L N +V
Sbjct: 61 LSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFV 120
Query: 151 RPICLPDVTETPEPYSTCTAV-GWGAVFEHGPDPDHMREVQVPIL--PACKH-----YED 202
PICLP E P+ V GWG F P+ + E+++PI+ C+ +
Sbjct: 121 MPICLP---EGPQQEGAMVIVSGWGKQFLQRF-PETLMEIEIPIVDHSTCQKAYAPLKKK 176
Query: 203 RIADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTR 262
D+ICAG +GG+D C GDSGGP++ + +G+WY+ G VS G+ C + + GVY+
Sbjct: 177 VTRDMICAGEKEGGKDACAGDSGGPMVT-LNRERGQWYLVGTVSWGDDCGKKDRYGVYSY 235
Query: 263 VSQFVPWL 270
+ W+
Sbjct: 236 IHHNKDWI 243
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 119 bits (298), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 119 bits (298), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 82/253 (32%), Positives = 121/253 (47%), Gaps = 27/253 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFS-PTEQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+ALL+L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCL 120
Query: 156 PD---VTETPEPYSTCTAVGWGAVFE------HGPDPDHMREVQVPIL--PACK-HYEDR 203
PD VT GWG + E + P ++ V +PI+ P CK R
Sbjct: 121 PDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIR 180
Query: 204 IAD-VICAGMPQGGR---DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGV 259
I D + CAG D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 181 ITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRKGKYGF 239
Query: 260 YTRVSQFVPWLMS 272
YT V + W+
Sbjct: 240 YTHVFRLKAWIQK 252
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 119 bits (297), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 84/254 (33%), Positives = 127/254 (50%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV--DGFEKHYFE---- 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ ++K++ E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 119 bits (297), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 75/234 (32%), Positives = 121/234 (51%), Gaps = 16/234 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++AE A P++ ++ +G CGGV++ E WV++AAHC++ +V G
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
P++++ V R V H + + +DL LLQL+ VRP+ V P
Sbjct: 61 SQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPG 120
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPIL--PACK---HYEDRIAD-VICAGMPQGGRDT 219
+ C GWG V G PD ++ V +P+L C H++ I + ++CA RD+
Sbjct: 121 TLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDS 178
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMS 272
C+GD+GGPL+C + GVV+ G C +PG+YTRV+ + W+ S
Sbjct: 179 CKGDAGGPLVCG-------GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 118 bits (296), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GD+GGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 118 bits (296), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 121/254 (47%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGMPQGGR---DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRKGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 118 bits (295), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS G+GC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGKGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 118 bits (295), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + ++AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 117 bits (294), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 123/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+ DSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 117 bits (294), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 70/235 (29%), Positives = 124/235 (52%), Gaps = 21/235 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
V+GG + ++ P+L LY G+F CG ++++ WV+TAAHC + F++ G+ +
Sbjct: 1 VLGGDECDINEHPFLAFLYSHGYF-CGLTLINQEWVVTAAHC----DSTNFQMQLGVHSK 55
Query: 106 FSFSPTEQVR-PVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ EQ R P + + + + D+ L++L P+ ++++ P+ LP + P
Sbjct: 56 KVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLP--SNPPSV 113
Query: 165 YSTCTAVGWGAVF---EHGPDPDHMREVQVPILPACKHYEDRI--ADVICAGMPQGGRDT 219
S C +GWG++ E PD + + + C+ + + +CAG+ +GG+DT
Sbjct: 114 GSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPAKTTLCAGVLEGGKDT 173
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHG-EGCARPNEPGVYTRVSQFVPWLMSN 273
C GDSGGPL+C G++ G+VS+G C + +PG+YT V + W+ N
Sbjct: 174 CVGDSGGPLIC-----NGQF--QGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRN 221
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 117 bits (294), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 123/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS G GC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSAGAGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 117 bits (294), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 123/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS G GC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSAGAGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 117 bits (294), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 122/244 (50%), Gaps = 22/244 (9%)
Query: 43 SGRVVGGKKAELGAWPWLIALY--RDGFFH--CGGVVLDESWVMTAAHCVDGFEKHYFEV 98
S RVV G+ A +W W ++L +DG FH CGG ++ WV+TA HC+ ++V
Sbjct: 9 SSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCIS--TSRTYQV 66
Query: 99 YAGMLRRFSFSPTEQVRPVS--RIVMHSMFKRAEMT--NDLALLQLAAPLRYNRYVRPIC 154
G R +EQV P++ + +H ++ + ND+AL++L+ + V+
Sbjct: 67 VLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLAN 126
Query: 155 LPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKHYE----DRIADVI 208
LP + + C GWG ++ GP PD ++E +P++ C Y+ ++
Sbjct: 127 LPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQYDWWGITVKKTMV 186
Query: 209 CAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVS--HGEGCARPNEPGVYTRVSQF 266
CAG R C GDSGGPL C P + G W V GV S GC +P V+TRVS F
Sbjct: 187 CAGGDT--RSGCDGDSGGPLNC--PAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAF 242
Query: 267 VPWL 270
+ W+
Sbjct: 243 IDWI 246
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 117 bits (293), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 82/260 (31%), Positives = 127/260 (48%), Gaps = 39/260 (15%)
Query: 43 SGRVVGGKKAELGAWPWLIALYRDGF----FHCGGVVLDESWVMTAAHCVDGFEKHYFEV 98
S RV G + +L + PW+ L F F CGG ++ E +++TAAHCV G + +E+
Sbjct: 116 SQRVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVHGLQNDLYEI 175
Query: 99 YAGMLRRFSFSPTEQVRP---------------VSRIVMHSMFKRAEMTNDLALLQLAAP 143
G R S E R + + ++H + + +D+ALL+L
Sbjct: 176 RLGEHR---ISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALLKLNRS 232
Query: 144 LRYNRYVRPICLP---DVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACK 198
+ + ++++PICLP ++ E E ST GWG E+G D + + VP+ P AC
Sbjct: 233 VPFQKHIKPICLPITDELKEKAEQISTYFVTGWGTT-ENGSSSDVLLQANVPLQPRSACS 291
Query: 199 HYEDRIADV--ICAGMPQGG--RDTCQGDSGGPLLCPVP--GSQGRWYVA-GVVSHG-EG 250
R + +C G GG +D+C+GDSGGPL P G V G+VS G
Sbjct: 292 QAYRRAVPLSQLCVG---GGDLQDSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVT 348
Query: 251 CARPNEPGVYTRVSQFVPWL 270
C + + PG+YT V ++V W+
Sbjct: 349 CGQISLPGLYTNVGEYVQWI 368
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 117 bits (293), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 81/253 (32%), Positives = 121/253 (47%), Gaps = 27/253 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFS-PTEQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+ALL+L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCL 120
Query: 156 PD---VTETPEPYSTCTAVGWGAVFE------HGPDPDHMREVQVPIL--PACK-HYEDR 203
PD VT GWG + E + P ++ V +PI+ P CK R
Sbjct: 121 PDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIR 180
Query: 204 IAD-VICAGMPQGGR---DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGV 259
I D + CAG D C+GD+GGP + P + RWY G+VS GEGC R + G
Sbjct: 181 ITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFN-NRWYQMGIVSWGEGCDRKGKYGF 239
Query: 260 YTRVSQFVPWLMS 272
YT V + W+
Sbjct: 240 YTHVFRLKRWIQK 252
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 117 bits (293), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 123/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+GDSGGP + P + RWY G+VS GEGC + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCRDDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 116 bits (291), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 81/235 (34%), Positives = 114/235 (48%), Gaps = 19/235 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRD---GFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
VVGG +A G +P+++ L + GF CGG + + V+TAAHCV G + G
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGF--CGGALYAQDIVLTAAHCVSGSGNNTSITATGG 58
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
+ S +VR ++++ F + D AL++LA P+ +P L T T
Sbjct: 59 VVDLQSSSAVKVRS-TKVLQAPGFTKETYGKDWALIKLAQPIN-----QPT-LKIATTTA 111
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRIA---DVICAGMPQGGR 217
T T GWGA E G ++ + VP + AC+ I ++ICAG
Sbjct: 112 YNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMICAGYDTKQE 171
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
DTCQGDSGGP+ + W G+VS GEGCAR + GVYT VS F + S
Sbjct: 172 DTCQGDSGGPMF--RKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIAS 224
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 116 bits (291), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 123/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D C+ DSGGP + P + RWY G+VS GEGC R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 116 bits (291), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 81/253 (32%), Positives = 120/253 (47%), Gaps = 27/253 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFS-PTEQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+ALL+L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCL 120
Query: 156 PD---VTETPEPYSTCTAVGWGAVFE------HGPDPDHMREVQVPIL--PACK-HYEDR 203
PD VT GWG + E + P ++ V +PI+ P CK R
Sbjct: 121 PDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIR 180
Query: 204 IAD-VICAGMPQGGR---DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGV 259
I D + CAG D C+GDSGGP + P + RWY G+VS G GC R + G
Sbjct: 181 ITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSAGAGCDRKGKYGF 239
Query: 260 YTRVSQFVPWLMS 272
YT V + W+
Sbjct: 240 YTHVFRLKRWIQK 252
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 115 bits (289), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 82/257 (31%), Positives = 121/257 (47%), Gaps = 27/257 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G+ AE+G PW + L+R CG ++ + WV+TAAHC+ F
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 98 VYAGMLRRFSFS-PTEQVRPVSRIVMHSMFKRAE-MTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + E + D+ALL+L P+ + Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL 120
Query: 156 PDVTETPEPYS---TCTAVGWGAVFEHGP------DPDHMREVQVPIL--PACK-HYEDR 203
PD + GWG E P ++ V +P++ P CK R
Sbjct: 121 PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR 180
Query: 204 IAD-VICAGMP--QGGR-DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGV 259
I D + CAG +G R D C+GDSGGP + P RWY G+VS GEGC R + G
Sbjct: 181 ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSP-YNNRWYQMGIVSWGEGCDRDGKYGF 239
Query: 260 YTRVSQFVPWLMSNSER 276
YT V + W+ +R
Sbjct: 240 YTHVFRLKKWIQKVIDR 256
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 115 bits (288), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 82/257 (31%), Positives = 121/257 (47%), Gaps = 27/257 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G+ AE+G PW + L+R CG ++ + WV+TAAHC+ F
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 98 VYAGMLRRFSFS-PTEQVRPVSRIVMHSMFKRAE-MTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + E + D+ALL+L P+ + Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL 120
Query: 156 PDVTETPEPYS---TCTAVGWGAVFEHGP------DPDHMREVQVPIL--PACK-HYEDR 203
PD + GWG E P ++ V +P++ P CK R
Sbjct: 121 PDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR 180
Query: 204 IAD-VICAGMP--QGGR-DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGV 259
I D + CAG +G R D C+GDSGGP + P RWY G+VS GEGC R + G
Sbjct: 181 ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSP-YNNRWYQMGIVSWGEGCDRDGKYGF 239
Query: 260 YTRVSQFVPWLMSNSER 276
YT V + W+ +R
Sbjct: 240 YTHVFRLKKWIQKVIDR 256
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 115 bits (288), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 76/247 (30%), Positives = 120/247 (48%), Gaps = 29/247 (11%)
Query: 50 KKAELGAWPWLIALYRDGF--------FHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
+AE G +PW++A+ + CGG ++ S V+T AHCV+ ++ + +
Sbjct: 135 NEAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCVNSYQSNLDAIKIR 194
Query: 102 MLRRFSFSPTE----QVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
+ + E Q R + ++++HS F + ND+ALL L PL + ICLP
Sbjct: 195 AGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTICLPQ 254
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPD---PDHMREVQVPILPACKHYED----RIA----- 205
++ + + C A GWG E G + ++++Q+P + K D R+
Sbjct: 255 QSQIFDS-TECFASGWGKK-EFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGLKFVL 312
Query: 206 --DVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRV 263
+CAG QG +DTC GD G PL CP P + R+ G+V+ G GC N PGVY V
Sbjct: 313 DQTFVCAGGEQG-KDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGVYANV 371
Query: 264 SQFVPWL 270
+ F W+
Sbjct: 372 AHFRNWI 378
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 115 bits (287), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 79/232 (34%), Positives = 111/232 (47%), Gaps = 18/232 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG +A G +P+++ L CGG + + V+TAAHCV G + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
S +VR ++++ F + D AL++LA P+ +P L T T
Sbjct: 57 LQSSSAVKVRS-TKVLQAPGFTKETYGKDWALIKLAQPIN-----QPT-LKIATTTAYNQ 109
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKHYEDRIA---DVICAGMPQGGRDTC 220
T T GWGA E G ++ + VP + AC+ I ++ICAG DTC
Sbjct: 110 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMICAGYDTKQEDTC 169
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
QGDSGGP+ + W G+VS GEGCAR + GVYT VS F + S
Sbjct: 170 QGDSGGPMF--RKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIAS 219
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 114 bits (286), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 80/247 (32%), Positives = 124/247 (50%), Gaps = 33/247 (13%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDG----------FEKH 94
R++GG + G+ PWL A+Y F C G ++ WV++AAHC +H
Sbjct: 35 RIIGGSSSLPGSHPWLAAIYIGDSF-CAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQH 93
Query: 95 YFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAP----LRYNRYV 150
+F + + F E+ P + ++S+F ++ +DL L++L +++V
Sbjct: 94 FFNRTTDVTQTFGI---EKYIPYT---LYSVFNPSD--HDLVLIRLKKKGDRCATRSQFV 145
Query: 151 RPICLPDVTETPEPYSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKHYEDRIADV 207
+PICLP+ T C GWG + E+ +RE VP++ C E AD+
Sbjct: 146 QPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADI 205
Query: 208 ----ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRV 263
+CAG D CQGDSGGPL C G Y+ G++S G+GC R ++PGVYTRV
Sbjct: 206 SPNMLCAGYFDCKSDACQGDSGGPLACE---KNGVAYLYGIISWGDGCGRLHKPGVYTRV 262
Query: 264 SQFVPWL 270
+ +V W+
Sbjct: 263 ANYVDWI 269
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 114 bits (286), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 120/234 (51%), Gaps = 22/234 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
V+GG + + +L +Y +G CGG ++++ WV+TA HC ++ +Y GM
Sbjct: 1 VIGGDECNINEHRFLALVYANGSL-CGGTLINQEWVLTARHC----DRGNMRIYLGM-HN 54
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMT--NDLALLQLAAPLRYNRYVRPICLPDVTETPE 163
+ +R + + R + D+ L++L P+R + ++ P+ LP + P
Sbjct: 55 LKVLNKDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLP--SNPPS 112
Query: 164 PYSTCTAVGWGAVFEHG---PDPDHMREVQVPILPACKH-YEDRIADVICAGMPQGGRDT 219
S C +GWG + PD H + + C+ Y+ A +CAG+ +GG+DT
Sbjct: 113 VGSVCRIMGWGTITSPNATLPDVPHCANINILDYAVCQAAYKGLAATTLCAGILEGGKDT 172
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVS-HGEGCARPNEPGVYTRVSQFVPWLMS 272
C+GDSGGPL+C G++ G++S G CA+P +PG+YT+V + W+ S
Sbjct: 173 CKGDSGGPLIC-----NGQF--QGILSVGGNPCAQPRKPGIYTKVFDYTDWIQS 219
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 114 bits (284), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 125/244 (51%), Gaps = 24/244 (9%)
Query: 44 GRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHY----FEVY 99
GR+ GG+KA+ G +PW + + G G +L ++WV+TAAH V +E+ + ++
Sbjct: 85 GRIYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAV--YEQKHDASALDIR 140
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP--D 157
G L+R S T Q + + A ND+AL++L + N + PICLP +
Sbjct: 141 MGTLKRLSPHYT-QAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKE 199
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK---HYE-------DRIADV 207
TA GWG + + G ++ V +PI+ K YE A++
Sbjct: 200 AESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 258
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQF 266
+CAG+ GG+D+C+GDSGG L+ + RW+V G+VS G C + GVYT+V +
Sbjct: 259 LCAGLESGGKDSCRGDSGGALVF-LDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINY 317
Query: 267 VPWL 270
+PW+
Sbjct: 318 IPWI 321
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 114 bits (284), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 82/258 (31%), Positives = 123/258 (47%), Gaps = 33/258 (12%)
Query: 46 VVGGKKAELGAWPWLIALYRD------GFFHCGGVVLDESWVMTAAHCV------DGFEK 93
+V G AE+G PW + L+ F CG ++ + WV+TAAHC+ F +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 94 HYFEVYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVR 151
+ V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+
Sbjct: 61 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 120
Query: 152 PICLPDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKH 199
P+CLPD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PVCLPD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 179
Query: 200 YED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARP 254
RI D + CA P G+ D C+GDSGGP + P + RWY G+VS GEGC R
Sbjct: 180 STRIRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGCDRD 238
Query: 255 NEPGVYTRVSQFVPWLMS 272
+ G YT V + W+
Sbjct: 239 GKYGFYTHVFRLKKWIQK 256
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 113 bits (283), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 122/254 (48%), Gaps = 29/254 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PDVTETPEPYSTC----TAVGWGAVFEHGP------DPDHMREVQVPIL--PACKHYED- 202
PD ET GWG + E P ++ V +PI+ P CK
Sbjct: 121 PD-RETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 203 RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPG 258
RI D + CAG P G+ D +GDSGGP + P + RWY G+VS GEG R + G
Sbjct: 180 RITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNN-RWYQMGIVSWGEGADRDGKYG 238
Query: 259 VYTRVSQFVPWLMS 272
YT V + W+
Sbjct: 239 FYTHVFRLKKWIQK 252
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 113 bits (282), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 79/246 (32%), Positives = 123/246 (50%), Gaps = 33/246 (13%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDG----------FEKHY 95
++GG + G+ PWL A+Y F C G ++ WV++AAHC +H+
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSF-CAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 96 FEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAP----LRYNRYVR 151
F + + F E+ P + ++S+F ++ +DL L++L +++V+
Sbjct: 60 FNRTTDVTQTFGI---EKYIPYT---LYSVFNPSD--HDLVLIRLKKKGDRCATRSQFVQ 111
Query: 152 PICLPDVTETPEPYSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKHYEDRIADV- 207
PICLP+ T C GWG + E+ +RE VP++ C E AD+
Sbjct: 112 PICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADIS 171
Query: 208 ---ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
+CAG D CQGDSGGPL C G Y+ G++S G+GC R ++PGVYTRV+
Sbjct: 172 PNMLCAGYFDCKSDACQGDSGGPLACE---KNGVAYLYGIISWGDGCGRLHKPGVYTRVA 228
Query: 265 QFVPWL 270
+V W+
Sbjct: 229 NYVDWI 234
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 113 bits (282), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 79/246 (32%), Positives = 123/246 (50%), Gaps = 33/246 (13%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDG----------FEKHY 95
++GG + G+ PWL A+Y F C G ++ WV++AAHC +H+
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSF-CAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 96 FEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAP----LRYNRYVR 151
F + + F E+ P + ++S+F ++ +DL L++L +++V+
Sbjct: 60 FNRTTDVTQTFGI---EKYIPYT---LYSVFNPSD--HDLVLIRLKKKGDRCATRSQFVQ 111
Query: 152 PICLPDVTETPEPYSTCTAVGWGAVFEHGPD-PDHMREVQVPILP--ACKHYEDRIADV- 207
PICLP+ T C GWG + E+ +RE VP++ C E AD+
Sbjct: 112 PICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADIS 171
Query: 208 ---ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS 264
+CAG D CQGDSGGPL C G Y+ G++S G+GC R ++PGVYTRV+
Sbjct: 172 PNMLCAGYFDCKSDACQGDSGGPLACE---KNGVAYLYGIISWGDGCGRLHKPGVYTRVA 228
Query: 265 QFVPWL 270
+V W+
Sbjct: 229 NYVDWI 234
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 112 bits (281), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 74/254 (29%), Positives = 119/254 (46%), Gaps = 33/254 (12%)
Query: 47 VGGKKAELGAWPWLIALYRDGF------FHCGGVVLDESWVMTAAHCVDGFEKHYF---- 96
GG ++ + PW A++ F CGG+++ WV+TAAHC F++ Y
Sbjct: 15 TGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHC---FQESYLPDQL 71
Query: 97 EVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAP----LRYNRYVRP 152
+V G R EQ V + ++H F ND+ALLQL + + + VR
Sbjct: 72 KVVLGRTYRVKPGEEEQTFKVKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQESDSVRA 131
Query: 153 ICLPDVTETPEPYSTCTAVGWGAVFEHGP-DPDHMREVQVPILPACK------HYEDRIA 205
ICLP+ ++ C G+G P + ++E V + P+ + +
Sbjct: 132 ICLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFLFNKTVTN 191
Query: 206 DVICAGMPQGGR------DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGV 259
+++CAG + G D CQGDSGGPL+C + + G++S G GC + PGV
Sbjct: 192 NMLCAGDTRSGEIYPNVHDACQGDSGGPLVCM---NDNHMTLLGIISWGVGCGEKDVPGV 248
Query: 260 YTRVSQFVPWLMSN 273
YT+V+ ++ W+ N
Sbjct: 249 YTKVTNYLGWIRDN 262
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 111 bits (278), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 75/235 (31%), Positives = 121/235 (51%), Gaps = 19/235 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+V G + + P+ ALY G CGGV++ WV+TAAHC +K +V+ G
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLGKHNL 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+++ V R V+H + A D+ LL+LA P + + ++P LP +
Sbjct: 57 RQRESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSANT 114
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTCQ 221
++C +GWG + G PD ++ + ++ C+H Y +I +++CAG + G+D+CQ
Sbjct: 115 TSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMSNSE 275
GDSGGPL+C G R G+VS G C +PGVYT V ++ W+ +
Sbjct: 174 GDSGGPLVC---GDHLR----GLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 111 bits (278), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 80/232 (34%), Positives = 113/232 (48%), Gaps = 20/232 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG +A G +P+++ L CGG + + V+TAAHCV G + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
S +VR ++++ + D AL++LA P+ +P L T T
Sbjct: 57 LQSSSAVKVRS-TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPT-LKIATTTAYNQ 107
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKH-YEDRIA--DVICAGMPQGGRDTC 220
T T GWGA E G ++ + VP + AC+ Y + + + ICAG GG DTC
Sbjct: 108 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYDTGGVDTC 167
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
QGDSGGP+ + W G+VS GEGCAR + GVYT VS F + S
Sbjct: 168 QGDSGGPMFRKDNADE--WIQVGIVSWGEGCARKGKYGVYTEVSTFASAIAS 217
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 111 bits (277), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 24/242 (9%)
Query: 46 VVGGKKAELGAWPWLIALY----RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
++GG +A+ + P++ L G CGG ++ E +V+TAAHC +V G
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGS----KIQVTLG 56
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+Q+ PV +I+ H + ++ND+ LL+L + + + V+P+ LP
Sbjct: 57 AHNIKEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPRRNVK 116
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL------PACKHYEDRIADVICAGMPQG 215
+P C GWG + G D ++EV++ + K+Y D+ A+ ICAG P+
Sbjct: 117 VKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFDK-ANEICAGDPKI 175
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
R + +GDSGGPL+C + AG+VS+G+ + P +T+VS F+ W+ +
Sbjct: 176 KRASFRGDSGGPLVC-------KKVAAGIVSYGQNDG--STPRAFTKVSTFLSWIKKTMK 226
Query: 276 RA 277
++
Sbjct: 227 KS 228
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 111 bits (277), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG +A G +P+++ L CGG + + V+TAAHCV G + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
S +VR ++++ + D AL++LA P+ +P L T T
Sbjct: 57 LQSSSAVKVRS-TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPT-LKIATTTAYNQ 107
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKH-YEDRIA--DVICAGMPQ-GGRDT 219
T T GWGA E G ++ + VP + AC+ Y + + + ICAG P GG DT
Sbjct: 108 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYPDTGGVDT 167
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
CQGDSGGP+ + W G+VS G GCARP PGVYT VS F + S
Sbjct: 168 CQGDSGGPMF--RKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 218
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 110 bits (276), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 78/244 (31%), Positives = 125/244 (51%), Gaps = 24/244 (9%)
Query: 44 GRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHY----FEVY 99
G++ GG+KA+ G +PW + + G G +L ++WV+TAAH V +E+ + ++
Sbjct: 160 GQIYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAV--YEQKHDASALDIR 215
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP--D 157
G L+R S T Q + + A ND+AL++L + N + PICLP +
Sbjct: 216 MGTLKRLSPHYT-QAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKE 274
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK---HYE-------DRIADV 207
TA GWG + + G ++ V +PI+ K YE A++
Sbjct: 275 AESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 333
Query: 208 ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQF 266
+CAG+ GG+D+C+GDSGG L+ + RW+V G+VS G C + GVYT+V +
Sbjct: 334 LCAGLESGGKDSCRGDSGGALVF-LDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINY 392
Query: 267 VPWL 270
+PW+
Sbjct: 393 IPWI 396
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 110 bits (276), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 77/242 (31%), Positives = 123/242 (50%), Gaps = 24/242 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHY----FEVYAG 101
+ GG+KA+ G +PW + + G G +L ++WV+TAAH V +E+ + ++ G
Sbjct: 1 IYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAV--YEQKHDASALDIRMG 56
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP--DVT 159
L+R S T Q + + A ND+AL++L + N + PICLP +
Sbjct: 57 TLKRLSPHYT-QAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAE 115
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK---HYE-------DRIADVIC 209
TA GWG + + G ++ V +PI+ K YE A+++C
Sbjct: 116 SFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLC 174
Query: 210 AGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVP 268
AG+ GG+D+C+GDSGG L+ + RW+V G+VS G C + GVYT+V ++P
Sbjct: 175 AGLESGGKDSCRGDSGGALVF-LDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIP 233
Query: 269 WL 270
W+
Sbjct: 234 WI 235
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 110 bits (274), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 76/236 (32%), Positives = 123/236 (52%), Gaps = 21/236 (8%)
Query: 46 VVGGKK-AELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
+VGG + + P+ ++L F GG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCS---YKSRIQVRLGEHN 57
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
EQ ++I+ H F + ND+ L++L++P N V + LP
Sbjct: 58 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR--SCAAA 115
Query: 165 YSTCTAV-GWGAVFEHGPD-PDHMR-EVQVPIL--PACK-HYEDRIA-DVICAGMPQGGR 217
+ C+ + GWG G P ++ ++ P+L +CK Y +I ++IC G +GG+
Sbjct: 116 GTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGK 175
Query: 218 DTC-QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGC-ARPNEPGVYTRVSQFVPWLM 271
D+C QGDSGGP++C S G+ + G+VS G GC A+ N+PGVYT+V +V W+
Sbjct: 176 DSCSQGDSGGPVVC----SNGQ--LQGIVSWGYGCSAQKNKPGVYTKVCNYVNWIQ 225
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 109 bits (273), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 74/242 (30%), Positives = 111/242 (45%), Gaps = 14/242 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDG---FFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
V+GG A G +PW ++ R CG +L + ++A+HCVDG + V AG+
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIAGL 60
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFK--RAEMTNDLALLQLAAPLRYNRYVRPICLPDVTE 160
++ S T Q V MH + A +ND+A+L LA + ++ LP
Sbjct: 61 WQQSDTSGT-QTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPANNN 119
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIA--------DVICAGM 212
+TC GWG PD +++ +P++ + + + IC
Sbjct: 120 NDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNHICVQD 179
Query: 213 PQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
P G C GDSGGPL CP G++ + VVS G G P+ P VYTRVS ++ W+
Sbjct: 180 PAGNTGACNGDSGGPLNCPDGGTRVVGVTSWVVSSGLGACLPDYPSVYTRVSAYLGWIGD 239
Query: 273 NS 274
NS
Sbjct: 240 NS 241
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 109 bits (273), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 76/242 (31%), Positives = 123/242 (50%), Gaps = 24/242 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHY----FEVYAG 101
+ GG+KA+ G +PW + + G G +L ++WV+TAAH V +E+ + ++ G
Sbjct: 1 IYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAV--YEQKHDASALDIRMG 56
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP--DVT 159
L+R S T Q + + A ND+AL++L + N + PICLP +
Sbjct: 57 TLKRLSPHYT-QAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAE 115
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK---HYE-------DRIADVIC 209
TA GWG + + G ++ V +PI+ K YE A+++C
Sbjct: 116 SFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLC 174
Query: 210 AGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVP 268
AG+ GG+D+C+GD+GG L+ + RW+V G+VS G C + GVYT+V ++P
Sbjct: 175 AGLESGGKDSCRGDAGGALVF-LDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIP 233
Query: 269 WL 270
W+
Sbjct: 234 WI 235
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 109 bits (273), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 113/233 (48%), Gaps = 21/233 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG +A G +P+++ L CGG + + V+TAAHCV G + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+VR ++++ + D AL++LA P+ +P L T T
Sbjct: 57 LQSGAAVKVRS-TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPT-LKIATTTAYNQ 107
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKH-YEDRIA--DVICAGMPQ-GGRDT 219
T T GWGA E G ++ + VP + AC+ Y + + + ICAG P GG DT
Sbjct: 108 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYPDTGGVDT 167
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
CQGDSGGP+ + W G+VS G GCARP PGVYT VS F + S
Sbjct: 168 CQGDSGGPMF--RKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 218
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 109 bits (272), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 75/236 (31%), Positives = 122/236 (51%), Gaps = 19/236 (8%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++V G + + P+ ALY G CGGV++ WV+TAAHC +K +V+ G
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLGKHN 56
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+++ V R V+H + A D+ LL+LA P + + ++P LP +
Sbjct: 57 LRQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQ 114
Query: 165 YSTCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTC 220
++C +GWG + G PD ++ + ++ C+H Y +I +++CAG + G+D+C
Sbjct: 115 TTSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSC 173
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMSNSE 275
QGDSGGPL+C G R G+VS G C +PGVYT V ++ W+ +
Sbjct: 174 QGDSGGPLVC---GDHLR----GLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 222
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 109 bits (272), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG + + P+++ L D C G ++ + WV+TAAHC K +V G
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHC--NLNKRS-QVILGAHSI 57
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
PT+Q+ V + + + A DL LLQL + N+YV + LP + +P
Sbjct: 58 TREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPG 117
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPIL--PAC---KHYEDRIA---DVICAGMPQGGR 217
+ C GWG D +REV++ I+ C HY +++CAG +GGR
Sbjct: 118 TMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGR 177
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG--EGCARPNEPGVYTRVS-QFVPWLM 271
D+C GDSG PLLC GV S G C P PGVY +S + + W++
Sbjct: 178 DSCNGDSGSPLLC-------EGVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWII 227
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 74/237 (31%), Positives = 110/237 (46%), Gaps = 21/237 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG + + P+++ L D C G ++ + WV+TAAHC K +V G
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHC--NLNKRS-QVILGAHSI 57
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
PT+Q+ V + + + A DL LLQL + N+YV + LP + +P
Sbjct: 58 TREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPG 117
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPIL--PAC---KHYEDRIA---DVICAGMPQGGR 217
+ C GWG D +REV + I+ C HY +++CAG +GGR
Sbjct: 118 TMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGR 177
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG--EGCARPNEPGVYTRVS-QFVPWLM 271
D+C GDSG PLLC GV S G C P PGVY +S + + W++
Sbjct: 178 DSCNGDSGSPLLC-------EGVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWII 227
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 73/236 (30%), Positives = 113/236 (47%), Gaps = 14/236 (5%)
Query: 46 VVGGKKAELGAWPWLIALY---RDGFFH-CGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
VVGG+ A +WPW I+L D + H CGG ++ ++V+TAAHC+ + V
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTYRVAVGKN 60
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
L + V V I +H + + ND+AL++LA + + ++ CLP+
Sbjct: 61 NLEVEDEEGSLFV-GVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACLPEKDSL 119
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYE---DRIADVICAGMPQGG 216
C GWG ++ +GP D +++ P++ C + R+ + G
Sbjct: 120 LPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVKKTMVCAGGDGV 179
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE--GCARPNEPGVYTRVSQFVPWL 270
C GDSGGPL C + G W V G+VS G GC +P VYTRVS ++ W+
Sbjct: 180 ISACNGDSGGPLNCQL--ENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDWI 233
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 108 bits (269), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 75/235 (31%), Positives = 121/235 (51%), Gaps = 19/235 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+V G + + P+ ALY G CGGV++ WV+TAAHC +K +V+ G
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLGKHNL 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
+++ V R V+H + A D+ LL+LA P + + ++P LP +
Sbjct: 57 GQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQT 114
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTCQ 221
++C +GWG + G PD ++ + ++ C+H Y +I +++CAG + G+D+CQ
Sbjct: 115 TSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQ 173
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMSNSE 275
GDSGGPL+C G R G+VS G C +PGVYT V ++ W+ +
Sbjct: 174 GDSGGPLVC---GDHLR----GLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 108 bits (269), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 113/233 (48%), Gaps = 21/233 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
VVGG +A G +P+++ L CGG + + V+TAAHCV G + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
S +VR ++++ + D AL++LA P+ +P L T T
Sbjct: 57 LQSSSAVKVRS-TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPT-LKIATTTAYNQ 107
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILP--ACKH-YEDRIA--DVICAGMPQ-GGRDT 219
T T GWGA E G ++ + VP + AC+ Y + + + ICAG P GG D
Sbjct: 108 GTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYPDTGGVDP 167
Query: 220 CQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
CQGDSGGP+ + W G+VS G GCARP PGVYT VS F + S
Sbjct: 168 CQGDSGGPMF--RKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 218
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 108 bits (269), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 69/240 (28%), Positives = 119/240 (49%), Gaps = 19/240 (7%)
Query: 45 RVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAGML 103
++GGK+ + P++ ++ G CGGV++D WV+TAAHC F K V G
Sbjct: 2 EIIGGKEVSPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSPTVVLGAH 61
Query: 104 RRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE 163
++Q + + + S +ND+ L++L + N++V+ + + T
Sbjct: 62 SLSKNEASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRSKTSL-R 120
Query: 164 PYSTCTAVGWGAVFEHGPDP-DHMREVQVPILP-----ACKHYEDR---IADVICAGMPQ 214
+ C GWGA P D +REV V +L + +Y D++CAG +
Sbjct: 121 SGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVCAGDAK 180
Query: 215 GGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVS-QFVPWLMSN 273
G +D+C+GD+GGPL+C +G ++ +VS G C +PG+YT ++ ++ W+ SN
Sbjct: 181 GQKDSCKGDAGGPLIC-----KGVFH--AIVSGGHECGVATKPGIYTLLTKKYQTWIKSN 233
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 107 bits (267), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 72/235 (30%), Positives = 114/235 (48%), Gaps = 21/235 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
V GG + + L+ L+ F CGG ++++ WV+TAAHC + + F++ G+ +
Sbjct: 1 VFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHC----DSNNFQLLFGVHSK 56
Query: 106 FSFSPTEQVR-PVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ EQ R P + + K E+ D+ L++L + + + ++ P L + P
Sbjct: 57 KILNEDEQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHIAP--LSLPSSPPSV 114
Query: 165 YSTCTAVGWGAVF---EHGPDPDHMREVQVPILPACK---HYEDRIADVICAGMPQGGRD 218
S C +GWG E PD H + + C+ + +CAG+ QGGRD
Sbjct: 115 GSVCRIMGWGKTIPTKEIYPDVPHCANINILDHAVCRTAYSWRQVANTTLCAGILQGGRD 174
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVS-HGEGCARPNEPGVYTRVSQFVPWLMS 272
TC DSGGPL+C G+VS G C +P EPGVYT+V ++ W+ S
Sbjct: 175 TCHFDSGGPLIC-------NGIFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKS 222
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 107 bits (267), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 49 GKKAELGAWPWLIALY--RDGFFH--CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
G+ A +W W ++L +DG FH CGG ++ WV+TA HC+ ++V G
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCIS--TSRTYQVVLGEYD 59
Query: 105 RFSFSPTEQVRPVS--RIVMHSMFKRAEMT--NDLALLQLAAPLRYNRYVRPICLPDVTE 160
R +EQV P++ + +H ++ + ND+AL++L+ + V+ LP +
Sbjct: 60 RSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLPPAGD 119
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPA--CKHYE----DRIADVICAGMPQ 214
+ C GWG ++ GP PD +++ +P + C ++ ++CAG
Sbjct: 120 ILPNEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWGITVKKTMVCAGGDT 179
Query: 215 GGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVS--HGEGCARPNEPGVYTRVSQFVPWL 270
R C GDSGGPL C P + G W V GV S GC +P V+TRVS F+ W+
Sbjct: 180 --RSGCNGDSGGPLNC--PAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWI 233
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 107 bits (267), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 71/236 (30%), Positives = 123/236 (52%), Gaps = 21/236 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
V+GG + ++ +L+A + F CGG +++ WV+TAAHC + F++ G+ +
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC----DSTNFQMQLGVHSK 56
Query: 106 FSFSPTEQVR-PVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ EQ R P + + + + D+ L++L P+ ++++ P L + P
Sbjct: 57 KVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAP--LSLPSSPPSV 114
Query: 165 YSTCTAVGWGA---VFEHGPDPDHMREVQVPILPACKH-YEDRIAD--VICAGMPQGGRD 218
S C +GWG+ V E PD + + + C+ Y + +A+ +CAG+ QGG+D
Sbjct: 115 GSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKD 174
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMSN 273
TC GDSGGPL+C G++ G+VS+G C + +PG+YT V + W+ N
Sbjct: 175 TCGGDSGGPLIC-----NGQF--QGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 76/240 (31%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 46 VVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
++ G ++ PW AL R +CG V++ W++TAAHC K F V G
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHC----RKKVFRVRLG--- 53
Query: 105 RFSFSPT----EQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTE 160
+S SP +Q+ + + H + +NDL L++L +R + VRPI + +
Sbjct: 54 HYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVS--SH 111
Query: 161 TPEPYSTCTAVGWGAVFE---HGPDPDHMREVQVPILPACKH-YEDRIADVICAGMPQGG 216
P + C GWG H P + V C+ Y +I D + + G
Sbjct: 112 CPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQIDDTMFCAGDKAG 171
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMSNSE 275
RD+CQGDSGGP++C GS + G+VS G+ CARPN PGVYT + +F W+ +
Sbjct: 172 RDSCQGDSGGPVVC--NGS-----LQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETIQ 224
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 71/236 (30%), Positives = 123/236 (52%), Gaps = 21/236 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
V+GG + ++ +L+A + F CGG +++ WV+TAAHC + F++ G+ +
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC----DSTDFQMQLGVHSK 56
Query: 106 FSFSPTEQVR-PVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ EQ R P + + + + D+ L++L P+ ++++ P L + P
Sbjct: 57 KVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAP--LSLPSSPPSV 114
Query: 165 YSTCTAVGWGA---VFEHGPDPDHMREVQVPILPACKH-YEDRIAD--VICAGMPQGGRD 218
S C +GWG+ V E PD + + + C+ Y + +A+ +CAG+ QGG+D
Sbjct: 115 GSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKD 174
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHG-EGCARPNEPGVYTRVSQFVPWLMSN 273
TC GDSGGPL+C G++ G+VS+G C + +PG+YT V + W+ N
Sbjct: 175 TCGGDSGGPLIC-----NGQF--QGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 74/237 (31%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGML 103
VVGG + + P+L+ALY HC G +++ WV+TAAHC ++ + GM
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHC----DRRNIRIKLGMH 56
Query: 104 RRFSFSPTEQVRPVSR---IVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTE 160
+ + EQ+R V R +++ F + D+ L++L P+ Y+ ++ P+ LP +
Sbjct: 57 SKNIRNEDEQIR-VPRGKYFCLNTKFPNG-LDKDIMLIRLRRPVTYSTHIAPVSLP--SR 112
Query: 161 TPEPYSTCTAVGWGAVFEHG-PDPDHMREVQVPILPACKHYEDRI---ADVICAGMPQGG 216
+ S C +GWG + PD H + + C+ + + +CAG+ +GG
Sbjct: 113 SRGVGSRCRIMGWGKISTTTYPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGILKGG 172
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG-EGCARPNEPGVYTRVSQFVPWLMS 272
RDTC GDSGGPL+C G + G+V+ G E C + +P VYT+V + W+ S
Sbjct: 173 RDTCHGDSGGPLIC-----NGEMH--GIVAGGSEPCGQHLKPAVYTKVFDYNNWIQS 222
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 74/240 (30%), Positives = 113/240 (47%), Gaps = 20/240 (8%)
Query: 46 VVGGKKAELGAWPWL--IALYRDGFFH-CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
++GG +A+ + P++ + G H CGG ++ E +V+TAAHC+ V G
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCLGS----SINVTLGA 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
T+QV PV R + H + + ND+ LL+L V PI LP
Sbjct: 57 HNIMERERTQQVIPVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINLPRSLAEV 116
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK---HYEDRIA-DVICAGMPQGGRD 218
+P C+ GWG + + P D ++EV + + K +++ I ICAG P ++
Sbjct: 117 KPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQSEEKCIARFKNYIPFTQICAGDPSKRKN 176
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSERAK 278
+ GDSGGPL+C G+VS+G P VYTR+S F+ W+ S R K
Sbjct: 177 SFSGDSGGPLVC-------NGVAQGIVSYGRNDG--TTPDVYTRISSFLSWIHSTMRRYK 227
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 23/240 (9%)
Query: 46 VVGGKKAELGAWPWLIALY---RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
++GG +A+ + P++ L + CGG ++ + +V+TAAHC V G
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWGS----SINVTLGA 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
PT+Q PV R + H + +ND+ LLQL + R V+P+ LP
Sbjct: 57 HNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQV 116
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK------HYEDRIADVICAGMPQGG 216
+P TC+ GWG G ++EV++ + K HY D + +C G P+
Sbjct: 117 KPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIE-LCVGDPEIK 175
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
+ + +GDSGGPL+C G+VS+G P P T+VS FV W+ +R
Sbjct: 176 KTSFKGDSGGPLVC-------NKVAQGIVSYGRNNGMP--PRACTKVSSFVHWIKKTMKR 226
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 105 bits (263), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 23/240 (9%)
Query: 46 VVGGKKAELGAWPWLIALY---RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
++GG +A+ + P++ L + CGG ++ + +V+TAAHC V G
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGS----SINVTLGA 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
PT+Q PV R + H + +ND+ LLQL + R V+P+ LP
Sbjct: 57 HNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQV 116
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK------HYEDRIADVICAGMPQGG 216
+P TC+ GWG G ++EV++ + K HY D + +C G P+
Sbjct: 117 KPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIE-LCVGDPEIK 175
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
+ + +GDSGGPL+C G+VS+G P P T+VS FV W+ +R
Sbjct: 176 KTSFKGDSGGPLVC-------NKVAQGIVSYGRNNGMP--PRACTKVSSFVHWIKKTMKR 226
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 76/241 (31%), Positives = 120/241 (49%), Gaps = 19/241 (7%)
Query: 43 SGRVVGGKKAELGAWPWLIAL--YRDGFFH--CGGVVLDESWVMTAAHCVDGFEKHYFEV 98
S RVVGG+ A +WPW I+L RD + CGG ++ + V+TAAHC+ + +
Sbjct: 11 SARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYRVAL 70
Query: 99 YAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP-D 157
L + + V V I +H + + ND+AL++LA + ++ CLP +
Sbjct: 71 GKNNLEVEDEAGSLYV-GVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACLPSE 129
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYE----DRIADVICAG 211
+ P+ Y C GWG ++ +GP +++ P++ C + ++CAG
Sbjct: 130 GSLLPQDYP-CFVTGWGRLYTNGPIAAELQQGLQPVVDYATCSQRDWWGTTVKETMVCAG 188
Query: 212 MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG--CARPNEPGVYTRVSQFVPW 269
G C GDSGGPL C + G+W V G+VS G G C +P V+TRVS ++ W
Sbjct: 189 -GDGVISACNGDSGGPLNCQ---ADGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSAYIDW 244
Query: 270 L 270
+
Sbjct: 245 I 245
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 104 bits (260), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 78/236 (33%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 46 VVGGKKAELGAWPWLIALYR---DGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG +A +PW +++ R D F CGG ++++ WV+ AAHC+ G + G
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHF-CGGSIINDRWVVCAAHCMQGEAPALVSLVVGE 59
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
+ S Q V I ++ + A + ND+++++ A + ++ V PIC PD
Sbjct: 60 HDSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPD-PAND 118
Query: 163 EPYSTCTAVGWGAVFEHGP-DPDHMREVQVPILPA--CK--HYEDRI-ADVICAGMPQG- 215
Y GWG + G P +R V + I C + D I D+ICA G
Sbjct: 119 YVYRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIYDDMICATDNTGM 178
Query: 216 -GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
RD+CQGDSGGPL V G + + G+VS G GCA PGVY+RV W+
Sbjct: 179 TDRDSCQGDSGGPL--SVKDGSGIFSLVGIVSWGIGCAS-GYPGVYSRVGFHAGWI 231
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 119/234 (50%), Gaps = 23/234 (9%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++ G++ + PW AL++ CGGV++ + WV+TAAHC +K + V G
Sbjct: 1 ILEGRECIPHSQPWQAALFQGERLICGGVLVGDRWVLTAAHC----KKQKYSVRLGDHSL 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRA---EMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
S EQ V++ + H + + + ++D+ L++L V+P+ L ++ P
Sbjct: 57 QSRDQPEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQLANL--CP 114
Query: 163 EPYSTCTAVGWGAVF---EHGPDPDHMREVQVPILPACKH-YEDRIAD-VICAGMPQGGR 217
+ C GWG V E+ P+ + EV++ C+ Y +I + ++CAG G
Sbjct: 115 KVGQKCIISGWGTVTSPQENFPNTLNCAEVKIYSQNKCERAYPGKITEGMVCAGSSNGA- 173
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
DTCQGDSGGPL+C + G+ S G C +P +PGVYT++ ++ W+
Sbjct: 174 DTCQGDSGGPLVC-------DGMLQGITSWGSDPCGKPEKPGVYTKICRYTTWI 220
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 104 bits (259), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/255 (30%), Positives = 127/255 (49%), Gaps = 25/255 (9%)
Query: 38 NPILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFE 97
NP+ R++GG+KA++G +PW + G GG +L + W++TAAH + E H +
Sbjct: 82 NPVEQRQRIIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKE-HEAQ 138
Query: 98 VYAGMLRRFSFSPTEQV-----RPVSRIVMHSMFKRAEMTN---DLALLQLAAPLRYNRY 149
A + + E++ P+ R+ +H +++ E N D+ALL+L +
Sbjct: 139 SNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPN 198
Query: 150 VRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHY---EDRI 204
+ PICLPD +T V V E D +R V++P+ AC+++ ++R+
Sbjct: 199 LLPICLPD-NDTFYDLGLMGYVSGFGVMEEKIAHD-LRFVRLPVANPQACENWLRGKNRM 256
Query: 205 ----ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVY 260
++ CAG P +D CQGDSGG P + RW G+VS G GC+R G Y
Sbjct: 257 DVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTD-RWVATGIVSWGIGCSRGY--GFY 313
Query: 261 TRVSQFVPWLMSNSE 275
T+V +V W+ E
Sbjct: 314 TKVLNYVDWIKKEME 328
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 103 bits (258), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 76/242 (31%), Positives = 116/242 (47%), Gaps = 30/242 (12%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + E + PW + + G CGGV++ WV+TAAHC+ ++ + G
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCI----RNKSVILLGRHSL 56
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTN-----------DLALLQLAAPLRYNRYVRPIC 154
F T QV VS H ++ + + N DL LL+L+ P V+ +
Sbjct: 57 FHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMD 116
Query: 155 LPDVTETPEPYSTCTAVGWGAVF-EHGPDPDHMREVQVPILP----ACKHYEDRIADVIC 209
LP T+ P +TC A GWG++ E P ++ V + ++ A H + ++C
Sbjct: 117 LP--TQEPALGTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQVHPQKVTKFMLC 174
Query: 210 AGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG-EGCARPNEPGVYTRVSQFVP 268
AG GG+ TC GDSGGPL+C + G+ S G E CA P P +YT+V +
Sbjct: 175 AGRWTGGKSTCSGDSGGPLVC-------NGVLQGITSWGSEPCALPERPSLYTKVVHYRK 227
Query: 269 WL 270
W+
Sbjct: 228 WI 229
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 103 bits (256), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 78/255 (30%), Positives = 127/255 (49%), Gaps = 25/255 (9%)
Query: 38 NPILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFE 97
NP+ R++GG+KA++G +PW + G GG +L + W++TAAH + E H +
Sbjct: 82 NPVEQRQRIIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKE-HEAQ 138
Query: 98 VYAGMLRRFSFSPTEQV-----RPVSRIVMHSMFKRAEMTN---DLALLQLAAPLRYNRY 149
A + + E++ P+ R+ +H +++ E N D+ALL+L +
Sbjct: 139 SNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPN 198
Query: 150 VRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHY---EDRI 204
+ PICLPD +T V V E D +R V++P+ AC+++ ++R+
Sbjct: 199 LLPICLPD-NDTFYDLGLMGYVSGFGVMEEKIAHD-LRFVRLPVANPQACENWLRGKNRM 256
Query: 205 ----ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVY 260
++ CAG P +D CQGD+GG P + RW G+VS G GC+R G Y
Sbjct: 257 DVFSQNMFCAGHPSLKQDACQGDAGGVFAVRDPNTD-RWVATGIVSWGIGCSRGY--GFY 313
Query: 261 TRVSQFVPWLMSNSE 275
T+V +V W+ E
Sbjct: 314 TKVLNYVDWIKKEME 328
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 22/239 (9%)
Query: 46 VVGGKKAELGAWPWLIA---LYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
++GG +A+ + P++ L CGG+++ + +V+TAAHC + V G
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLGA 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
T+Q PV R + H + +ND+ LLQL ++ VRP+ LP
Sbjct: 57 HNIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKAQV 116
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK-----HYEDRIADVICAGMPQGGR 217
+P C+ GWG V ++EV + + C+ H A IC G P+ +
Sbjct: 117 KPGQLCSVAGWGYV-SMSTLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQ 175
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
+GDSGGPL+C + G++S+G P PGVY +VS F+PW+ +R
Sbjct: 176 TGFKGDSGGPLVC-------KDVAQGILSYGNKKGTP--PGVYIKVSHFLPWIKRTMKR 225
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 37/263 (14%)
Query: 39 PILGSGRVVGGKKAELGAWPWLIALYRDGFFH---CGGVVLDESWVMTAAHCVDGFEKHY 95
P R++GG A++ +PW + FF GG +++E WV+TAAH V+G +
Sbjct: 76 PFEEKQRIIGGSDADIKNFPWQV------FFDNPWAGGALINEYWVLTAAHVVEGNREPT 129
Query: 96 FEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFK-------RAEMTNDLALLQLAAPLRYNR 148
V + ++ + ++ + P + +H +K R ND+AL++L P++
Sbjct: 130 MYVGSTSVQTSRLAKSKMLTP-EHVFIHPGWKLLAVPEGRTNFDNDIALVRLKDPVKMGP 188
Query: 149 YVRPICLPDVTETPEPYSTCTAV--GWGAVFEHGPDPDHMREVQVPILPACKHYEDRIA- 205
V PICLP + + GWG E ++ ++P+ P K E ++
Sbjct: 189 TVSPICLPGTSSDYNLMDGDLGLISGWGRT-EKRDRAVRLKAARLPVAPLRKCKEVKVEK 247
Query: 206 ------------DVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCAR 253
++ICAG + G D+C+GDSGG P + ++Y AG+VS G C
Sbjct: 248 PTADAEAYVFTPNMICAGG-EKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCGT 306
Query: 254 PNEPGVYTRVSQFVPWLMSNSER 276
G+YTRV +V W+M +
Sbjct: 307 ---YGLYTRVKNYVDWIMKTMQE 326
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 78/255 (30%), Positives = 127/255 (49%), Gaps = 25/255 (9%)
Query: 38 NPILGSGRVVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFE 97
NP+ +++GG+KA++G +PW + G GG +L + W++TAAH + E H +
Sbjct: 150 NPVEQRQQIIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKE-HEAQ 206
Query: 98 VYAGMLRRFSFSPTEQV-----RPVSRIVMHSMFKRAEMTN---DLALLQLAAPLRYNRY 149
A + + E++ P+ R+ +H +++ E N D+ALL+L +
Sbjct: 207 SNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPN 266
Query: 150 VRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHY---EDRI 204
+ PICLPD +T V V E D +R V++P+ AC+++ ++R+
Sbjct: 267 LLPICLPD-NDTFYDLGLMGYVSGFGVMEEKIAHD-LRFVRLPVANPQACENWLRGKNRM 324
Query: 205 ----ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVY 260
++ CAG P +D CQGDSGG P + RW G+VS G GC+R G Y
Sbjct: 325 DVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTD-RWVATGIVSWGIGCSRGY--GFY 381
Query: 261 TRVSQFVPWLMSNSE 275
T+V +V W+ E
Sbjct: 382 TKVLNYVDWIKKEME 396
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 101 bits (251), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 69/239 (28%), Positives = 111/239 (46%), Gaps = 22/239 (9%)
Query: 46 VVGGKKAELGAWPWLIA---LYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
++GG +A+ + P++ L CGG+++ + +V+TAAHC + V G
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLGA 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
T+Q PV R + H + +N++ LLQL ++ VRP+ LP
Sbjct: 57 HNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQV 116
Query: 163 EPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACK-----HYEDRIADVICAGMPQGGR 217
+P C+ GWG V ++EV + + C+ H A IC G P+ +
Sbjct: 117 KPGQLCSVAGWGYV-SMSTLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQ 175
Query: 218 DTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
+GDSGGPL+C + G++S+G P PGVY +VS F+PW+ +R
Sbjct: 176 TGFKGDSGGPLVC-------KDVAQGILSYGNKKGTP--PGVYIKVSHFLPWIKRTMKR 225
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 76/248 (30%), Positives = 123/248 (49%), Gaps = 25/248 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG+KA++G +PW + G GG +L + W++TAAH + E H + A +
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKE-HEAQSNASLDVF 57
Query: 106 FSFSPTEQV-----RPVSRIVMHSMFKRAEMTN---DLALLQLAAPLRYNRYVRPICLPD 157
+ E++ P+ R+ +H +++ E N D+ALL+L + + PICLPD
Sbjct: 58 LGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPD 117
Query: 158 VTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHY---EDRI----ADVI 208
+T V V E D +R V++P+ AC+++ ++R+ ++
Sbjct: 118 -NDTFYDLGLMGYVSGFGVMEEKIAHD-LRFVRLPVANPQACENWLRGKNRMDVFSQNMF 175
Query: 209 CAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVP 268
CAG P +D CQGDSGG P + RW G+VS G GC+R G YT+V +V
Sbjct: 176 CAGHPSLKQDACQGDSGGVFAVRDPNTD-RWVATGIVSWGIGCSRG--YGFYTKVLNYVD 232
Query: 269 WLMSNSER 276
W+ E
Sbjct: 233 WIKKEMEE 240
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 120/237 (50%), Gaps = 25/237 (10%)
Query: 46 VVGGKKAELGAWPWLIALY--RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGML 103
++GG + + +L+ALY R CGG ++++ WV+TAAHC ++ F + GM
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHC----DRKNFRIKLGMH 56
Query: 104 RRFSFSPTEQVR-PVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
+ + EQ R P + S D+ L++L +P++ ++++ P + P
Sbjct: 57 SKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHIAP--FSLPSSPP 114
Query: 163 EPYSTCTAVGWGAVF-EHGPDPDHMREVQVPIL-------PACKHYEDRIADVICAGMPQ 214
S C +GWG + G PD V + +L P + + +CAG+ +
Sbjct: 115 SVGSVCRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILE 174
Query: 215 GGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
GG+DTC+GDSGGPL+C G++ G+ S G+ CA+P++P YT+V + W+
Sbjct: 175 GGKDTCKGDSGGPLIC-----NGQF--QGIASWGDDPCAQPHKPAAYTKVFDHLDWI 224
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 17/243 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++ + P++ +L R+G CGGV++ WV+TAAHC+ + G+
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCL-AQRMAQLRLVLGLHTL 59
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRA-EMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
S T ++ + H +K + NDLALLQL ++ +R +RP+ LP +
Sbjct: 60 DSPGLTFHIKAA---IQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVAA 116
Query: 165 YSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRI------ADVICAGMPQGGRD 218
+ C+ GWG + G +RE+ + +L R ++C +
Sbjct: 117 GTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQA 176
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMSNSERA 277
C+GDSGGPL+C +GR +AGV+S C +P V T V+ +V W+ + R+
Sbjct: 177 PCKGDSGGPLVC----GKGR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVTGRS 231
Query: 278 KVE 280
+E
Sbjct: 232 ALE 234
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 46 VVGGKKAELGAWPWLIALY---RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
+VGG +A+ + P++ +L G CGG ++ S+V+TAAHC+ + V G
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVNVVLGA 60
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
+ PT+Q V+++ +++ + ND+ L+QL++P + V + LP + P
Sbjct: 61 HNVRTQEPTQQHFSVAQVFLNN-YDAENKLNDILLIQLSSPANLSASVATVQLPQ-QDQP 118
Query: 163 EPYST-CTAVGWGAVFEHGPDPDHMREVQVPILP-ACKHYEDRIADVICAGMPQGGRDTC 220
P+ T C A+GWG V H P ++E+ V ++ C+ + IC +P+ C
Sbjct: 119 VPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVTFFCRPHN------ICTFVPRRKAGIC 172
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMSN 273
GDSGGPL+C + G+ S GCA P +TRV+ +V W+ S
Sbjct: 173 FGDSGGPLIC-------DGIIQGIDSFVIWGCATRLFPDFFTRVALYVDWIRST 219
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 68/243 (27%), Positives = 118/243 (48%), Gaps = 17/243 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++ + P++ +L R+G CGGV++ WV+TAAHC+ + G+
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCL-AQRMAQLRLVLGLHTL 59
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRA-EMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
S T ++ + H +K + N+LALLQL ++ +R +RP+ LP +
Sbjct: 60 DSPGLTFHIKAA---IQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVVAA 116
Query: 165 YSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIAD------VICAGMPQGGRD 218
+ C+ GWG + G +RE+ + +L R + ++C +
Sbjct: 117 GTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQA 176
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMSNSERA 277
C+GDSGGPL+C +GR +AGV+S C +P V T V+ +V W+ + R+
Sbjct: 177 PCKGDSGGPLVC----GKGR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVTGRS 231
Query: 278 KVE 280
+E
Sbjct: 232 ALE 234
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++ G+ + PW AL + C GV++ WV++AAHC F+ Y
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHC---FQNSYTIGLGLHSLE 57
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
P Q+ S V H + R + NDL L++L + + +R I + ++ P
Sbjct: 58 ADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISI--ASQCPTAG 115
Query: 166 STCTAVGWGAVFEHGPDPDHMR--EVQVPILPACKHYEDRIA--DVICAGMPQGGRDTCQ 221
++C GWG + +G P ++ V V C D + + CAG Q +D+C
Sbjct: 116 NSCLVSGWG-LLANGRMPTVLQCVNVSVVSEEVCSKLYDPLYHPSMFCAGGGQDQKDSCN 174
Query: 222 GDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
GDSGGPL+C Y+ G+VS G+ C + PGVYT + +F W+
Sbjct: 175 GDSGGPLIC-------NGYLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWI 217
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 115/248 (46%), Gaps = 30/248 (12%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG + E + PW +A+Y G F CGGV++ WV+TAAHC+ ++++ G
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCMSD----DYQIWLGRHNL 56
Query: 106 FSFSPTEQVRPVSRIVMH-----SMFKRA------EMTNDLALLQLAAPLRYNRYVRPIC 154
T Q VS + S+ K+ ++++DL LL+LA P R V+ +
Sbjct: 57 SKDEDTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAVKILD 116
Query: 155 LPDVTETPEPYSTCTAVGWGAV---FEHGPDPDHMREVQVPILPAC-KHYEDRIAD-VIC 209
LP T+ P+ STC GWG + G E+++ C + Y +++ + V+C
Sbjct: 117 LP--TQEPKLGSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKCARAYPEKMTEFVLC 174
Query: 210 AGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVP 268
A C GDSGG L+C G+ S G CA N+ V+T+V
Sbjct: 175 ATHRDDSGSICLGDSGGALICDG-------VFQGITSWGYSECADFNDNFVFTKVMPHKK 227
Query: 269 WLMSNSER 276
W+ E+
Sbjct: 228 WIKETIEK 235
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 67/234 (28%), Positives = 107/234 (45%), Gaps = 17/234 (7%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG +A +WP AL+ D + CGG ++ W++TAAHC+DG + +V G
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDG--AGFVDVVLGAHNI 58
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
T+ + +H + ++ND+A+++L P+ + + LP +
Sbjct: 59 REDEATQVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLP--STDVGVG 116
Query: 166 STCTAVGWGAVFEHGPD-PDHMREVQVPILPA--CKHYEDRIADVICAGMPQGGRDTCQG 222
+ T GWG + D +R+V VPI+ C + D GG+ TC G
Sbjct: 117 TVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGIVTDGNICIDSTGGKGTCNG 176
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHG--EGCARPNEPGVYTRVSQFVPWLMSNS 274
DSGGPL G Y G+ S G GC P +TRV+ F+ W+ + +
Sbjct: 177 DSGGPL-----NYNGLTY--GITSFGAAAGC-EAGYPDAFTRVTYFLDWIQTQT 222
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 18/220 (8%)
Query: 59 WLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM--LRRFSFSPTEQVRP 116
W+++L CGG ++ ESWV+TA C + +E + G+ + +QV
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCKQVLN 72
Query: 117 VSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAV 176
VS++V +DL L++LA P + +V I LP+ T ++C+ GWG
Sbjct: 73 VSQLVY------GPEGSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGYT 126
Query: 177 FEHGPDPDHMREVQVPIL---PACKHYEDRIA---DVICAGMPQGGRDTCQGDSGGPLLC 230
D +R + I+ +H+ ++ ICAG + G C+GD GGPL+C
Sbjct: 127 GLINYD-GLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVC 185
Query: 231 PVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
V GV+ G GCA PN PG++ RV+ + W+
Sbjct: 186 E---QHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWI 222
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 18/220 (8%)
Query: 59 WLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM--LRRFSFSPTEQVRP 116
W+++L CGG ++ ESWV+TA C + +E + G+ + +QV
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCKQVLN 72
Query: 117 VSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAV 176
VS++V +DL L++LA P + +V I LP+ T ++C+ GWG
Sbjct: 73 VSQLVY------GPEGSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGYT 126
Query: 177 FEHGPDPDHMREVQVPIL---PACKHYEDRIA---DVICAGMPQGGRDTCQGDSGGPLLC 230
D +R + I+ +H+ ++ ICAG + G C+GD GGPL+C
Sbjct: 127 GLINYD-GLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVC 185
Query: 231 PVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
V GV+ G GCA PN PG++ RV+ + W+
Sbjct: 186 E---QHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWI 222
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 94.7 bits (234), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 20/232 (8%)
Query: 46 VVGGKKAELGAWPWL----IALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
++GG + A P++ I + C G ++ ++VMTAAHC V G
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAG----RSITVLLG 56
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
+ T Q V + H + + ND+ LL+L V + + + +
Sbjct: 57 AHNKKVKEDTWQKLEVEKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISAKSNS 116
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYEDRIAD-VICAGMPQGGRD 218
P C AVGWG + P D ++EV++ IL ACKH+ED + +C G P+ R+
Sbjct: 117 IPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHFEDFHQEPQLCVGNPKKIRN 176
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+GDSGGPLLC G+ S+ A+P P V+TR+S + PW+
Sbjct: 177 VYKGDSGGPLLCA-------GIAQGIASYVLRNAKP--PSVFTRISHYRPWI 219
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 94.7 bits (234), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 71 CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAE 130
CGG ++ + +V+TAAHC + V G + T+Q+ PV++ + H + +
Sbjct: 30 CGGFLVRDKFVLTAAHC----KGRSMTVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPDD 85
Query: 131 MTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQ 190
+ND+ LL+L + R VRP+ LP +P C GWG V G P + EV+
Sbjct: 86 RSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVK 145
Query: 191 VPILP--ACK-HYEDRI--ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVV 245
+ + C+ ++ A+ IC G + + +GDSGGPL+C + AG+V
Sbjct: 146 LTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFRGDSGGPLVC-------KRAAAGIV 198
Query: 246 SHGEGCARPNEPGVYTRVSQFVPWL 270
S+G+ + P V+TRV FV W+
Sbjct: 199 SYGQ--TDGSAPQVFTRVLSFVSWI 221
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 94.4 bits (233), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 31/240 (12%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
V+GG + + L+A + F C G +++E WV+TAAHC + F++ G+ +
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHC----DNTNFQMKLGVHSK 56
Query: 106 FSFSPTEQVR-PVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ EQ R P + + + + D+ L++L + + + ++ + L + P
Sbjct: 57 KVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHI--VPLSLPSSPPSV 114
Query: 165 YSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIAD-----------VICAGMP 213
S C +GWG++ P + VP +D + +CAG+
Sbjct: 115 GSVCHIMGWGSI-----TPIKVTYPDVPYCAYINLLDDAVCQAGYPELLTEYRTLCAGIL 169
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWLMS 272
+GG+DTC GDSGGPL+C G++ G+VS G C + +PGVYT+V + W+ S
Sbjct: 170 EGGKDTCGGDSGGPLIC-----NGQF--QGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQS 222
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 71 CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAE 130
CGG ++ +V+TAAHC G E V G T+Q V + ++H +
Sbjct: 30 CGGFLISRQFVLTAAHC-KGRE---ITVILGAHDVRKRESTQQKIKVEKQIIHESYNSVP 85
Query: 131 MTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQ 190
+D+ LL+L + V + LP ++ P + C A GWG P +REV+
Sbjct: 86 NLHDIMLLKLEKKVELTPAVNVVPLPSPSDFIHPGAMCWAAGWGKTGVRDPTSYTLREVE 145
Query: 191 VPIL--PAC---KHYEDRIADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVV 245
+ I+ AC ++YE + +C G P R GDSGGPLLC G+V
Sbjct: 146 LRIMDEKACVDYRYYEYKFQ--VCVGSPTTLRAAFMGDSGGPLLCA-------GVAHGIV 196
Query: 246 SHGEGCARPNEPGVYTRVSQFVPWL 270
S+G A+P P ++TRVS +VPW+
Sbjct: 197 SYGHPDAKP--PAIFTRVSTYVPWI 219
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/244 (31%), Positives = 115/244 (47%), Gaps = 27/244 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRD---GFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
++GG+++ + P++ L G CGG ++ E +V+TAAHC V G
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGS----NINVTLGA 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
T+Q R + H + + + ND+ LLQL+ +R NR V P+ LP E
Sbjct: 57 HNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGL 116
Query: 163 EPYSTCTAVGWGAV-FEHGPDPDHMREVQVPI------LPACKHYEDRIADVICAGMPQG 215
P + CT GWG V G D +REVQ+ + L Y+ R IC G +
Sbjct: 117 RPGTLCTVAGWGRVSMRRGTDT--LREVQLRVQRDRQCLRIFGSYDPR--RQICVGDRRE 172
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSE 275
+ +GDSGGPLLC G+VS+G+ P P V+TRVS F+PW+ +
Sbjct: 173 RKAAFKGDSGGPLLCNN-------VAHGIVSYGKSSGVP--PEVFTRVSSFLPWIRTTMR 223
Query: 276 RAKV 279
K+
Sbjct: 224 SFKL 227
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 71 CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAE 130
CGG ++ + +V+TAAHC + V G + T+Q+ PV++ + H + +
Sbjct: 30 CGGFLVRDKFVLTAAHC----KGRSMTVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPDD 85
Query: 131 MTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQ 190
+ND+ LL+L + R VRP+ LP +P C GWG V G P + EV+
Sbjct: 86 RSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVK 145
Query: 191 VPILP--ACK-HYEDRI--ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVV 245
+ + C+ ++ A+ IC G + + + DSGGPL+C + AG+V
Sbjct: 146 LTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFEEDSGGPLVC-------KRAAAGIV 198
Query: 246 SHGEGCARPNEPGVYTRVSQFVPWL 270
S+G+ + P V+TRV FV W+
Sbjct: 199 SYGQ--TDGSAPQVFTRVLSFVSWI 221
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 113/238 (47%), Gaps = 27/238 (11%)
Query: 46 VVGGKKAELGAWPWLIALYRD---GFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM 102
++GG+++ + P++ L G CGG ++ E +V+TAAHC V G
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGS----NINVTLGA 56
Query: 103 LRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETP 162
T+Q R + H + + + ND+ LLQL+ +R NR V P+ LP E
Sbjct: 57 HNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGL 116
Query: 163 EPYSTCTAVGWGAV-FEHGPDPDHMREVQVPI------LPACKHYEDRIADVICAGMPQG 215
P + CT GWG V G D +REVQ+ + L Y+ R IC G +
Sbjct: 117 RPGTLCTVAGWGRVSMRRGTDT--LREVQLRVQRDRQCLRIFGSYDPR--RQICVGDRRE 172
Query: 216 GRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSN 273
+ +GDSGGPLLC G+VS+G+ P P V+TRVS F+PW+ +
Sbjct: 173 RKAAFKGDSGGPLLCNN-------VAHGIVSYGKSSGVP--PEVFTRVSSFLPWIRTT 221
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 20/234 (8%)
Query: 44 GRVVGGKKAELGAWPWL----IALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVY 99
G ++GG + + + P++ I CGG ++ ++V+TAAHC V
Sbjct: 1 GEIIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAG----RSITVT 56
Query: 100 AGMLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVT 159
G T Q V + H + + + +D+ LL+L V + P
Sbjct: 57 LGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQF 116
Query: 160 ETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYEDRIADV-ICAGMPQGG 216
P C GWG P D ++EV++ ++ AC H+ D ++ +C G P+
Sbjct: 117 NFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKT 176
Query: 217 RDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+ +GDSGGPLLC G+VS+G A+P P V+TR+S + PW+
Sbjct: 177 KSAFKGDSGGPLLCA-------GVAQGIVSYGRSDAKP--PAVFTRISHYRPWI 221
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 89.4 bits (220), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 71 CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAE 130
CGG ++ ++V+TAAHC V G T Q V + H + +
Sbjct: 30 CGGFLIRRNFVLTAAHCAG----RSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTST 85
Query: 131 MTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQ 190
+ +D+ LL+L V + P P C GWG P D ++EV+
Sbjct: 86 LHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVK 145
Query: 191 VPIL--PACKHYEDRIADV-ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSH 247
+ ++ AC H+ D ++ +C G P+ + +GDSGGPLLC G+VS+
Sbjct: 146 LRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQ-------GIVSY 198
Query: 248 GEGCARPNEPGVYTRVSQFVPWL 270
G A+P P V+TR+S + PW+
Sbjct: 199 GRSDAKP--PAVFTRISHYQPWI 219
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 89.0 bits (219), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 20/232 (8%)
Query: 46 VVGGKKAELGAWPWL----IALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
++GG +++ + P++ I CGG ++ ++V+TAAHC V G
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAG----RSITVTLG 56
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
T Q V + H + + + +D+ LL+L V + P
Sbjct: 57 AHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNF 116
Query: 162 PEPYSTCTAVGWGAVFEHGPDPDHMREVQVPIL--PACKHYEDRIADV-ICAGMPQGGRD 218
P C GWG P D ++EV++ ++ AC H+ D ++ +C G P+ +
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKS 176
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
+GDSGGPLLC G+VS+G A+P P V+TR+S + PW+
Sbjct: 177 AFKGDSGGPLLCA-------GVAQGIVSYGRSDAKP--PAVFTRISHYRPWI 219
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 57/150 (38%), Positives = 85/150 (56%), Gaps = 19/150 (12%)
Query: 130 EMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPD----PDH 185
+ ++DL LL+L +P + V+ + LP T+ PE STC A GWG++ E GPD PD
Sbjct: 5 DYSHDLMLLRLQSPAKITDAVKVLELP--TQEPELGSTCEASGWGSI-EPGPDDFEFPDE 61
Query: 186 MREVQVPILP----ACKHYEDRIADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYV 241
++ VQ+ +L A H + ++CAG GG+DTC GDSGGPL+C G W
Sbjct: 62 IQCVQLTLLQNTFCADAHPDKVTESMLCAGYLPGGKDTCMGDSGGPLIC-----NGMW-- 114
Query: 242 AGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
G+ S G C N+P +YT++ ++ W+
Sbjct: 115 QGITSWGHTPCGSANKPSIYTKLIFYLDWI 144
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 71 CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAE 130
CGG ++ ++V+TAAHC V G T Q V + H + +
Sbjct: 30 CGGFLIRRNFVLTAAHCAG----RSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTST 85
Query: 131 MTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQ 190
+ +D+ LL+L V + P P C GWG P D ++EV+
Sbjct: 86 LHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVK 145
Query: 191 VPIL--PACKHYEDRIADV-ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSH 247
+ ++ AC H+ D ++ +C G P+ + +GDSGGPLLC G+VS+
Sbjct: 146 LRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQ-------GIVSY 198
Query: 248 GEGCARPNEPGVYTRVSQFVPWL 270
G A+P P V+TR+S + PW+
Sbjct: 199 GRSDAKP--PAVFTRISHYQPWI 219
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 88.6 bits (218), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 71 CGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFKRAE 130
CGG ++ ++V+TAAHC V G T Q V + H + +
Sbjct: 30 CGGFLIRRNFVLTAAHCAG----RSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTST 85
Query: 131 MTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQ 190
+ +D+ LL+L V + P P C GWG P D ++EV+
Sbjct: 86 LHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVK 145
Query: 191 VPIL--PACKHYEDRIADV-ICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSH 247
+ ++ AC H+ D ++ +C G P+ + +GDSGGPLLC G+VS+
Sbjct: 146 LRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCA-------GVAQGIVSY 198
Query: 248 GEGCARPNEPGVYTRVSQFVPWL 270
G A+P P V+TR+S + PW+
Sbjct: 199 GRSDAKP--PAVFTRISHYRPWI 219
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 87.4 bits (215), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 4/130 (3%)
Query: 46 VVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
+V G++A G+WPW ++L + GF CGG +++E+WV+TAAHC G V AG
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC--GVTTSDV-VVAGEFD 57
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ S S Q ++++ +S + + ND+ LL+L+ +++ V +CLP ++
Sbjct: 58 QGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAA 117
Query: 165 YSTCTAVGWG 174
+TC GWG
Sbjct: 118 GTTCVTTGWG 127
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 45/127 (35%), Positives = 69/127 (54%), Gaps = 4/127 (3%)
Query: 49 GKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRRFS 107
G+ A G+WPW ++L + GF CGG ++ E WV+TAAHC K V AG + S
Sbjct: 1 GEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCG---VKTSDVVVAGEFDQGS 57
Query: 108 FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYST 167
QV ++++ + F + ND+ LL+LA P +++ V +CLP+V + P +
Sbjct: 58 DEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDDFPPGTV 117
Query: 168 CTAVGWG 174
C GWG
Sbjct: 118 CATTGWG 124
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 33/258 (12%)
Query: 45 RVVGGKKAELGAWPWLIAL-YRDGF----FHCGGVVLDESWVMTAAHCVDG--------F 91
+++ G +PW + Y++ F CGG +++ +++TAAHCV G
Sbjct: 22 KILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGRVLRVVGAL 81
Query: 92 EKHYFEVYAGMLRRFSFSPTEQVRP-------VSRIVMHSMF--KRAEMTNDLALLQLAA 142
K + + P + + H + + +D+AL++L
Sbjct: 82 NKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYHDIALIRLNR 141
Query: 143 PLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYED 202
+ + Y+RP+CLP E + T VGWG E G +++ VP++ A + +
Sbjct: 142 QVEFTNYIRPVCLPQPNEEVQVGQRLTVVGWGRT-ETGQYSTIKQKLAVPVVHAEQCAKT 200
Query: 203 ------RI-ADVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPN 255
R+ + +CAG + +D+C GDSGGPLL Q +++ G+VS G C
Sbjct: 201 FGAAGVRVRSSQLCAG-GEKAKDSCGGDSGGPLLAERANQQ--FFLEGLVSFGATCGTEG 257
Query: 256 EPGVYTRVSQFVPWLMSN 273
PG+YT+V ++ W+ N
Sbjct: 258 WPGIYTKVGKYRDWIEGN 275
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 4/130 (3%)
Query: 46 VVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
+V G+ A G+WPW ++L + GF CGG ++ E WV+TAAHC G + V AG
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHC--GVKTSDV-VVAGEFD 57
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEP 164
+ S QV ++++ + F + ND+ LL+LA P +++ V + LP+V + P
Sbjct: 58 QGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNVDDDFPP 117
Query: 165 YSTCTAVGWG 174
+ C GWG
Sbjct: 118 GTVCATTGWG 127
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG++A AWP++++L G CG ++ ++VM+AAHCV V G
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
PT QV V RI + + + ND+ +LQL N V+ LP
Sbjct: 61 SRREPTRQVFAVQRI-FENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNG 119
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIADVICAGMPQGGRDTCQGDSG 225
C A+GWG + + ++E+ V ++ + + +C + C GDSG
Sbjct: 120 VQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSN-----VCTLVRGRQAGVCFGDSG 174
Query: 226 GPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMS 272
PL+C + G+ S GCA P + V+QFV W+ S
Sbjct: 175 SPLVC-------NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 84.0 bits (206), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG++A AWP++++L G CG ++ ++VM+AAHCV V G
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
PT QV V RI + + + ND+ +LQL N V+ LP
Sbjct: 61 SRREPTRQVFAVQRI-FENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNG 119
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIADVICAGMPQGGRDTCQGDSG 225
C A+GWG + + ++E+ V ++ + + +C + C GDSG
Sbjct: 120 VQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSN-----VCTLVRGRQAGVCFGDSG 174
Query: 226 GPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMS 272
PL+C + G+ S GCA P + V+QFV W+ S
Sbjct: 175 SPLVC-------NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 14/228 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG++A AWP++++L G CG ++ ++VM+AAHCV V G
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
PT QV V RI + + ND+ +LQL N V+ LP
Sbjct: 61 SRREPTRQVFAVQRI-FEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNG 119
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIADVICAGMPQGGRDTCQGDSG 225
C A+GWG + + ++E+ V ++ + + +C + C GDSG
Sbjct: 120 VQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSN-----VCTLVRGRQAGVCFGDSG 174
Query: 226 GPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMS 272
PL+C + G+ S GCA P + V+QFV W+ S
Sbjct: 175 SPLVC-------NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 14/228 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG++A AWP++++L G CG ++ ++VM+AAHCV V G
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
PT QV V RI + + ND+ +LQL N V+ LP
Sbjct: 61 SRREPTRQVFAVQRI-FEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNG 119
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIADVICAGMPQGGRDTCQGDSG 225
C A+GWG + + ++E+ V ++ + + +C + C GDSG
Sbjct: 120 VQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSN-----VCTLVRGRQAGVCFGDSG 174
Query: 226 GPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMS 272
PL+C + G+ S GCA P + V+QFV W+ S
Sbjct: 175 SPLVC-------NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 71/237 (29%), Positives = 100/237 (42%), Gaps = 28/237 (11%)
Query: 46 VVGGKKAELGAWPWLIALY-RDGFFHCGGVVLDESWVMTAAHCVDGFEKHY--FEVYAGM 102
VVGG G PW ++L R G CGG ++ E W++TA C +EV+ G
Sbjct: 1 VVGGHP---GNSPWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYEVWLGT 57
Query: 103 LRRF--SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTE 160
L + P+ Q PV+++V + L LL+L + N+ V ICLP
Sbjct: 58 LFQNPQHGEPSLQRVPVAKMVC------GPSGSQLVLLKLERSVTLNQRVALICLPPEWY 111
Query: 161 TPEPYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIA-------DVICAGMP 213
P + C GWG G D + V +L + E I +C
Sbjct: 112 VVPPGTKCEIAGWGETKGTGND----TVLNVALLNVISNQECNIKHRGRVRESEMCTEGL 167
Query: 214 QGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
C+GD GGPL C + W + G++ CAR P V+TRVS FV W+
Sbjct: 168 LAPVGACEGDYGGPLAC---FTHNSWVLEGIIIPNRVCARSRWPAVFTRVSVFVDWI 221
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 14/228 (6%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG++A AWP++++L G CG ++ ++VM+AAHCV V G
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
PT QV V RI + + + ND+ +LQL N V+ LP
Sbjct: 61 SRREPTRQVFAVQRI-FENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNG 119
Query: 166 STCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIADVICAGMPQGGRDTCQGDSG 225
C A+GWG + + ++E+ V ++ + + +C + C GD G
Sbjct: 120 VQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSN-----VCTLVRGRQAGVCFGDXG 174
Query: 226 GPLLCPVPGSQGRWYVAGVVSHGE-GCARPNEPGVYTRVSQFVPWLMS 272
PL+C + G+ S GCA P + V+QFV W+ S
Sbjct: 175 SPLVC-------NGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 21/238 (8%)
Query: 46 VVGGKKAELGAWPWL----IALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
++ G +A G +P+ I L CGG ++D W++TAAHCV + VY G
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCV--HDAVSVVVYLG 58
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTET 161
++ E V RI+ HSMF ND+AL+++ + Y ++PI LP E
Sbjct: 59 SAVQYE---GEAVVNSERIISHSMFNPDTYLNDVALIKIPH-VEYTDNIQPIRLPSGEEL 114
Query: 162 PEPYST--CTAVGWGAVFEHGPDPDHMREVQVPILPACKHY-EDRIADVICAGMPQGGRD 218
+ T GWG + + + + Y I + G G+
Sbjct: 115 NNKFENIWATVSGWGQSNTDTVILQYTYNLVIDNDRCAQEYPPGIIVESTICGDTSDGKS 174
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSH--GEGCARPNEPGVYTRVSQFVPWLMSNS 274
C GDSGGP + + + GVVS G GC +P ++RV+ ++ W+ N+
Sbjct: 175 PCFGDSGGPFVL-----SDKNLLIGVVSFVSGAGC-ESGKPVGFSRVTSYMDWIQQNT 226
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 68/229 (29%), Positives = 95/229 (41%), Gaps = 20/229 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM--L 103
+VGG+KA +P+L ++ G CGG ++ +VMTAA C V G L
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 104 RRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE 163
RR + Q +S + + + + NDL LLQL V + LP T E
Sbjct: 61 RRRE-RQSRQTFSISSMSENG-YDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVE 118
Query: 164 PYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIA-DVICAGMPQGGRDTCQG 222
+ C GWG+ G R V V + P ED+ + +C G+ C G
Sbjct: 119 AGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTP-----EDQCRPNNVCTGVLTRRGGICNG 173
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
D G PL+C GV S G C R P +TRV+ F W+
Sbjct: 174 DGGTPLVC-------EGLAHGVASFSLGPCGR--GPDFFTRVALFRDWI 213
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 39/293 (13%)
Query: 7 GARNMAGNPMEARNMAGNPLGARNMATDMAGNPILGSGRVVGGKKAELGAWPWLIALYRD 66
G + N + G L NP+ R++GG G++PW +
Sbjct: 64 GVYTLDSNKQWTNKVTGEKLPECEAVCGKPKNPVDQVQRIMGGSLDAKGSFPWQAKMISH 123
Query: 67 GFFHCGGVVLDESWVMTAAHCVDGFEKHYFEV--YAGMLRRFSFSPTEQVRPVSRIVMHS 124
G +++E W++T A + K+ + A LR + +Q + +++ H
Sbjct: 124 HNLTSGATLINEQWLLTTAKNLRLGHKNDTKAKDIAPTLRLYVGK--KQEVEIEKVIFHP 181
Query: 125 MFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPYSTCTAVGWGAVFEHGPD-- 182
T D+ L++L + N V PICLP + Y VG+ + + +
Sbjct: 182 ----DNSTVDIGLIKLKQKVPVNERVMPICLPS-----KDYVNVGLVGYVSGWGRNANLN 232
Query: 183 -PDHMREVQVPILPACK---HYEDRIA------------------DVICAGMPQGGRDTC 220
+H++ V +P+ K +YE CAG+ + DTC
Sbjct: 233 FTEHLKYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTC 292
Query: 221 QGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSN 273
GD+G WY AG++S + C R E GVY RV+ + W+ +
Sbjct: 293 YGDAGSAFAVH-DKDDDTWYAAGILSFDKSC-RTAEYGVYVRVTSILDWIQTT 343
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 39/93 (41%), Positives = 59/93 (63%), Gaps = 11/93 (11%)
Query: 183 PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGR 238
P ++ ++ P+L +CK Y +I ++IC G QGG+D+CQGDSGGP++C
Sbjct: 7 PSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVC-------N 59
Query: 239 WYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLM 271
+ G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 60 GQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 75.1 bits (183), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 68/229 (29%), Positives = 95/229 (41%), Gaps = 20/229 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM--L 103
+VGG+KA +P+L ++ G CGG ++ +VMTAA C V G L
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 104 RRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE 163
RR + Q +S + + + + NDL LLQL V + LP T E
Sbjct: 61 RRRE-RQSRQTFSISSMSENG-YDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVE 118
Query: 164 PYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIA-DVICAGMPQGGRDTCQG 222
+ C GWG+ G R V V + P ED+ + +C G+ C G
Sbjct: 119 AGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTP-----EDQCRPNNVCTGVLTRRGGICNG 173
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
D G PL+C GV S G C R P +TRV+ F W+
Sbjct: 174 DQGTPLVC-------EGLAHGVASFSLGPCGR--GPDFFTRVALFRDWI 213
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 75.1 bits (183), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 68/229 (29%), Positives = 95/229 (41%), Gaps = 20/229 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGM--L 103
+VGG+KA +P+L ++ G CGG ++ +VMTAA C V G L
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 104 RRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE 163
RR + Q +S + + + + NDL LLQL V + LP T E
Sbjct: 61 RRRE-RQSRQTFSISSMSENG-YDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVE 118
Query: 164 PYSTCTAVGWGAVFEHGPDPDHMREVQVPILPACKHYEDRIA-DVICAGMPQGGRDTCQG 222
+ C GWG+ G R V V + P ED+ + +C G+ C G
Sbjct: 119 AGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTP-----EDQCRPNNVCTGVLTRRGGICNG 173
Query: 223 DSGGPLLCPVPGSQGRWYVAGVVSHGEG-CARPNEPGVYTRVSQFVPWL 270
D G PL+C GV S G C R P +TRV+ F W+
Sbjct: 174 DGGTPLVC-------EGLAHGVASFSLGPCGR--GPDFFTRVALFRDWI 213
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 38/93 (40%), Positives = 59/93 (63%), Gaps = 11/93 (11%)
Query: 183 PDHMREVQVPILP--ACKH-YEDRIA-DVICAGMPQGGRDTCQGDSGGPLLCPVPGSQGR 238
P ++ ++ P+L +CK Y +I ++IC G +GG+D+CQGDSGGP++C
Sbjct: 7 PSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVC-------N 59
Query: 239 WYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLM 271
+ G+VS G GCA+ N+PGVYT+V +V W+
Sbjct: 60 GQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 70.9 bits (172), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GGKK+++ PW + + D CGG +L ++V+TAA CVDG + ++ G R
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCVDGTKPSDISIHYGSSYR 60
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRY-NRYVRPICLPDVTETPEP 164
+ + + + + H + M N+ A+++ P++ ++ + I LP + PEP
Sbjct: 61 TTKGTSVMAKKIYIVRYHPL----TMQNNYAVIETEMPIKLDDKTTKKIELPSLLYDPEP 116
Query: 165 YSTCTAVGWGAV-FEHGPDPDHMREVQVPIL--PAC-KHYEDRIAD------VICAGMPQ 214
++ GWG+ F+ + E ++ +C + Y+ AD V CAG
Sbjct: 117 DTSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYIYDGVFCAGGEY 176
Query: 215 GGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPNE-PGVYTRVSQFV 267
GD+G P + G + GV S+ + P+E P V+ RV +V
Sbjct: 177 DETYIGYGDAGDPAV-----QNGT--LVGVASY--ISSMPSEFPSVFLRVGYYV 221
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 9/92 (9%)
Query: 183 PDHMREVQVPILPAC---KHYEDRIADVI-CAGMPQGGRDTCQGDSGGPLLCPVPGSQGR 238
P+ +++ +PI+ K + +I DV+ CAG G D+C GDSGGPL+C G
Sbjct: 6 PEKLQQAALPIVSEADCKKSWGSKITDVMTCAGAS--GVDSCMGDSGGPLVCQ---KDGV 60
Query: 239 WYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
W +AG+VS G G + PGVY+RV+ +PW+
Sbjct: 61 WTLAGIVSWGSGVCSTSTPGVYSRVTALMPWV 92
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 37/122 (30%), Positives = 64/122 (52%), Gaps = 10/122 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G AE+G PW + L+R CG ++ + WV+TAAHC+ F ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 98 VYAGMLRRFSFSPT-EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 156 PD 157
PD
Sbjct: 121 PD 122
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 183 PDHMREVQVPILPAC---KHYEDRIADVI-CAGMPQGGRDTCQGDSGGPLLCPVPGSQGR 238
P+ +++ +PI+ K + +I DV+ CAG G D+C GDSGGPL+C G
Sbjct: 6 PEKLQQAALPIVSEADCKKSWGSKITDVMTCAG--ASGVDSCMGDSGGPLVCQ---KDGV 60
Query: 239 WYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
W +AG+VS G G + P VY+RV+ +PW+
Sbjct: 61 WTLAGIVSWGSGVCSTSTPAVYSRVTALMPWV 92
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 10/122 (8%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV------DGFEKHYFE 97
+V G+ AE+G PW + L+R CG ++ + WV+TAAHC+ F
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 98 VYAGMLRRFSFS-PTEQVRPVSRIVMHSMFKRAE-MTNDLALLQLAAPLRYNRYVRPICL 155
V G R + E++ + +I +H + E + D+ALL+L P+ + Y+ P+CL
Sbjct: 61 VRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCL 120
Query: 156 PD 157
PD
Sbjct: 121 PD 122
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 183 PDHMREVQVPILPA--CKHY-EDRIAD-VICAGMPQGGRDTCQGDSGGPLLCPVPGSQGR 238
PD +++ +P+L CK Y +I D +ICAG G +C GDSGGPL+C G
Sbjct: 4 PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCK---KNGA 58
Query: 239 WYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
W + G+VS G + PGVY RV+ V W+
Sbjct: 59 WTLVGIVSWGSSTCSTSTPGVYARVTALVNWV 90
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 183 PDHMREVQVPILPA--CKHYE-DRIAD-VICAGMPQGGRDTCQGDSGGPLLCPVPGSQGR 238
PD +++ +P+L CK Y +I D +ICAG G +C GDSGGPL+C G
Sbjct: 3 PDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGAS--GVSSCMGDSGGPLVCK---KNGA 57
Query: 239 WYVAGVVSHGEGCARPNEPGVYTRVSQFVPWL 270
W + G+VS G + PGVY RV+ V W+
Sbjct: 58 WTLVGIVSWGSSTCSTSTPGVYARVTALVNWV 89
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 23/235 (9%)
Query: 48 GGKKAELGAWPWLIALYR---DGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLR 104
GG+K ++ PW +A+ + CGG +L + +V+TAAHCV F++ +
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCV--FDQKPETIVIQYES 59
Query: 105 RFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYN-RYVRPICLPDVTETPE 163
+ + P V S +++ M ND+A+L+L+ PL+ + +P LPD+ P+
Sbjct: 60 TNLWEDPGKSDPYVSHVYLSFYRQETMENDIAILELSRPLKLDGLKSKPAKLPDIEFRPK 119
Query: 164 PYSTCTAVGWGAVFEHGPDPDHMREVQVPI--LPACKHYEDRI---ADVICAGMPQGGRD 218
S G+G P ++ Q+ + L C+ I V CA + G
Sbjct: 120 TGSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDLDECRTKYGPIFLSLQVFCAQ--KVGVS 177
Query: 219 TCQGDSGGPLLCPVPGSQGRWYVAGVVSHGEGCARPN-EPGVYTRVSQFVPWLMS 272
GD+G P + + + GV ++ RP P V+T+V +V W+
Sbjct: 178 LESGDAGDPTV-------QQDTLVGVAAYFP--KRPEGAPEVFTKVGSYVSWIQD 223
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 40/97 (41%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 183 PDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGS 235
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P +
Sbjct: 3 PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 62
Query: 236 QGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
RWY G+VS GEGC R + G YT V + W+
Sbjct: 63 N-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 61.6 bits (148), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 40/97 (41%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 183 PDHMREVQVPIL--PACKHYED-RIAD-VICAGM-PQGGR--DTCQGDSGGPLLCPVPGS 235
P ++ V +PI+ P CK RI D + CAG P G+ D C+GDSGGP + P +
Sbjct: 3 PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 62
Query: 236 QGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMS 272
RWY G+VS GEGC R + G YT V + W+
Sbjct: 63 N-RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 40/101 (39%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 183 PDHMREVQVPIL--PACK-HYEDRIAD-VICAGMP--QGGR-DTCQGDSGGPLLCPVPGS 235
P ++ V +P++ P CK RI D + CAG +G R D C+GDSGGP + P
Sbjct: 7 PSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSP-Y 65
Query: 236 QGRWYVAGVVSHGEGCARPNEPGVYTRVSQFVPWLMSNSER 276
RWY G+VS GEGC R + G YT V + W+ +R
Sbjct: 66 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDR 106
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 60.5 bits (145), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 36/129 (27%), Positives = 58/129 (44%), Gaps = 7/129 (5%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
+VGG + P+ ++L F CGG +++ WV++AAHC K +V G
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY----KSRIQVRLGEHNI 55
Query: 106 FSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPEPY 165
EQ ++I+ H F + ND+ L++L++P N V + LP
Sbjct: 56 DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR--SCAAAG 113
Query: 166 STCTAVGWG 174
+ C GWG
Sbjct: 114 TECLISGWG 122
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 72/268 (26%), Positives = 108/268 (40%), Gaps = 64/268 (23%)
Query: 57 WPWLIALYR--DGFFHCGGVVLDESWVMTAAHC--VDGFEKHYFEVYAGMLRR------F 106
W I++ R G C G V+ E +V+TAAHC VD E H +V G +R
Sbjct: 236 WQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKE-HSIKVSVGGEKRDLEIEVV 294
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE--- 163
F P + + + D+AL++L L+Y + +RPICLP T
Sbjct: 295 LFHPNYNINGKKEAGIPEFYDY-----DVALIKLKNKLKYGQTIRPICLPCTEGTTRALR 349
Query: 164 --PYSTCT--------AVGWGAVFEHGPDPDHMREVQVPILPACK--------HYE---D 202
P +TC A A+F + R+ +V I K Y D
Sbjct: 350 LPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRK-EVYIKNGDKKGSCERDAQYAPGYD 408
Query: 203 RIADV--------ICAG--MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG---- 248
++ D+ +C G P +TC+GDSGGPL+ + R+ GV+S G
Sbjct: 409 KVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIV---HKRSRFIQVGVISWGVVDV 465
Query: 249 -EGCARPNEPGVYTR-----VSQFVPWL 270
+ R + + R + Q +PWL
Sbjct: 466 CKNQKRQKQVPAHARDFHINLFQVLPWL 493
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 72/268 (26%), Positives = 108/268 (40%), Gaps = 64/268 (23%)
Query: 57 WPWLIALYR--DGFFHCGGVVLDESWVMTAAHC--VDGFEKHYFEVYAGMLRR------F 106
W I++ R G C G V+ E +V+TAAHC VD E H +V G +R
Sbjct: 228 WQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKE-HSIKVSVGGEKRDLEIEVV 286
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE--- 163
F P + + + D+AL++L L+Y + +RPICLP T
Sbjct: 287 LFHPNYNINGKKEAGIPEFYDY-----DVALIKLKNKLKYGQTIRPICLPCTEGTTRALR 341
Query: 164 --PYSTCT--------AVGWGAVFEHGPDPDHMREVQVPILPACK--------HYE---D 202
P +TC A A+F + R+ +V I K Y D
Sbjct: 342 LPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRK-EVYIKNGDKKGSCERDAQYAPGYD 400
Query: 203 RIADV--------ICAG--MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG---- 248
++ D+ +C G P +TC+GDSGGPL+ + R+ GV+S G
Sbjct: 401 KVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIV---HKRSRFIQVGVISWGVVDV 457
Query: 249 -EGCARPNEPGVYTR-----VSQFVPWL 270
+ R + + R + Q +PWL
Sbjct: 458 CKNQKRQKQVPAHARDFHINLFQVLPWL 485
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 69/267 (25%), Positives = 106/267 (39%), Gaps = 62/267 (23%)
Query: 57 WPWLIALYR--DGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAGMLRR------FS 107
W I++ R G C G V+ E +V+TAAHC +K H +V G +R
Sbjct: 480 WQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVL 539
Query: 108 FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE---- 163
F P + + + D+AL++L L+Y + +RPICLP T
Sbjct: 540 FHPNYNINGKKEAGIPEFYDY-----DVALIKLKNKLKYGQTIRPICLPCTEGTTRALRL 594
Query: 164 -PYSTCT--------AVGWGAVFEHGPDPDHMREVQVPILPACKHYE-----------DR 203
P +TC A A+F + R+ +V I K D+
Sbjct: 595 PPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRK-EVYIKNGDKKGSCERDAQYAPGYDK 653
Query: 204 IADV--------ICAG--MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG----- 248
+ D+ +C G P +TC+GDSGGPL+ + R+ GV+S G
Sbjct: 654 VKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIV---HKRSRFIQVGVISWGVVDVC 710
Query: 249 EGCARPNEPGVYTR-----VSQFVPWL 270
+ R + + R + Q +PWL
Sbjct: 711 KNQKRQKQVPAHARDFHINLFQVLPWL 737
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 55.5 bits (132), Expect = 4e-08, Method: Composition-based stats.
Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAGMLRR 105
++GG++ E + PW +A+Y F CGGV+++ WV+TAAHC + +EV+ G
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHC----KNDNYEVWLGRHNL 56
Query: 106 FSFSPTEQVRPVSRIVMHSMF 126
F T Q V+ H F
Sbjct: 57 FENENTAQFFGVTADFPHPGF 77
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 69/267 (25%), Positives = 106/267 (39%), Gaps = 62/267 (23%)
Query: 57 WPWLIALYR--DGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAGMLRR------FS 107
W I++ R G C G V+ E +V+TAAHC +K H +V G +R
Sbjct: 461 WQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVL 520
Query: 108 FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE---- 163
F P + + + D+AL++L L+Y + +RPICLP T
Sbjct: 521 FHPNYNINGKKEAGIPEFYDY-----DVALIKLKNKLKYGQTIRPICLPCTEGTTRALRL 575
Query: 164 -PYSTCT--------AVGWGAVFEHGPDPDHMREVQVPILPACKHYE-----------DR 203
P +TC A A+F + R+ +V I K D+
Sbjct: 576 PPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRK-EVYIKNGDKKGSCERDAQYAPGYDK 634
Query: 204 IADV--------ICAG--MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG----- 248
+ D+ +C G P +TC+GDSGGPL+ + R+ GV+S G
Sbjct: 635 VKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIV---HKRSRFIQVGVISWGVVDVC 691
Query: 249 EGCARPNEPGVYTR-----VSQFVPWL 270
+ R + + R + Q +PWL
Sbjct: 692 KNQKRQKQVPAHARDFHINLFQVLPWL 718
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 69/267 (25%), Positives = 106/267 (39%), Gaps = 62/267 (23%)
Query: 57 WPWLIALYR--DGFFHCGGVVLDESWVMTAAHCVDGFEK-HYFEVYAGMLRR------FS 107
W I++ R G C G V+ E +V+TAAHC +K H +V G +R
Sbjct: 470 WQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVL 529
Query: 108 FSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE---- 163
F P + + + D+AL++L L+Y + +RPICLP T
Sbjct: 530 FHPNYNINGKKEAGIPEFYDY-----DVALIKLKNKLKYGQTIRPICLPCTEGTTRALRL 584
Query: 164 -PYSTCT--------AVGWGAVFEHGPDPDHMREVQVPILPACKHYE-----------DR 203
P +TC A A+F + R+ +V I K D+
Sbjct: 585 PPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRK-EVYIKNGDKKGSCERDAQYAPGYDK 643
Query: 204 IADV--------ICAG--MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG----- 248
+ D+ +C G P +TC+GDSGGPL+ + R+ GV+S G
Sbjct: 644 VKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIV---HKRSRFIQVGVISWGVVDVC 700
Query: 249 EGCARPNEPGVYTR-----VSQFVPWL 270
+ R + + R + Q +PWL
Sbjct: 701 KNQKRQKQVPAHARDFHINLFQVLPWL 727
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 71/268 (26%), Positives = 107/268 (39%), Gaps = 64/268 (23%)
Query: 57 WPWLIALYR--DGFFHCGGVVLDESWVMTAAHC--VDGFEKHYFEVYAGMLRR------F 106
W I++ R G C G V+ E +V+TAAHC VD E H +V G +R
Sbjct: 29 WQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKE-HSIKVSVGGEKRDLEIEVV 87
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPDVTETPE--- 163
F P + + + D+AL++L L+Y + +RPICLP T
Sbjct: 88 LFHPNYNINGKKEAGIPEFY-----DYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALR 142
Query: 164 --PYSTCT--------AVGWGAVFEHGPDPDHMREVQVPILPACKHYE-----------D 202
P +TC A A+F + R+ +V I K D
Sbjct: 143 LPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRK-EVYIKNGDKKGSCERDAQYAPGYD 201
Query: 203 RIADV--------ICAG--MPQGGRDTCQGDSGGPLLCPVPGSQGRWYVAGVVSHG---- 248
++ D+ +C G P +TC+GDSGGPL+ + R+ GV+S G
Sbjct: 202 KVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIV---HKRSRFIQVGVISWGVVDV 258
Query: 249 -EGCARPNEPGVYTR-----VSQFVPWL 270
+ R + + R + Q +PWL
Sbjct: 259 CKNQKRQKQVPAHARDFHINLFQVLPWL 286
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 16/110 (14%)
Query: 58 PWLIALYRDGFFHCGGVVLDESWVMTAAHCV-DGFEKHYFEVYAG----------MLRRF 106
PW + + C G ++ + WV+TAAHC DG + + V G ++ +
Sbjct: 244 PWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKA 303
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP 156
SP V + + +D+ALL+LA ++ + + RPICLP
Sbjct: 304 VISPGFDVFAKKNQGILEFY-----GDDIALLKLAQKVKMSTHARPICLP 348
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 16/110 (14%)
Query: 58 PWLIALYRDGFFHCGGVVLDESWVMTAAHCV-DGFEKHYFEVYAG----------MLRRF 106
PW + + C G ++ + WV+TAAHC DG + + V G ++ +
Sbjct: 236 PWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKA 295
Query: 107 SFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLP 156
SP V + + +D+ALL+LA ++ + + RPICLP
Sbjct: 296 VISPGFDVFAKKNQGILEFY-----GDDIALLKLAQKVKMSTHARPICLP 340
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 7/116 (6%)
Query: 44 GRVVGGKKA-ELGAWPWLIALYR-DGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
G + K+A +L PW + L +G CGGV++ E++V+T A C + Y
Sbjct: 91 GVLTSEKRAPDLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSLLHRNITVKTY-- 148
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
R S P + ++ + +H + NDL+LL+L P++ P+C P+
Sbjct: 149 -FNRTSQDPL--MIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPE 201
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 7/116 (6%)
Query: 44 GRVVGGKKA-ELGAWPWLIALYR-DGFFHCGGVVLDESWVMTAAHCVDGFEKHYFEVYAG 101
G + K+A +L PW + L +G CGGV++ E++V+T A C + Y
Sbjct: 50 GVLTSEKRAPDLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSLLHRNITVKTY-- 107
Query: 102 MLRRFSFSPTEQVRPVSRIVMHSMFKRAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
R S P + ++ + +H + NDL+LL+L P++ P+C P+
Sbjct: 108 -FNRTSQDPL--MIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPE 160
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 42.4 bits (98), Expect = 3e-04, Method: Composition-based stats.
Identities = 18/45 (40%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 46 VVGGKKAELGAWPWLIALYRDG--FFHCGGVVLDESWVMTAAHCV 88
+V G AE+G PW + L+R CG ++ + WV+TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 41.2 bits (95), Expect = 7e-04, Method: Composition-based stats.
Identities = 15/47 (31%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 112 EQVRPVSRIVMHSMFK-RAEMTNDLALLQLAAPLRYNRYVRPICLPD 157
E++ + +I +H + R + D+AL++L P+ ++ Y+ P+CLPD
Sbjct: 3 EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPD 49
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 34.7 bits (78), Expect = 0.059, Method: Composition-based stats.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 46 VVGGKKAELGAWPWLIALYRDGFFHCGGVVLDESWVMTAAHC 87
+VGG + P+ ++L F CGG +++ WV++AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHC 41
>pdb|3PK1|A Chain A, Crystal Structure Of Mcl-1 In Complex With The Baxbh3
Domain
pdb|3PK1|C Chain C, Crystal Structure Of Mcl-1 In Complex With The Baxbh3
Domain
Length = 189
Score = 32.0 bits (71), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 10/35 (28%), Positives = 22/35 (62%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMH 123
DG ++++ + GMLR+ + V+ +SR+++H
Sbjct: 81 DGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIH 115
>pdb|3D7V|A Chain A, Crystal Structure Of Mcl-1 In Complex With An Mcl-1
Selective Bh3 Ligand
pdb|3IO9|A Chain A, Biml12y In Complex With Mcl-1
Length = 162
Score = 31.6 bits (70), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 10/35 (28%), Positives = 22/35 (62%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMH 123
DG ++++ + GMLR+ + V+ +SR+++H
Sbjct: 53 DGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIH 87
>pdb|2NLA|A Chain A, Crystal Structure Of The Mcl-1:mnoxab Bh3 Complex
Length = 157
Score = 31.6 bits (70), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 10/35 (28%), Positives = 22/35 (62%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMH 123
DG ++++ + GMLR+ + V+ +SR+++H
Sbjct: 48 DGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIH 82
>pdb|2PQK|A Chain A, X-Ray Crystal Structure Of Human Mcl-1 In Complex With Bim
Bh3
pdb|3KJ0|A Chain A, Mcl-1 In Complex With Bim Bh3 Mutant I2dy
pdb|3KJ1|A Chain A, Mcl-1 In Complex With Bim Bh3 Mutant I2da
pdb|3KJ2|A Chain A, Mcl-1 In Complex With Bim Bh3 Mutant F4ae
pdb|3KZ0|A Chain A, Mcl-1 Complex With Mcl-1-Specific Selected Peptide
pdb|3KZ0|B Chain B, Mcl-1 Complex With Mcl-1-Specific Selected Peptide
pdb|3MK8|A Chain A, The Mcl-1 Bh3 Helix Is An Exclusive Mcl-1 Inhibitor And
Apoptosis Sensitizer
Length = 158
Score = 31.6 bits (70), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 10/35 (28%), Positives = 22/35 (62%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMH 123
DG ++++ + GMLR+ + V+ +SR+++H
Sbjct: 49 DGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIH 83
>pdb|4HW4|A Chain A, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW4|B Chain B, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
Length = 157
Score = 31.6 bits (70), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 10/35 (28%), Positives = 22/35 (62%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMH 123
DG ++++ + GMLR+ + V+ +SR+++H
Sbjct: 48 DGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIH 82
>pdb|4HW2|A Chain A, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW2|B Chain B, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW2|C Chain C, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW2|D Chain D, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW2|E Chain E, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW2|F Chain F, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|A Chain A, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|B Chain B, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|C Chain C, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|D Chain D, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|E Chain E, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|F Chain F, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|G Chain G, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|H Chain H, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|I Chain I, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|J Chain J, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|K Chain K, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
pdb|4HW3|L Chain L, Discovery Of Potent Mcl-1 Inhibitors Using Fragment-Based
Methods And Structure-Based Design
Length = 153
Score = 31.2 bits (69), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 10/35 (28%), Positives = 22/35 (62%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMH 123
DG ++++ + GMLR+ + V+ +SR+++H
Sbjct: 48 DGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIH 82
>pdb|2KBW|A Chain A, Solution Structure Of Human Mcl-1 Complexed With Human
Bid_bh3 Peptide
Length = 164
Score = 31.2 bits (69), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 10/35 (28%), Positives = 22/35 (62%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMH 123
DG ++++ + GMLR+ + V+ +SR+++H
Sbjct: 56 DGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIH 90
>pdb|3LW2|A Chain A, Mouse Plasminogen Activator Inhibitor-1 (Pai-1)
Length = 379
Score = 30.8 bits (68), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 12/41 (29%), Positives = 22/41 (53%)
Query: 77 DESWVMTAAHCVDGFEKHYFEVYAGMLRRFSFSPTEQVRPV 117
D +V V GF H+F+++ M+++ FS E+ R +
Sbjct: 95 DAIFVQRDLELVQGFMPHFFKLFQTMVKQVDFSEVERARFI 135
>pdb|1WSX|A Chain A, Solution Structure Of Mcl-1
pdb|2JM6|B Chain B, Solution Structure Of Mcl-1 Complexed With Noxab
pdb|2ROC|A Chain A, Solution Structure Of Mcl-1 Complexed With Puma
pdb|2ROD|A Chain A, Solution Structure Of Mcl-1 Complexed With Noxaa
Length = 162
Score = 28.5 bits (62), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 12/39 (30%), Positives = 23/39 (58%), Gaps = 1/39 (2%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFK 127
DG ++++ + GMLR+ V+ SR+++H +FK
Sbjct: 53 DGVQRNHETAFQGMLRKLDIKNEGDVKSFSRVMVH-VFK 90
>pdb|4G35|A Chain A, Mcl-1 In Complex With A Biphenyl Cross-Linked Noxa Peptide
Length = 165
Score = 28.1 bits (61), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 12/39 (30%), Positives = 23/39 (58%), Gaps = 1/39 (2%)
Query: 89 DGFEKHYFEVYAGMLRRFSFSPTEQVRPVSRIVMHSMFK 127
DG ++++ + GMLR+ V+ SR+++H +FK
Sbjct: 56 DGVQRNHETAFQGMLRKLDIKNEGDVKSFSRVMVH-VFK 93
>pdb|2PUK|A Chain A, Crystal Srtucture Of The Binary Complex Between
Ferredoxin: Thioredoxin Reductase And Thioredoxin M
pdb|2PUK|E Chain E, Crystal Srtucture Of The Binary Complex Between
Ferredoxin: Thioredoxin Reductase And Thioredoxin M
pdb|2PUO|A Chain A, Crystal Srtucture Of The Nem Modified
Ferredoxin:thioredoxin Reductase
Length = 109
Score = 27.7 bits (60), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 21/42 (50%), Gaps = 6/42 (14%)
Query: 185 HMREVQVPILPACKHYEDRIADVI-----CAGMPQGGRDTCQ 221
H E+ P+ P C+HYED+ A+V C +P R C
Sbjct: 40 HKEELGSPLCP-CRHYEDKEAEVKNTFWNCPCVPMRERKECH 80
>pdb|1DJ7|A Chain A, Crystal Structure Of Ferredoxin Thioredoxin Reductase
Length = 117
Score = 27.7 bits (60), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 21/42 (50%), Gaps = 6/42 (14%)
Query: 185 HMREVQVPILPACKHYEDRIADVI-----CAGMPQGGRDTCQ 221
H E+ P+ P C+HYED+ A+V C +P R C
Sbjct: 46 HKEELGSPLCP-CRHYEDKEAEVKNTFWNCPCVPMRERKECH 86
>pdb|2PVG|A Chain A, Crystal Srtucture Of The Binary Complex Between Ferredoxin
And Ferredoxin:thioredoxin Reductase
Length = 108
Score = 27.3 bits (59), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 21/42 (50%), Gaps = 6/42 (14%)
Query: 185 HMREVQVPILPACKHYEDRIADVI-----CAGMPQGGRDTCQ 221
H E+ P+ P C+HYED+ A+V C +P R C
Sbjct: 39 HKEELGSPLCP-CRHYEDKEAEVKNTFWNCPCVPMRERKECH 79
>pdb|2PU9|A Chain A, Crystal Srtucture Of The Binary Complex Between
Ferredoxin: Thioredoxin Reductase And Thioredoxin F
pdb|2PVO|A Chain A, Crystal Srtucture Of The Ternary Complex Between
Thioredoxin F, Ferredoxin, And Ferredoxin: Thioredoxin
Reductase
Length = 110
Score = 27.3 bits (59), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 21/42 (50%), Gaps = 6/42 (14%)
Query: 185 HMREVQVPILPACKHYEDRIADVI-----CAGMPQGGRDTCQ 221
H E+ P+ P C+HYED+ A+V C +P R C
Sbjct: 39 HKEELGSPLCP-CRHYEDKEAEVKNTFWNCPCVPMRERKECH 79
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.138 0.455
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,741,055
Number of Sequences: 62578
Number of extensions: 441862
Number of successful extensions: 2215
Number of sequences better than 100.0: 386
Number of HSP's better than 100.0 without gapping: 374
Number of HSP's successfully gapped in prelim test: 12
Number of HSP's that attempted gapping in prelim test: 700
Number of HSP's gapped (non-prelim): 401
length of query: 286
length of database: 14,973,337
effective HSP length: 98
effective length of query: 188
effective length of database: 8,840,693
effective search space: 1662050284
effective search space used: 1662050284
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 51 (24.3 bits)